[{"topic":"Diseases","id":"44215","proposer":"12005","edm":"83","session":"2012-13","title":"Gluten-Free Prescriptions","text":"That this House recognises that people with coeliac disease, for whom the only treatment is a strict gluten-free diet for life, must have access to gluten-free prescriptions to maintain their health as recommended by all healthcare professional guidelines; notes that without access to prescriptions the most vulnerable people, those on low incomes, the elderly and those with mobility problems, will suffer most as confirmed by independent research; and considers that the potential health risk to patients, including osteoporosis, infertility and cancer of the small bowel, may cost the NHS more in the long run.","date":"2012-05-17","status":"o"},{"topic":"Diseases","id":"44217","proposer":"12005","edm":"85","session":"2012-13","title":"Gluten-Free Challenge Campaign","text":"That this House recognises that people with coeliac disease have an autoimmune disease for which the only treatment is a lifelong adherence to a gluten-free diet; considers that for many of those diagnosed, eating out is a continuous challenge; urges those in the hospitality industry to reap the benefits of this market by providing safe, gluten-free options on menus; and commends and supports Coeliac UK for its Gluten-free Challenge campaign which aims to make eating out possible for all people with the condition, to significantly improve their quality of life and create understanding of coeliac disease.","date":"2012-05-17","status":"o"},{"topic":"Diseases","id":"44194","proposer":"11589","edm":"62","session":"2012-13","title":"Group B Streptococcus","text":"That this House is concerned that the reported incidence of Group B streptococcus (GBS) infection in newborn babies in England, Wales and Northern Ireland increased by 32 per cent between 2003 and 2010; recognises that GBS is the most common cause of life-threatening infection in newborn babies in the UK; notes that without preventative action one in 1,000 newborn babies per year will develop GBS infection, of whom approximately 75 will die and 40 will survive with long-term problems; welcomes the current review of the benefits of a national screening programme being undertaken by the UK National Screening Committee; and further notes that where screening programmes have been introduced, including in the United States, Spain, Australia and France, reported cases of GBS infection in newborn babies have fallen by 86 per cent, 86 per cent, 82 per cent and 71 per cent respectively.","date":"2012-05-15","status":"o"},{"topic":"Diseases","id":"44196","proposer":"10258","edm":"64","session":"2012-13","title":"Group B Streptococcus (No. 2)","text":"That this House notes that Group B streptococcus (GBS) is the most common cause of life-threatening infection in newborn babies in the UK and Ireland, affecting one in 2000 babies born every year; congratulates Group B Strep Support, the UK's only charity focused on GBS infection in newborn babies, on its continued work to raise awareness of the infection, testing and prevention; recognises that a small but growing number of NHS trusts have introduced ECM testing which is twice as effective as traditional HVS testing; is concerned that prevalence of deaths relating to GBS has been steadily rising since 2003; urges the Department of Health to ensure ECM testing is available urgently; and further supports both the efficacy of screening and the need for a vaccine made available on the NHS.","date":"2012-05-15","status":"o"},{"topic":"Diseases","id":"44140","proposer":"10521","edm":"8","session":"2012-13","title":"Cystic Fibrosis Week 2012","text":"That this House welcomes Cystic Fibrosis Week which took place from 29 April to 5 May 2012; notes that Cystic Fibrosis Week provided a valuable opportunity to increase awareness and knowledge of cystic fibrosis and campaign for improvements in care and support for the 9,000 people with the condition in the UK; acknowledges that cystic fibrosis is one of the UK's most common life-threatening inherited diseases; further welcomes the latest figures which show that the median age of survival has increased to 41 years; acknowledges concerns that cystic fibrosis services are struggling because of the increased patient population, cutbacks in posts vital to cystic fibrosis care and cuts in beds suitable for accommodating people with cystic fibrosis; and calls on the Government to ensure cystic fibrosis services are adequately resourced with extra bed capacity suitable for people with cystic fibrosis.","date":"2012-05-09","status":"o"},{"topic":"Diseases","id":"44151","proposer":"10527","edm":"19","session":"2012-13","title":"Type 1 Diabetes Research","text":"That this House supports the Juvenile Diabetes Research Foundation (JDRF) in its campaign to increase awareness and understanding about type 1 diabetes; notes that type 1 and type 2 diabetes are separate and distinct conditions; acknowledges that type 1 diabetes is a chronic, life-threatening auto immune condition and is not caused by eating sugary food, by being overweight or by lifestyle choices; further notes with concern that type 1 is a leading cause of kidney failure, adult blindness, stroke, heart attacks and nerve damage and that incidence of the condition is increasing by four per cent year on year; further notes that approximately five per cent of the entire NHS budget is spent on treating type 1 diabetes; recognises that JDRF is the world's leading charitable funder of type 1 diabetes research and the only organisation dedicated solely to finding the cure for type 1; and believes that more funding for medical research will lead to the development of better treatments for type 1 diabetes, resulting in fewer complications and hospitalisations, improved cost efficiencies for the NHS budget and lead to a cure.","date":"2012-05-09","status":"o"},{"topic":"Diseases","id":"44154","proposer":"10527","edm":"22","session":"2012-13","title":"National Implementation Plan For Diabetes","text":"That this House notes there are 3.7 million people in the UK with diabetes, including an estimated 850,000 who have not been diagnosed, and a further sevenmillion are at high risk, and that every year diabetes results in around 24,000 excess deaths; further notes with concern that in 2011 diabetes cost the NHS an estimated 1 million an hour and currently accounts for 10 per cent of the total NHS budget, and that 80 per cent of this spend is on dealing with the serious but avoidable complications of diabetes; further notes that there are wide variations in the number of people with diabetes who receive the nine tests recommended by the National Institute of Health and Clinical Excellence (NICE) which are essential for the successful management of the condition and reduction of its complications; is deeply concerned by Diabetes UK's State of the Nation 2012 report that shows the number of people who received all nine of their recommended annual checks varies widely between 6 per cent and 69 per cent; and therefore calls on Her Majesty's Government to create a national implementation plan for diabetes to deliver the already agreed NICE quality standard and the National Service Framework outcomes in order to save costs and improve lives.","date":"2012-05-09","status":"o"},{"topic":"Diseases","id":"44155","proposer":"10527","edm":"23","session":"2012-13","title":"Avoidable Deaths From Diabetes","text":"That this House notes with alarm that up to 24,000 people with diabetes die in England each year from causes that could have been avoided; further notes that there is no reason why people with diabetes cannot live long and healthy lives if they receive the right care and support to help them manage their condition; recognises Diabetes UK's 15 healthcare essentials campaign which outlines 15 diabetes checks or services that every person with diabetes should receive or have access to; further notes that half of people with type 2 and more than two-thirds of people with type 1 diabetes are not receiving the care they need to stay healthy; and calls on the Government to place a greater emphasis on prioritising diabetes in the Health Outcomes and Commissioning Frameworks to improve standards of care so that the 2.3 million people with diabetes in England receive the care they need to stay healthy.","date":"2012-05-09","status":"o"},{"topic":"Diseases","id":"44161","proposer":"13934","edm":"29","session":"2012-13","title":"International Thalassaemia Day 2012","text":"That this House celebrates International Thalassaemia Day on 8 May 2012; recognises the importance of the day in raising global awareness of thalassaemia; agrees with the key theme that thalassaemia patients and affected communities should have access to approproprate information on this condition; notes that although thalassaemia is a serious, lifelong medical condition, with modern medical treatment it is manageable; welcomes the improvements that have been made in the UK in the treatment of and screening for thalassaemia; but expresses concern that access to screening and the care received by patients is still variable; and calls on the Government to continue improving services and the availability of information for patients with this rare condition.","date":"2012-05-09","status":"o"},{"topic":"Diseases","id":"44127","proposer":"10614","edm":"3019","session":"2010-12","title":"European Diabetes Leadership Forum","text":"That this House congratulates the OECD and Danish Diabetes Association on their hosting of the European Diabetes Leadership Forum in Copenhagen; welcomes the Copenhagen Road Map containing practical solutions for Europe to address the diabetes epidemic, produced by the forum attendees, which included governmental figures, private sector organisations and diabetes specialists; and urges the Government to build on the momentum of Denmark's commitment to addressing diabetes and chronic diseases during its European presidency, and to follow best practice outlined in the Copenhagen Road Map to tackle this problem which costs the NHS 1 million an hour.","date":"2012-04-30","status":"o"},{"topic":"Diseases","id":"44129","proposer":"11672","edm":"3021","session":"2010-12","title":"Jane Tomlinson Appeal And Anniversary Challenge","text":"That this House applauds the contribution of the Jane Tomlinson Appeal, established by the late Jane Tomlinson CBE and now continued by Jane's husband Mike and family, which continues to raise millions of pounds for children's and cancer charities including Cancer Research UK, Macmillan Cancer Support and children's hospices, Martin House and Hannah House; congratulates all those who took part in the Jane Tomlinson Appeal 10th Anniversary Challenge, taking on an eight day challenge in which they completed the Paris Marathon and a six day cycle route to London ahead of the London Marathon via Hull and the Jane Tomlinson Appeal's home turf of Yorkshire, raising many thousands of pounds for the Appeal and associated charities; notes that the challenge marked 10 years since Jane became the first terminally-ill breast cancer patient to complete the London Marathon; appreciates the dedication and innovation of the Jane Tomlinson Appeal and the many other charities working to fund and promote research into cancer and cancer treatments, often in memory of loved ones lost to the diseaseor inrecognition of having battled and survived cancer; and supports and encourages all efforts to help tackle this disease through charitable means.","date":"2012-04-30","status":"o"},{"topic":"Diseases","id":"44121","proposer":"10521","edm":"3013","session":"2010-12","title":"Cystic Fibrosis Week 2012","text":"That this House welcomes Cystic Fibrosis Week which takes place from 29 April to 5 May 2012; notes that Cystic Fibrosis Week provides a valuable opportunity to increase awareness and knowledge of cystic fibrosis and campaign for improvements in care and support for the 9,000 people with the condition in the UK; acknowledges that cystic fibrosis is one of the UK's most common life-threatening inherited diseases; further welcomes the latest figures which show that the median age of survival has increased to 41 years; acknowledges concerns that cystic fibrosis services are struggling because of the increased patient population, cut backs in posts vital to cystic fibrosis care and cuts in beds suitable for accommodating people with cystic fibrosis; and calls on the Government to ensure cystic fibrosis services are adequately resourced with extra bed capacity suitable for people with cystic fibrosis.","date":"2012-04-25","status":"o"},{"topic":"Diseases","id":"44110","proposer":"13934","edm":"3002","session":"2010-12","title":"London Model Of Care For Tuberculosis","text":"That this House expresses serious concern at the high risk of tuberculosis (TB) in London, which is the highest of any major city in Western Europe; notes that communities and healthcare professionals are poorly informed about TB risks and that current screening guidelines are not applied consistently or cost-effectively, increasing the risk of transmission; and calls on the Government to support the London Health Programme's Model of Care for Tuberculosis Services, which proposes to improve early detection and diagnosis through the creation of awareness-raising programmes for communities and health and social care workers, a pan-London commissioning board to co-ordinate and take responsibility for commissioning specialist TB services across the capital, better detection of latent TB and further work to controlTB in London.","date":"2012-04-24","status":"o"},{"topic":"Diseases","id":"44085","proposer":"10754","edm":"2977","session":"2010-12","title":"Time For Action Campaign","text":"That this House recognises the importance of Action for ME's Time for Action campaign to educate policy makers, service providers and the public on myalgic encephalomyelitis (ME), a misunderstood disease which affects more than 250,000 people in the UK and leaves half of its sufferers unable to work; acknowledges a lack of understanding of ME that has resulted in many sufferers unable to access support; and welcomes the campaign's commitment to ending the ignorance, injustice and neglect of ME once and for all.","date":"2012-04-18","status":"o"},{"topic":"Diseases","id":"44067","proposer":"10292","edm":"2959","session":"2010-12","title":"Children's Heart Federation's Think Heart Campaign","text":"That this House notes that over 5,000 children are born each year with congenital heart disease (CHD) and a further 500 to 1,000 develop heart defects after they are born; further notes that CHD can cause great distress to parents and families and, therefore, welcomes the Children's Heart Federation's Think HEART campaign based upon the work of Dr Joan LaRovere, which seeks to educate parents and professionals about the warning signs of CHD, which include a child failing to thrive as a result of a heart rate which is too fast or too slow, a child being sleepy, quiet or too tired to eat, a child being blue, dusky or grey coloured, breathing too fast or too slow or if they are cold to touch; and calls on the Government to back the Think HEART campaign and give it whatever help it can to spread this important message which will raise awareness and help to save children's lives through earlier diagnosis of CHD.","date":"2012-04-17","status":"o"},{"topic":"Diseases","id":"44068","proposer":"24865","edm":"2960","session":"2010-12","title":"Advanced Parkinson's Disease","text":"That this House notes with concern that an estimated 127,000 people in the UK have Parkinson's disease, that a further 10,000 people will be diagnosed with the disease in 2012 and that one in 20 will be under the age of 40; recognises that Parkinson's is a complex progressive disease that impacts on every aspect of daily living, which is especially true as the disease progresses into the advanced stage; is concerned by the findings of the Public Accounts Committee's recent report on services for people with neurological conditions which demonstrates that there are considerable geographical variations in service provision for people with Parkinson's disease and no system for holding commissioners to account for quality of care at all stages of the disease; further notes that early identification of problems and access to an expert who specialises in movement disorders gives patients greater flexibility of treatment and management options, particularly in the later stages of the disease when conventional therapies can no longer control symptoms adequately; welcomes the launch of the Advanced Parkinson's Pathfinders Handbook, which was developed in collaboration between the European Parkinson's Disease Association and Abbott to help people know what they should expect as their disease progresses and to provide information and support on how to get the most out of life with Parkinson's disease; and urges the Government to ensure the proposed NICE quality standard for Parkinson's disease is prioritised for development and reflects the progressive nature of the disease to ensure that the changing needs of people with Parkinson's disease are met at every stage of their patient journey.","date":"2012-04-17","status":"o"},{"topic":"Diseases","id":"44052","proposer":"10614","edm":"2944","session":"2010-12","title":"Rise In Diabetes Complications","text":"That this House is deeply concerned that the rates of people with diabetes in England suffering strokes and kidney failure have risen by over 30 per cent since 2006-07; notes that the right health checks could have helped prevent the 16,000 people with diabetes estimated to have had a stroke and the 8,800 thought to have suffered kidney failure in 2009-10; further notes with alarm the Diabetes UK survey which showed that 22 per cent of people with diabetes had not had their kidney function checked in the previous year and seven per cent had not had their blood pressure checked; and calls on the Government to ensure that primary care trusts provide people with diabetes with the nine health checks they require each year according to National Institute for Health and Clinical Excellenceguidelines.","date":"2012-04-16","status":"o"},{"topic":"Diseases","id":"44035","proposer":"12005","edm":"2928","session":"2010-12","title":"Gluten-Free Challenge Campaign","text":"That this House recognises that people with coeliac disease have an autoimmune disease for which the only treatment is a lifelong adherence to a gluten-free diet; considers that for many of those diagnosed, eating out is a continuous challenge; urges those in the hospitality industry to reap the benefits of this market by providing safe, gluten-free options on menus; and commends and supports Coeliac UK for its Gluten-free Challenge campaign which aims to make eating out possible for all people with the condition, to significantly improve their quality of life and create understanding of coeliac disease.","date":"2012-03-27","status":"o"},{"topic":"Diseases","id":"44029","proposer":"10614","edm":"2922","session":"2010-12","title":"Role Of Plastics In Diabetes","text":"That this House is deeply concernedby the recent literature reviewed by Professor Miquel Porta of Spain and Professor Duk-Hee Lee of South Korea showing links between chemicals in plastics, including the now banned PCBs, the plastic-softenersphthalates and the plastic-hardener Bisphenol A and diabetes and obesity; notes that they are common substances in food packaging and plastic bottles; further noteswith alarm that both diabetes and obesity are becoming increasingly common, with diabetes set to rise to 10 per cent of the population by 2032; and calls on the Governmentto conduct further research to establish the dangers posed to the nation's health.","date":"2012-03-26","status":"o"},{"topic":"Diseases","id":"44003","proposer":"10222","edm":"2898","session":"2010-12","title":"World Tuberculosis Day, 24 March 2012","text":"That this House recognises that tuberculosis (TB) kills nearly 3,800 people each day and that the disease is the leading cause of death of HIV-infected people in the developing world; welcomes the leading role the Government has been playing in response to the epidemic and the positive role it has to play influencing other governments; notes the considerable progress that has been made in recent years with improved focus on research and development into new tools and decreases in TB prevalance in the UK and globally; acknowledges the critical role of the Global Fund to Fight Aids, Tuberculosis and Malaria in addressing TB; further notes that the Global Fund is estimated to have saved 4.1 million lives since its formation in 2002; and calls on the Government to continue to support research and development into new tools and to step up the fight to control TB and TB\/HIV co-infection bilaterally and multilaterally.","date":"2012-03-20","status":"o"},{"topic":"Diseases","id":"43951","proposer":"10614","edm":"2847","session":"2010-12","title":"Regional Variations In Diabetes Amputations","text":"That this House is deeply concerned by the regional variations in the number of amputations due to diabetes; notes that diabetes sufferers in certain areas are 10 times more likely to have an amputation than those in others; further notes that it is estimated that 80 per cent. of amputations due to diabetes are preventable with the right care and there are therefore approximately 80 preventable amputations due to diabetes a week; is alarmed by the fact that research shows these regional variations are related to the way care is organised; and calls on the Government to support a 50 per cent. reduction in amputations over five years and establish a specialist foot care team in every hospital in the UK.","date":"2012-03-08","status":"o"},{"topic":"Diseases","id":"43806","proposer":"11707","edm":"2706","session":"2010-12","title":"Draft Nice Guidance For The Use Of Abiraterone","text":"That this House notes with serious concern that the National Institute for Health and Clinical Excellence (NICE) has issued draft guidance for the use of the drug abiraterone, a life extending treatment for men in the final stages of prostate cancer, which could, if implemented, prevent the use of this cancer drug for the treatment of this condition in the NHS in England and Wales; is aware that prostate cancer is the most common cancer in men in the UK, that 32,500 men are diagnosed with prostate cancer and that 10,000 men die from the disease in England and Wales every year; further notes that abiraterone can extend the life of men in the final stages of prostate cancerby an average of four months and improves their quality of life; calls on the Government to act immediately to ensure that men with prostate cancer are able to access this treatment to treat their health condition and help to prolong their life; further calls on NICE to reconsider its draft guidance and recommend abiraterone for the benefit of men with prostate cancer and their families; and considers that men should be able to access this drug through the Cancer Drugs Fund, if their clinicians prescribe it, irrespective of this draft decision by NICE.","date":"2012-02-08","status":"o"},{"topic":"Diseases","id":"43670","proposer":"24946","edm":"2576","session":"2010-12","title":"Phenylenediamine Allergies","text":"That this House expresses concern over recent instances of severe allergic reactions caused by para-phenylenediamine (PPD) used in temporary tattoos and hair dye products; further expresses particular sympathy with the family of Julie McCabe, who has been left with severe brain damage as a result of an allergic reaction to PPD; notes with concern the lack of public awareness of the risks associated with using products containing PPD on a sustained basis; further notes the availability of inexpensive and reliable skin tests for PPD allergies; and urges the Government to consider statutory regulation to make the use of such tests mandatory in the hair dressing industry where products containing PPD are being used, and to require all advertising of products containing PPD to carry clear and appropriate warning messages.","date":"2012-01-10","status":"o"},{"topic":"Diseases","id":"43648","proposer":"10527","edm":"2553","session":"2010-12","title":"Avoidable Deaths From Diabetes","text":"That this House notes with alarm that up to 24,000 people with diabetes die in England each year from causes that could have been avoided according to NHS figures published this month; further notes that there is no reason why people with diabetes cannot live long and healthy lives if they receive the right care and support to help them manage their condition; recognises Diabetes UK's 15 healthcare essentials campaign which outlines 15 diabetes checks or services that every person with diabetes should receive or have access to; further notes that half of people with Type 2 and more than two-thirds of people with Type 1 diabetes are not receiving the care they need to stay healthy; and calls on the Government to place a greater emphasis on prioritising diabetes in the Health Outcomes and Commissioning Frameworks to improve standards of care so that the 2.3 million people with diabetes in England receive the care they need to stay healthy.","date":"2011-12-19","status":"o"},{"topic":"Diseases","id":"43638","proposer":"13864","edm":"2543","session":"2010-12","title":"Diabetes UK","text":"That this House notes the recent Diabetes UK Report which found that up to 24,000 people with diabetes in England die earlier from causes that could have been avoided through better management of the condition; further notes that young people with diabetes aged 15 to 34 years have the highest mortality risk; further notes that this is an issue throughout the entire UK; and calls for a new strategy to deal with the transition from paediatric to adult diabetes care services and promotes services such as telehealth to assist diabetes patients at home.","date":"2011-12-14","status":"o"},{"topic":"Diseases","id":"43628","proposer":"10614","edm":"2533","session":"2010-12","title":"International Diabetes Federation","text":"That this House congratulates the International Diabetes Federation (IDF) on its recent hosting of the Global Diabetes Forum in Dubai; welcomes the work of the IDF in bringing together Government, private sector organisations and diabetes specialists to discuss practical solutions to this global epidemic; urges the Government to build upon the momentum of events such as this to formulate a clear and informed plan to combat a condition that the IDF estimates will affect 522 million adults, or one in 10 adults, within the next two decades.","date":"2011-12-12","status":"o"},{"topic":"Diseases","id":"43598","proposer":"10678","edm":"2503","session":"2010-12","title":"Cancer Does Not Discriminate Campaign","text":"That this House welcomes the launch of the cancer does not discriminate campaign which aims to raise cancer awareness in black and ethnic minority communities, in an effort to increase early detection as well as improving the patient experience; notes that there is a reported substantial disparity in the incidence rates of different cancers based on ethnicity; further notes that prostate cancer for black African and black Caribbean men is around twice as high as the rates for white men andthe incidence rate of cervical cancer for Asian females over 65 is around twice as high as for white females; is concerned that black African and black Caribbean women have a lower knowledge of the signs of breast cancer than white women; and believes that without a targeted campaign to raise awareness of different types of cancers, their symptoms and the availability of screenings, the disparity in cancer incidence rates between black and ethnic minority and white communities will continue.","date":"2011-12-01","status":"o"},{"topic":"Diseases","id":"43570","proposer":"10834","edm":"2476","session":"2010-12","title":"Meningitis","text":"That this House notes that meningitis and septicaemia are serious and potentially life-threatening diseases, with one in 10 dying, while a quarter of survivors are left with life-altering after-effects such as amputations, brain damage, deafness, blindness and epilepsy; further notes that babies, teenagers and young adults are most at risk, with the diseases killing more babies and young children in the UK than any other infectious disease; welcomes the fact that over the last decade there has been significant progress in raising awareness and tackling the diseases with the introduction of new vaccinations; further notes however that there are many strains of bacterial meningitis for which there are no vaccinations; and calls on the Government to introduce new vaccines as soon as readily available to protect against all strains of meningitis and septicaemia.","date":"2011-11-24","status":"o"},{"topic":"Diseases","id":"43526","proposer":"10428","edm":"2434","session":"2010-12","title":"Social Care Costs -\u0000 Dementia","text":"That this House is aware of the vital importance of the provision of social care for people suffering from dementia, currently estimated as affecting around 750,000 people in the UK, two-thirds of whom live in the community; recalls the findings of the Dilnot Commission in July which included within it a recommendation to create a fairer funding mechanism for social care, rather than the current system which leaves tens of thousands of families to pay all of their loved ones' care costs whilst they themselves suffer this terrible terminal health condition; praises the work of the Alzheimer's Society which has campaigned for many years to end such dementia tax; and urges the Government to hear its call for them to engage in urgent cross party talks to explore how a fairer, transparent system can be developed and then established.","date":"2011-11-15","status":"o"},{"topic":"Diseases","id":"43529","proposer":"24892","edm":"2437","session":"2010-12","title":"World Aids Day 2011","text":"That this House notes, 30 years on from the first officially reported cases of HIV, the importance of World Aids Day 2011 on 1 December; welcomes the significant treatment advances which mean that many people with HIV are now living long and active lives; further notes that despite this medical progress, attitudes to HIV have not moved on to the same extent, with one in three people living with HIV in the UK reporting discrimination related to their HIV status; welcomes the Government's recognition of the damaging effect of stigma; further notes that the Government has provided much needed and welcome support to tackle stigma relating to mental health; and calls on the Government to take similar action to address HIV-related stigma, developing an explicit and strategic plan to reduce HIV-related stigma as an integral part of our national response to the epidemic.","date":"2011-11-15","status":"o"},{"topic":"Diseases","id":"43503","proposer":"10614","edm":"2413","session":"2010-12","title":"Diabetes Blue Monument Challenge","text":"That this House welcomes the number of organisations, including the Leicester Mercury, who are joining together to light iconic monuments in the internationally recognised colour for diabetes awareness, to raise the profile of this important health issue; calls on other organisations to participate in this year's International Diabetes Federation Blue Monument Challenge; recognises the significance of World Diabetes Day in the effort to raise awareness of this growing global emergency; and urges the Government to adopt strong policies promoting healthier lifestyles to combat diabetes which affects an estimated 2.6 million people in the UK and 180 million people worldwide.","date":"2011-11-09","status":"o"},{"topic":"Diseases","id":"43458","proposer":"10312","edm":"2369","session":"2010-12","title":"Discrimination Against People Affected By Leprosy","text":"That this House notes that leprosy is completely curable; welcomes LEPRA Health in Action's Humanity in Action campaign to enddiscrimination againstpeople affected by leprosy worldwide; further welcomes the Government's signing of United Nations Human Rights Council (UNHRC)resolution A\/HRC\/15\/30 on the elimination of discrimination against persons affected by leprosy and their family members; supports UNHRC submission A\/HRC\/15\/30 on the draft set of principles and guidelines for the elimination of discrimination against persons affected by leprosy and their family members; further notes that legislation which discriminates against sufferers of leprosy is still in place in numerous countries, including the UK;calls on the Government to bring forward legislative proposals to enddiscrimination against people withleprosy; and further calls on the Government to do all that it can to put an end to discrimination against persons affected by leprosy worldwide.","date":"2011-11-03","status":"o"},{"topic":"Diseases","id":"43461","proposer":"13934","edm":"2372","session":"2010-12","title":"World Diabetes Day (No. 3)","text":"That this House recognises that diabetes is a serious illness; notes that many complications resulting from diabetes can be prevented if people with diabetes receive all the vital 15 health checks and services they need as part of an integrated diabetes service; further notes that 14 November 2011 is World Diabetes Day; and calls on the Government to act by supporting DiabetesUK's 15 measures campaign and ensure that the 2.9 million people diagnosed with the condition in the UK receive the care they need to stay healthy.","date":"2011-11-03","status":"o"},{"topic":"Diseases","id":"43448","proposer":"10715","edm":"2359","session":"2010-12","title":"Lung Cancer Surgery","text":"That this House recognises the achievements of the NHS in improving the number of patients accessing surgery for lung cancer by 60 per cent. from 3,276 operations in 2006 to 5,265 patients receiving an operation in 2010 and the impact this has on surviving the illness; notes the role of the Society for Cardiothoracic Surgery and the Royal College of Surgeons of England in changing training to produce a new specialism in lung cancer surgery; and calls on those trusts lagging behind to employ lung specialists and invest in training for minimally invasive techniques so even more patients may benefit from improved life expectancy.","date":"2011-11-02","status":"o"},{"topic":"Diseases","id":"43451","proposer":"24928","edm":"2362","session":"2010-12","title":"Ipilimumab (Yervoy) For Patients With Advanced Melanoma","text":"That this House welcomes the campaign by the Karen Clifford Skin Cancer Charity and Factor50 to improve access to treatments for patients with advanced melanoma; notes that in 2008 there were 11,767 new cases of malignant melanoma diagnosed in the UK and that whilst the majority of skin cancers are treatable, malignant melanoma is a particularly aggressive form of skin cancer causing the deaths of over 2,000 people in the UK each year; further notes that melanoma is the second most common cancer among young adults aged between 15 and 34 and that recent data published in the British Journal of Cancer predicts that the incidence rate of melanoma will increase more than any other cancer by 2030, rising by 52 per cent. for both men and women; is therefore deeply concerned that the National Institute for Health and Clinical Excellence(NICE) has issued draft guidance which restricts the use of Ipilimumab (Yervoy) for previously treated advanced malignant melanoma for patients in England and Wales; is furtherconcerned that there have been no licensed treatments for this patient group for over 30 years; and calls on NICE to reconsider its draft guidance for the benefit of patients with advanced melanoma, many of whom have young families.","date":"2011-11-02","status":"o"},{"topic":"Diseases","id":"43454","proposer":"10222","edm":"2365","session":"2010-12","title":"Pancreatic Cancer UK And Pancreatic Cancer Awareness Month","text":"That this House welcomes Pancreatic Cancer Awareness month in November and the launch of Pancreatic Cancer UK's Study for Survival report; expresses concern over the report's findings of unacceptable standards of care and treatment for the majority of patients; acknowledges that there is an urgent need to address shortcomings in the pancreatic cancer patient experience to improve survival rates and quality of life; notes that pancreatic cancer has the worst survival rate for any cancer in the UK, with only three per cent. of people diagnosed with the disease surviving beyond five years, something which has not changed significantly in the last 40 years; expresses disappointment that pancreatic cancer receives only one per cent. of research funding for cancer in the UK, despite being the cause of five per cent. of cancer deaths; encourages all-party commitment to support and improvement in care through a number of measures, including improving early diagnosis, eradicating geographical variations in care and ensuring that patients are better involved in their care and supported by clinical nurse specialists; supports Pancreatic Cancer UK's Campaign for Hope, which aims to double survival rates for pancreatic cancer patients over the next five years; and calls on the Government to ensure this ambition becomes a reality.","date":"2011-11-02","status":"o"},{"topic":"Diseases","id":"43431","proposer":"11707","edm":"2343","session":"2010-12","title":"Movember","text":"That this House welcomes the start of Movember on 1 November, the aim of which is to raise vital funds and awareness for men's health, specifically prostate cancer and other cancers that affect men; notes that 11.7 million was raised in 2010 by thousands of men growing a moustache throughout the month of November; hopes that 2011 will be even more successful, that more men will participate and that it will raise even more money to support the number one and number two male specific cancers: prostate and testicular cancer; and further notes that the funds raised are directed to programmes run directly by Movember and their men's health partners, The Prostate Cancer Charity and the Institute of Cancer Research, to support a broad range of innovative, world-class programmes in the areas of awareness and education, survivorship and research.","date":"2011-11-01","status":"o"},{"topic":"Diseases","id":"43437","proposer":"24924","edm":"2349","session":"2010-12","title":"Institute Of Cardiovascular Medicine And Science","text":"That this House welcomes the establishment of the Institute of Cardiovascular Medicine and Science with the mission to improve outcomes in cardiovascular medicine; applauds the quality of the link established between Imperial College London, the Royal Brompton and Harefield Hospital and the Liverpool Heart and Chest Hospital in Broadgreen and their ambition to become a world leader in cardiovascular research by 2016, thereby improving patient outcomes through advances in prevention, diagnosis and treatment; notes that the underlying philosophy is to be academically-led but clinically-driven, providing an exciting opportunity to pool the expertise of cardiovascular clinicians from two major centres together with the international leaders in the field of cardiovascular medicine to train the next generation of specialists; is delighted that three of the four research themes are to be led by Liverpool clinicians Dr Rod Stables, Dr Derek Todd and Dr Jay Wright with Professor John Pepper leading the fourth theme at the Royal Brompton; and wishes the new Institute every success in the years ahead.","date":"2011-11-01","status":"o"},{"topic":"Diseases","id":"43439","proposer":"24794","edm":"2351","session":"2010-12","title":"The Prostate Cancer Charity And Movember","text":"That this House recognises that prostate cancer is the most common cancer amongst men with 37,000 men diagnosed each year and one man dying every hour from the disease in the UK; acknowledges that nine out of 10 men diagnosed with prostate cancer are over 60 years old and that those with a family history and men from an African Caribbean background are at higher risk; supports the right of every man over 50, and younger men at higher risk, to have access to balanced information about the prostate-specific antigen test which can help diagnose prostate cancer; welcomes the work carried out by the international charity Movember, where men are encouraged to grow moustaches to raise awareness and funds, with the money raised by Movember in the UK supporting the programmes of The Prostate Cancer Charity to support people affected by the disease and research into the causes, prevention and treatment of prostate cancer as well as the Institute for Cancer Research's programmes around testicular cancer; and calls on the Government to support Movember in raising vital awareness and funds for this terrible disease and to better last year's 112,000 participants and the 11.7 million raised in the UK.","date":"2011-11-01","status":"o"},{"topic":"Diseases","id":"43379","proposer":"24852","edm":"2291","session":"2010-12","title":"European Parliament Written Declaration On Epilepsy","text":"That this House welcomes the European Parliament's Written Declaration on Epilepsy 0022\/2011, submitted by MEPs Gay Mitchell, Nirj Deva, Marian Harkin, Peter Skinner and Angelika Werthmann and passed on 15 September 2011; notes that the Declaration was signed by 459 MEPs, which is the third highest number of signatures of all disease-related declarations since 2004; further notes that the Declaration states that six million people in Europe have epilepsy, with 300,000 new cases diagnosed each year; is concerned that, according to the Declaration, 40 per cent. of people with epilepsy in Europe do not receive appropriate treatment and 40 per cent. of children with epilepsy have difficulties at school; acknowledges that, according to the Declaration, people with epilepsy in Europe experience high levels of unemployment, are exposed to stigma and prejudice and can experience disruption to every aspect of life which can impose physical, psychological and social burdens on individuals and families; further welcomes the Declaration's calls for research and innovation in prevention and early diagnosis and treatment and for the recognition of epilepsy as a major disease that imposes a significant burden; and urges the Government to take steps to comply with the Declaration's demands for EU member states to introduce appropriate legislation to protect the rights of all people with epilepsy.","date":"2011-10-20","status":"o"},{"topic":"Diseases","id":"43354","proposer":"11427","edm":"2271","session":"2010-12","title":"Muscular Dystrophy Campaign And The Charity Times Campaigning Team Of The Year Award 2011","text":"That this House congratulates the Muscular Dystrophy Campaign on winning the Campaigning Team of the Year at the Charity Times Awards 2011; notes that the judges praised an outstanding campaign with outstanding results; recognises the tireless dedication and commitment of the Muscular Dystrophy Campaign's supporters in campaigning for service improvements; further notes the contribution of the All-Party Parliamentary Group for Muscular Dystrophy in working with the NHS and campaigners to improve services; welcomes the national neuromuscular work plan which is currently being undertaken by the Departmentof Health; and hopes that there will be further service improvements for people with muscular dystrophy and related neuromuscular conditions across the UK.","date":"2011-10-18","status":"o"},{"topic":"Diseases","id":"43325","proposer":"10527","edm":"2243","session":"2010-12","title":"Diabetes And Driving","text":"That this House notes with concern that the implementation of EU Directive 2009\/112\/EC may lead to the restriction of the freedom of the right to drive safely for people with diabetes; recognises that the EU Directive states that those who have more than one severe hypoglycaemia event within a 12-month period may be at the risk of losing their licence; further recognises the EU Directive's failure to specify that the severe hypoglycaemia events to be reported are those in waking hours, leading the DVLA to include hypoglycaemic events occurring during sleeping hours; and urges the Government to ensure that the Department of Transport and the DVLA provide clarity in their implementation of the Directive, specifying in detail how this will affect the driving rights of people with diabetes.","date":"2011-10-13","status":"o"},{"topic":"Diseases","id":"43271","proposer":"10614","edm":"2193","session":"2010-12","title":"Un Summit On Non-Communicable Diseases","text":"That this House notes the UN Secretary General Ban Ki-Moon's statement that non-communicable diseases (NCD) represent a `public health emergency in slow motion'; welcomes the decision by the Secretary of State for Health to attend the UN Summit on NCDs on 19 and 20 September 2011; further notes that obesity is now a global pandemic fuelling NCDs such as heart disease, diabetes and cancer; further notes that without action obesity-related diseases will cost the UK 45 billion a year; calls for the Secretary of State for Health to bring the obesity crisis to the top of the Summit agenda; and urges the Government to support the call for time-bound commitments and targets to tackle the NCD epidemic.","date":"2011-09-15","status":"o"},{"topic":"Diseases","id":"43249","proposer":"10159","edm":"2171","session":"2010-12","title":"Pleural Plaques Compensation Scheme","text":"That this House welcomes the Pleural Plaques Compensation Scheme which was introduced last year; is disappointed the scheme closed to new applicants on 1 August 2011; and urges the Government to reconsider its decision and put in place further plans to provide compensation to those sufferers diagnosed with pleural plaques since 17 October 2007.","date":"2011-09-13","status":"o"},{"topic":"Diseases","id":"43245","proposer":"24784","edm":"2167","session":"2010-12","title":"Argos Ltd","text":"That this House notes recent unfair criticism of Argos; believes that Argos is a great British company employing over 33,000 people and contributing 4.3 billion in sales to the UK economy, including two major sites in Harlow; welcomes the fact that Argos funds the Teenage Cancer Trust, which helps the NHS to provide vital treatment to all teenagers suffering from cancer; further notes that Argos has over 700 stores, serving over 130 million customers a year, with another 20 stores opening in 2011 (creating many hundreds ofnew jobs); and further notes that 18 million UK households, or around two thirds of the population have an Argos catalogue at home at any one time.","date":"2011-09-12","status":"o"},{"topic":"Diseases","id":"43222","proposer":"24735","edm":"2146","session":"2010-12","title":"Workout At Work Day","text":"That this House notes with concern that the economic cost to society in sickness absence due to musculoskeletal conditions is 7.4 billion a year and that 50 per cent. of people on incapacity benefit suffer from musculoskeletal problems; further notes research by the Chartered Society of Physiotherapy found that 36 per cent. of employees worked through their lunch break and 31 per cent. experienced pain at work at least once a week; believes these economic and personal costs could be greatly reduced by encouraging better working habits, and providing early access to services, such as physiotherapy, for people who develop musculoskeletal conditions; welcomes the Chartered Society of Physiotherapy's Workout at Work Day initiative on 8th September 2011, to mark World Physical Therapy Day and raise awareness amongst employers of the importance of encouraging activity in the workplace; and calls on businesses to ensure employees have access to a range of early intervention services, including physiotherapy, to help deliver improvements in health and public health outcomes.","date":"2011-09-07","status":"o"},{"topic":"Diseases","id":"43225","proposer":"11923","edm":"2149","session":"2010-12","title":"Radiotherapy Services At Westmorland General Hospital","text":"That this House notes that prior to July 2011, cancer patients from the South Lakes requiring chemotherapy treatment had to make gruelling journeys outside the area for treatment; welcomes the new Grizedale Chemotherapy Unit at Westmorland General Hospital which is now providing much needed treatment for hundreds of cancer patients across the South Lakes; believes that while this is a big step forward in the campaign to bring full cancer treatment services to the South Lakes it is still essential that radiotherapy services are also brought to Westmorland General Hospital; further notes that the National Radiotherapy Advisory Group recommends that radiotherapy patients should not have to travel more than 45 minutes to receive treatment and that currently patients in the South Lakes have to travel a minimum of 60 minutes to Royal Preston Hospital for treatment; further welcomes the fact that the University Hospitals of Morecambe Bay NHS Foundation Trust have submitted a business plan to NHS commissioners for a satellite radiotherapy unit at Westmorland General Hospital; and calls on the commissioners to approve this bid as soon as possible.","date":"2011-09-07","status":"o"},{"topic":"Diseases","id":"43127","proposer":"10754","edm":"2056","session":"2010-12","title":"Action Mesothelioma Day","text":"That this House congratulates the many asbestos support groups throughout the country who on 1 July 2011 came together to remember the thousands of people who have died of mesothelioma, an asbestos-related disease for which there is no cure; expresses concern that the British mesothelioma death rate is the highest in the world; is concerned at thisand the rising number of deaths of teachers and other support workers working inschools due tothe large number of schools which still contain asbestos; commends the work of the Asbestos in Schools Group; and calls on the Government to adopt US-style policies of disclosure with local authorities and governors, providing an annual update to parents and teachers on the condition and management of asbestos in schools.","date":"2011-07-11","status":"o"},{"topic":"Diseases","id":"43117","proposer":"24892","edm":"2046","session":"2010-12","title":"Atypical Haemolytic Uremic Syndrome","text":"That this House notes that atypical haemolytic uremic syndrome (aHUS) is a very rare disease causing irreversible kidney failure in children and adults; congratulates the scientific community for its research into the causes and treatment of aHUS; further notes that complement inhibitors, such as eculizumab, are likely to be the new standard of care for aHUS; further notes that an application for a nationally commissioned service to treat aHUS has been submitted to the Advisory Group for National Specialised Services and is supported by the British Association for Paediatric Nephrology, the British Transplantation Society, NHS Kidney Care and the Renal Association; and calls on the Government to ensure that aHUS patients have access to specialist services and therapies.","date":"2011-07-07","status":"o"},{"topic":"Diseases","id":"43042","proposer":"10611","edm":"1973","session":"2010-12","title":"Cardiac Services And Alder Hey Children's Hospital","text":"That this House notes the superb services the cardiac department at Alder Hey Children's Hospital provides to Liverpool, Merseyside and a wider catchment area of over seven million people across North West England and North Wales; welcomes the Government's decision to include Alder Hey Children's Hospital in all four options of the safe and sustainable review of congenital heart services to children; and urges the Government to ensure Alder Hey Children's Hospital, with its highly regarded cardiac unit, continues to be a centre for specialist cardiac surgical expertise.","date":"2011-06-22","status":"o"},{"topic":"Diseases","id":"43028","proposer":"24754","edm":"1959","session":"2010-12","title":"Effect Of Multiple Sclerosis On Working Life Years","text":"That this House welcomes the report Ready to Work: Meeting the employment and career aspirations of people with multiple sclerosis published on 20 June 2011 by The Work Foundation with the support of the MS Society, MS Trust, MSRC and Shift MS on the impact of multiple sclerosis on working life years; notes that 80 per cent. of people with multiple sclerosis retire within 15 years of diagnosis and that the condition costs the UK economy up to 2.8 billion per year; and calls on the Government to ensure that the needs of individuals with multiple sclerosis are better understood as part of its Work Programme, that the Access to Work scheme is continued and expanded to provide support for those with fluctuating conditions such as multiple sclerosis, that the crucial role of multiple sclerosis specialist nurses is safeguarded and that employers are encouraged to utilise occupational health professionals to improve the workplace for those with the condition.","date":"2011-06-21","status":"o"},{"topic":"Diseases","id":"43012","proposer":"24729","edm":"1943","session":"2010-12","title":"Specialist Palliative Care For People With Motor Neurone Disease","text":"That this House welcomes the publication of a report from the All-Party Parliamentary Group on Motor Neurone Disease (MND) on specialist palliative care for people with MND; supports the MND Association's call for everyone with MND to have access to appropriate palliative and end-of-life care to achieve quality in life and dignity in death; and calls on the Government to ensure that the very best in specialist palliative and end-of-life care is available to everyone with MND, wherever they live and whatever their circumstances.","date":"2011-06-20","status":"o"},{"topic":"Diseases","id":"43006","proposer":"10614","edm":"1937","session":"2010-12","title":"Lloydspharmacy And Diabetes","text":"That this House welcomes Lloydspharmacy's innovative and forward thinking approach to raising awareness of Type2 diabetes, announced during National Diabetes Week 2011; notes that 100,000 people are diagnosed with Type2 diabetes every year in the UK, around one new case every five minutes; further notes the advances in smartphone technology which allows people to use their telephone to assess their risk of developing Type2 diabetes along with educating them about the condition; and congratulates Lloydspharmacy for this important advance in diabetes awareness.","date":"2011-06-16","status":"o"},{"topic":"Diseases","id":"42950","proposer":"10527","edm":"1883","session":"2010-12","title":"Diabetes Week 12-18 June 2011","text":"That this House recognises that people with diabetes could be risking their health and experiencing emotional distress by keeping their diabetes secret; notes Diabetes Week istaking place from 12 to 18 June 2011; congratulates Diabetes UK for using this week to promote the message `Let's talk diabetes' highlighting the benefits for people with diabetes to talk about their condition; and calls on the Government to take action to ensure the provision of emotional and psychological support as an integral part of a diabetes care package as a matter of priority.","date":"2011-06-08","status":"o"},{"topic":"Diseases","id":"42931","proposer":"10715","edm":"1864","session":"2010-12","title":"Myeloma Awareness Week 2011","text":"That this House recognises Myeloma Awareness Week 2011, held from 21 to 28 June 2011, as an important event to raise awareness of this rare bone marrow cancer affecting 14,000 people in the UK; welcomes the launch in that week of the Myeloma Academy, an innovative educational resource, developed by Myeloma UK to support healthcare professionals involved in the treatment and care of myeloma patients; further recognises the importance of the Academy in helping deliver the Government's priorities for improving patient outcomes, equality and experience as outlined in Improving Outcomes, a Strategy for Cancer; and encourages hon. Members to endorse the Academy in their constituencies.","date":"2011-06-07","status":"o"},{"topic":"Diseases","id":"42893","proposer":"24852","edm":"1827","session":"2010-12","title":"National Epilepsy Week, 15 To 21 May 2011","text":"That this House notes that the week of 15 May 2011 is National Epilepsy Week 2011; recognises the need to raise awareness of epilepsy and related conditions among children and adults of all ages; acknowledges the hard work and perseverance of organisations including the Joint Epilepsy Council, Epilepsy Action and the National Centre for Young People with Epilepsy and others in providing expert support for those with epilepsy and related conditions; further notes with concern research recently published in the British Journal of General Practice which showed that epilepsy mortality rose by more than 30 per cent. between 1995 and 2005 at a time when mortality from all causes in the general population declined; and calls on the Government to take all possible steps to provide the necessary support in health and education to enable people with epilepsy and related conditions to fulfil their potential.","date":"2011-05-18","status":"o"},{"topic":"Diseases","id":"42897","proposer":"10428","edm":"1831","session":"2010-12","title":"Nice Review Of Cancer Drugs For The Treatment Of Chronic Myeloid Leukaemia","text":"That this House is alarmed that the National Institute for Health and Clinical Excellence (NICE) announced in its recent Appraisal Consultation document reviewing the use of the drugs Dasatinib, Nilotinib and high dose Imatinib for patients suffering from resistant chronic myeloid leukaemia (CML) that NICE had decided not to recommend NHS prescription of these life-saving cancer drugs for the treatment of this condition; is aware that currently more than 700 people in the UK discoverannuallythey have CML, and that currently more than 3,000 people are living with it; notes recent clinical evidence has established that patients benefiting from these drugs who show continued positive response from their use are likely to establish a normal average life expectancy the same as that experienced by most of the nation's population; and calls on the Government to act immediately to ensure chronic leukaemia sufferers acquire these drugs to deal with their health condition.","date":"2011-05-18","status":"o"},{"topic":"Diseases","id":"42865","proposer":"11707","edm":"1802","session":"2010-12","title":"Gp Training In Migraine And Headache Conditions (No. 2)","text":"That this House expressesits concern that the onset of migraine and headache results in 25,000,000 missed school and work days per year at an estimated cost to the economy of 2.5 billion; and calls on the Government to increase and sustain support for GP training to combat this medical condition and thereby avoid this unnecessary cost to the economy.","date":"2011-05-12","status":"o"},{"topic":"Diseases","id":"42848","proposer":"10614","edm":"1787","session":"2010-12","title":"Diabetes And The Asian Community","text":"That this House welcomes the work of the BBC Asian Network in its campaign to raise awareness of diabetes and other preventable diseases which affect the Asian community; notes that awareness and educationare key to preventing such diseases as diabetes and that the BBC Asian Network has a unique role to play in this task; recognises the impact of information and advice on preventing Type 2 diabetes alongside improving lifestyle factors; and calls on the Government to encourage greater awareness of the causes and prevention of conditions such as diabetes.","date":"2011-05-10","status":"o"},{"topic":"Diseases","id":"42827","proposer":"10032","edm":"1767","session":"2010-12","title":"Coeliac Awareness Week 2011","text":"That this House recognises that people withcoeliac disease have an autoimmune disease for which the only treatment is a lifelong adherence to a gluten-free diet; acknowledges that for many of those diagnosed, eating out is a continuous challenge which affects their lives every day; urges those in the hospitality industry to embrace the need for more choice and to improve the availability of gluten-free food; and commends and supports Coeliac UK for its Gluten-free Challenge campaign which aims to make eating out possible for all people with coeliac disease, to significantly improve their quality of life and create understanding of their condition.","date":"2011-04-28","status":"o"},{"topic":"Diseases","id":"42817","proposer":"11707","edm":"1760","session":"2010-12","title":"Muscular Dystrophy Campaign Report On Cost Benefit Of Developing Services","text":"That this House welcomes the publication of a report by the Muscular Dystrophy Campaign on the cost-benefit analysis of developing specialised neuromuscular services to prevent unplanned emergency admissions to hospital for people with neuromuscular conditions; acknowledges that specialist, multi-disciplinary services have been established by clinicians as the most effective way of delivering effective care for patients with complex neuromuscular conditions; notes that the development of specialist services could result in savings of approximately 25 million in England alone; further notes the vital role of wheelchair provision, specialist physiotherapy, specialist neuromuscular care advisers and access to specialist respiratory care in preventing unplanned emergency admissions; commends the campaign led by regional Muscle Groups, which contininue to work together to fight for fair access to clinically effective, specialised neuromuscular services across the UK; and calls on the Government to publicly announce a neuromuscular service strategy as a matter of urgency.","date":"2011-04-27","status":"o"},{"topic":"Diseases","id":"42796","proposer":"10240","edm":"1740","session":"2010-12","title":"Ms Register","text":"That this House recognises the MS Society's Register and its potential to support a comprehensive package of activities, including the commissioning of MS services, health and social care research and measurement of clinical outcomes; notes that theMS Register represents a world first in joint collection of patient, clinician and routine NHS data; and supports the MS Society's work to set up the MS Register inLondon, Swansea, Edinburgh, Belfast and Nottingham, the five pilot sites across the UK.","date":"2011-04-26","status":"o"},{"topic":"Diseases","id":"42763","proposer":"10527","edm":"1708","session":"2010-12","title":"Diabetes And The Un High Level Summit On Non-Communicable Diseases","text":"That this House notes the enormous impact of diabetes, with at least 2.8 million people diagnosed with the disease in the UK and 300 million globally, and is concerned that without decisive action the global figure could grow to 500 million within a generation; recognises that one person dies every eight seconds from diabetes and that the global health care costs of the disease are 234 billion; congratulates the International Diabetes Federation and its sister organisations in the NCD Alliance for their role in securing a UN High Level Summit on Non-Communicable Diseases (NCDs) on September 19-20 in New York; further notes that the scale of diabetes and the three other NCDs cancer, cardiovascular disease and chronic respiratory disease threatens social and economic progress and therefore should be a high priority for heads of state and government; urges the Prime Minister to attend the Summit and consider the NCD Alliance's Proposed Outcomes document, the 34 recommendations of which aim to reduce deaths from NCDs by two per cent. a year, saving 36 million deaths over 10 years; and believes that without concerted and co-ordinated action on an international scale healthy people will become a minority in a world where children die before their parents and where economic progress is reversed.","date":"2011-04-04","status":"o"},{"topic":"Diseases","id":"42730","proposer":"24726","edm":"1675","session":"2010-12","title":"Tuberculosis And HIV In Rwanda","text":"That this House welcomes the significant improvement in treatment rates for tuberculosis (TB) and HIV in Rwanda over the last decade; notes the importance of integration of TB and HIV services within wider health efforts in the country, particularly in maternity care; acknowledges the benefits that this approach can bring to a country's health system; is concerned by the continuing high levels of co-infection between TB and HIV and high mortality rates associated with both diseases in many African countries; and calls on the Government to support efforts to share best practice from Rwanda in other countries.","date":"2011-03-30","status":"o"},{"topic":"Diseases","id":"42692","proposer":"24892","edm":"1641","session":"2010-12","title":"Mitochondrial Disease And Pronuclear Transfer","text":"That this House notes the consultation by the Human Fertilisation and Embryology Authority (HFEA) about scientific methods to avoid the transmission of mitochondrial diseases; recognises that there is currently no cure for these devastating conditions affecting more than 6,000 people across the UK; welcomes research led by Professor Doug Turnbull and funded by the Muscular Dystrophy Campaign that shows pronuclear transfer has the potential to develop into an effective method to prevent mitochondrial diseases being passed from mother to child; calls on the HFEA to consult people living with the condition; and strongly urges the Department of Health to introduce regulations which would allow clinical studies to test the potential benefits and risks of pronuclear transfer in humans to be carried out in the UK.","date":"2011-03-22","status":"o"},{"topic":"Diseases","id":"42681","proposer":"10088","edm":"1630","session":"2010-12","title":"Awareness Of Lymphatic Cancer","text":"That this House notes that lymphoma is now the fifth most commonly diagnosed cancer in the UK with over 12,500 new cases a year and over 75,000 people living with the disease; commends the work of the Lymphoma Association as a charity specialising in providing information and support to those affected by lymphatic cancer; congratulates the Association on its 25th anniversary; and urges the Department of Health to pursue all possible avenues to raise awareness of the disease among both GPs and the public.","date":"2011-03-21","status":"o"},{"topic":"Diseases","id":"42622","proposer":"10614","edm":"1575","session":"2010-12","title":"Diabetes Misdiagnosis","text":"That this House notes with concern that an estimated100,000 people have been misdiagnosed diabetes or wrongly told which form of the disease they have; further notes that these mistakes have been made because of a lack of understanding of the condition by doctors and health professionals; recognises the impact of information and advice on preventing Type 2 diabetes alongside improving lifestyle factors; and calls on the Government to invest in a national framework and guidelines to steer GPs, to ensure quality of service and to avoid further misdiagnosis.","date":"2011-03-10","status":"o"},{"topic":"Diseases","id":"42625","proposer":"10754","edm":"1578","session":"2010-12","title":"Supreme Court Ruling On Dianne Willmore","text":"That this House notes the Supreme Court judgement of 9 March 2011 that upheld that Knowsley Metropolitan Borough Council negligently exposed Dianne Willmore to asbestos when she was a pupil at her secondary school; further notes with sadness that she died of mesothelioma aged 49 the day after the Appeal Court hearing; acknowledges the increasing numbers of school teachers who are dying of the asbestos-related cancer mesothelioma and that more than 140 died in the 10 year period from 1999 to 2008; believes that an assessment of the risk to children from asbestos exposure should be undertaken; and calls on the Government to commission such a study.","date":"2011-03-10","status":"o"},{"topic":"Diseases","id":"42605","proposer":"11607","edm":"1559","session":"2010-12","title":"Ovarian Cancer Survival Rates","text":"That this House welcomes the news that ovarian cancer survival has doubled over the last 30 years; notes that the five-year survival for women with early stages of the disease has increased from 21 per cent. in the early 1970s to 41 per cent. today; recognises that these figures mean over 1,000 more women a year in England and Wales are now surviving this cancer for at least five years; praises the work of people in the health service who have helped bring about these improved figures; further recognises there is still a lot of work to do to tackle issues like late diagnosis; welcomes the fact that Cancer Research UK is helping to fund a trial of ovarian cancer screening; further praises the work of Cancer Research UK in their commitment to finding new ways to treat and detect the disease; calls for more investment to help treat and detect the disease; and further calls on a nationwide screening programme to be introduced as soon as possible to help spot potential tumours much earlier.","date":"2011-03-09","status":"o"},{"topic":"Diseases","id":"42581","proposer":"24797","edm":"1548","session":"2010-12","title":"World Kidney Day 2011","text":"That this House welcomes World Kidney Day 2011, which seeks to improve the awareness, detection and treatment of kidney disease, including the link between kidney disease and hypertension; is concerned that over three million people face chronic kidney disease in the UK today and that this number is expected to rise over the next 10 years; is alarmed that an estimated 13,000 people are killed by the disease annually in this country; notes that high blood pressure may result in both kidney damage and an increased risk of stroke and other cardiovascular disease; further notes the importance of treating chronic kidney disease in order to reduce the burden of cardiovascular disease and the value of screening people with cardiovascular disease for kidney disease; welcomes the imminent publication by the National Institute for Health and Clinical Excellence of the Quality Standards on Chronic Kidney Disease; and urges the Government to encourage and measure the uptake of these standards by all healthcare professionals.","date":"2011-03-08","status":"o"},{"topic":"Diseases","id":"42585","proposer":"10222","edm":"1552","session":"2010-12","title":"World Tuberculosis Day 24 March 2011","text":"That this House is concerned at the continuing rise in the prevalence of tuberculosis (TB), both globally and in the UK; notes that TB is the cause of nearly 5,000 deaths per day and thatit is the leading cause of death of HIV-infected people in the developing world; recognises that the epidemic of TB drug resistance is being further inflamed by poor care management and drug use and that research into desperately needed new diagnostic tools, drugs and vaccines is severely under-resourced; and calls on the Government to mark World Tuberculosis Day on 24 March 2011 by committing the UK to seek maximum multi- and bilateral aid effectiveness in efforts to combat this preventable and curable disease.","date":"2011-03-08","status":"o"},{"topic":"Diseases","id":"42594","proposer":"24872","edm":"1543","session":"2010-12","title":"Stoma Care Specialists","text":"The this House acknowledges the valuable work of stoma care nurses in providing high quality care, advice and treatment to patients in healthcare settings and the community; observes that there are more than 100,000 people in the UK with a stoma and that specialist nursing support helps these patients lead full, independent lives; recognises the major benefits of stoma care services through improved health outcomes and the prevention of hospital readmissions; congratulates the World Council of Enterostomal Therapists UK on its work to raise awareness of the important contribution of stoma care nurses; and calls on the Government to ensure that NHS specialist stoma care services are maintained.","date":"2011-03-07","status":"o"},{"topic":"Diseases","id":"42468","proposer":"10074","edm":"1439","session":"2010-12","title":"National Tinnitus Week","text":"That this House supports National Tinnitus Week, which began on 7 February 2011; commends the continued work of the British Tinnitus Association in raising awareness and its sustained research into this condition; is concerned that nearly 10 per cent. of the population suffers from tinnitus in some form, which can cause pain, stress, disturbed sleep patterns and behavioural changes to its sufferers; notes that incidents are on the rise,linking hearing damage to personal music players; and calls on the Government to help raise awareness of tinnitus amongst GPs.","date":"2011-02-09","status":"o"},{"topic":"Diseases","id":"42407","proposer":"11963","edm":"1382","session":"2010-12","title":"Industrial Injuries Disablement Benefit And Prescribed Disease C23","text":"That this House expresses deep concern towards those who suffer from primary neoplasm of the epithelial lining of the urinary tract (Prescribed Disease C23) as a result of exposure to harmful substances as part of their employment; notes that the Government provides support for many of those who have obtained the condition in this way through Industrial Injuries Disablement Benefit; however, expresses concern that at present the benefit is only payable to workers involved in the Solderberg process of producing aluminium despite the Industrial Injuries Advisory Council acknowledging that there are people in other occupations where their work may have been a contributory factor in their illness; and calls on the Government to look again at the terms of prescription for Prescribed Disease C23 with a view to revising it to ensure that all those for who there is strong evidence to suggest they may have contracted the condition as a result of their employment are eligible for IndustrialInjuries Disablement Benefit.","date":"2011-02-01","status":"o"},{"topic":"Diseases","id":"42380","proposer":"11534","edm":"1359","session":"2010-12","title":"Health And Safety Executive's Hidden Killer Campaign","text":"That this House notes that the Health and Safety Executive's (HSE's) Hidden Killer campaign has played an exemplary role in informing construction workers about the dangers posed by exposure to asbestos; recognises construction workers are now at greater risk of dying from asbestos disease and that 4,000 people a year die from asbestos related illness; is alarmed to learn that the latest phase of the Hidden Killer campaign has been cancelled following a 35 per cent. cut in the HSE's budget; and calls on the Secretary of State for Work and Pensions to reverse this decision and reinstate this lifesaving campaign.","date":"2011-01-27","status":"o"},{"topic":"Diseases","id":"42312","proposer":"10122","edm":"1293","session":"2010-12","title":"Death Of Lana Ameen","text":"That this House deeply regrets the tragic death from swine influenza of Lana Ameen, aged three years; extends its deepest sympathies to her family; notes that Lana was not in one of the at risk groups whichwould have indicated a requirement for vaccination against swine influenza; and calls on the Secretary of State for Health to review all the available medical expert advice on vaccination to ensure that in the future there are no more tragic deaths.","date":"2011-01-18","status":"o"},{"topic":"Diseases","id":"42314","proposer":"10715","edm":"1295","session":"2010-12","title":"Beating Bowel Cancer's 1, 2, 3, Campaign","text":"That this House isconcerned that half of the 38,600 people diagnosed with bowel cancer every year in the UK will die from the condition but that bowel cancer is curable if detected early enough; welcomes the Government's announcements on bowel cancer, including the introduction of flexible sigmoidoscopy screening and local campaigns in England to improve public awareness of the signs and symptoms of bowel cancer; further welcomes the contribution made by the previous Government to improving earlier diagnosis but highlights the need for wider participation in bowel cancer screening to improve outcomes; and supports Beating Bowel Cancer's 1,2,3 campaign that seeks to increase the number of people taking part in the bowel cancer screening programme, which could save up to 1,279 lives every year in England.","date":"2011-01-18","status":"o"},{"topic":"Diseases","id":"42318","proposer":"24715","edm":"1299","session":"2010-12","title":"Vitamin B12 Deficiency","text":"That this House welcomes the benefits of vitamin B12 therapy; believes that greater emphasis must be placed on recognising and treating B12 deficiency which can be a major cause of ill health and unemployment; recognises that the replacement of the missing nutrient can restore quality of life, enthusiasm and energy to the individual; notes that many of the drugs used to treat misdiagnosis are expensive and can have lasting adverse effects; and calls on the health community to recognise and research vitamin B12 deficiency to ensure the needs and symptom patterns of patients can be treated in a way that is cost-effective, without side-effects and completely safe.","date":"2011-01-18","status":"o"},{"topic":"Diseases","id":"42229","proposer":"10057","edm":"1216","session":"2010-12","title":"Human Papilloma Virus Infection And Genital Warts","text":"That this House notes that diagnoses of genital warts in young people have continued to rise, with 66 per cent. of all newgenital warts diagnoses in women being in those under 25; supports the call by FPA, Brook, Terrence Higgins Trust, the Royal Societyfor Public Health, Medical Foundation for AIDS and Sexual Health and the British Association for Sexual Healthand HIV for the introduction of a quadrivalent Human Papilloma Virus (HPV) vaccine which protects against cervical cancer and against genital warts and will contribute to improving public health; urges the Government to reduce the currentinequalities which exist to ensure that it is not only those who have the knowledge and financial resources who are able to assess the quadrivalent HPV vaccine and benefit from the protection it offers; and urges the Government to take the opportunity to preventboth cervical cancer and genital warts.","date":"2010-12-16","status":"o"},{"topic":"Diseases","id":"42225","proposer":"10614","edm":"1212","session":"2010-12","title":"Obesity And Diabetes","text":"That this House notes with concern that the UK is one of the unhealthiest nations in Europe according to the OECD Health at a Glance report; further notes that the UK, with an average of 24.5 per cent. adult obesity, has the highest level of obesity in the EU; recognises that there is a high prevalence of Type 2 diabetes in those overweight or obese and that 2.8 million adults in the UK suffer from diabetes;urges the Government to recognise the importance of a healthy and active lifestyle to prevent the condition; and calls on the Government to provide more information about obesity and its related illnesses such as diabetes.","date":"2010-12-15","status":"o"},{"topic":"Diseases","id":"42212","proposer":"11607","edm":"1200","session":"2010-12","title":"The Year Of Rheumatoid Arthritis: One Year On","text":"That this House welcomes the publication of The Year of Rheumatoid Arthritis: One Year On, by the National Rheumatoid Arthritis Society and the British Society for Rheumatology which assessesthe progress made over the last year in improving the quality and standard of care for people with rheumatoid arthritis; welcomes the four recommendations which seek to improve and optimise best practice and to ensure consistency in service provision and patient care and notes the report's findings to improve care for people with rheumatoid arthritis; recognises people with rheumatoid arthritis who lack sufficient information and support to help them manage their condition can experience hopelessness, despair and depression; and calls on the Government to recognise the importance of early referral and greater awareness amongst general practitioners, safeguard the involvement of patients in the redesign of services and retain the specialist skills of the multi-disciplinary team and specialist nurses in particular.","date":"2010-12-14","status":"o"},{"topic":"Diseases","id":"42110","proposer":"10614","edm":"1106","session":"2010-12","title":"University Of Leicester Diabetes Research","text":"That this House congratulates medical scientists led by Professor Andrew Tobin at the University of Leicester on their discovery of a new mechanism for controlling blood sugar levels; notes that the research identifies a way in which our body controls the level of sugar in blood following a meal; further notes that this discovery has important implications for the 2.8 million diabetes sufferers in the UK; and calls on the Government to continue to fund ground-breaking research in Britain's universities and to work with diabetes charities and health professionals to raise awareness and prevent further increases in the number of sufferers.","date":"2010-11-30","status":"o"},{"topic":"Diseases","id":"42056","proposer":"11707","edm":"1066","session":"2010-12","title":"Pancreatic Cancer Awareness Week","text":"That this House notes that the week beginning 22 November 2010 is Pancreatic Cancer Awareness Week; furthernotes with concern that pancreatic cancer has the worst survival rate for any cancer in the UK, with only three per cent. of people diagnosed with the disease surviving beyond five years; recognises that survival rates have not changed significantly in the last 40 years; welcomes the current guarantee of a two-week referral time for anyone with suspected cancer; further welcomes the all-party commitment to improve access to diagnostic tools for cancers, including pancreatic cancer; acknowledges the good work of Pancreatic Cancer UK to improve survival rates and quality of life by undertaking the Study for Survival; and calls on the Government to support Pancreatic Cancer UK's Study for Survival.","date":"2010-11-22","status":"o"},{"topic":"Diseases","id":"42014","proposer":"10614","edm":"1025","session":"2010-12","title":"World Diabetes Day","text":"That this House welcomes World Diabetes Day on 14 November 2010; recognises the impact of diabetes in the UK and worldwide; notes that approximately 230 million people currently suffer from diabetes worldwide and that many more may be undiagnosed; further notes that World Diabetes Day provides much-needed global awareness of the condition; and urges the Government to workwith charities and practitioners to increase public awareness of the condition and the benefits of an active and healthy lifestyle.","date":"2010-11-17","status":"o"},{"topic":"Diseases","id":"42018","proposer":"24754","edm":"1029","session":"2010-12","title":"Muscular Dystrophy Campaign Cost Of Living With Muscle Disease Report","text":"That this House welcomes a new report by the Muscular Dystrophy Campaign, The Cost of Living with Muscle Disease which highlights the extreme financial hardship faced by many families affected by muscular dystrophy and related neuromuscular conditions; notes that the report reveals that 40 per cent. of households with muscle disease are struggling to cover necessities including heating, gas and water; further notes that high usage of fuel for wheelchair users with these conditions, paired with rising costs, is resulting in quarterly fuel bills as high as 1,000 for some households; is concerned that 80 per cent. of households say that the current benefits system is not covering the additional cost of living with a disability; and calls on the Government to take action to alleviate poverty among people with muscle disease.","date":"2010-11-17","status":"o"},{"topic":"Diseases","id":"42024","proposer":"24956","edm":"1035","session":"2010-12","title":"Withdrawal Of Legal Aid For Epilepsy Drug Court Case","text":"That this House notes with regret the decision of the Legal Services Commission to withdraw funding from the claimants in the Fetal Anti-Convulsant Litigation; further notes that the Legal Services Commission first tried to withdraw funding in 2008 but that the decision was reversed when faced with a judicial review; further notes that the withdrawal of this funding is likely to lead to the abandonment of the current action with the result that the claims will then fall outside the 10 year limitation rule; regrets that key evidence around this issue will then remain confidential; strongly regrets the lost opportunity for the parents and children to have the facts and responsibilities in the case decided in open court; and calls on the Government to urge the Legal Services Commission to reconsider its decision to withdraw legal aid funding.","date":"2010-11-17","status":"o"},{"topic":"Diseases","id":"42010","proposer":"10754","edm":"1021","session":"2010-12","title":"Battle To Raise Awareness Campaign","text":"That this House congratulates students from Bournemouth and Poole College for their work in campaigning for cervical cancer screenings to be more readily available; is pleased that 1,000 lives a year are saved as a direct result of cervical cancer screening; recognises that eight out of 10 cases of cervical cancer are prevented from developing due to early screenings; acknowledges that the average age of repeated sexual activity in the UK is 16 years; and calls on the Government to reconsider its policy on cervical cancer screening to make screenings available to women at a younger age.","date":"2010-11-16","status":"o"},{"topic":"Diseases","id":"41985","proposer":"10013","edm":"996","session":"2010-12","title":"Coalition Of Brain Tumour Organisations Manifesto","text":"That this House welcomes the manifesto published by the coalition of brain tumour organisations; and supports the three key recommendations, that medical guidelines should be set to ensure early diagnosis and treatment for everyone affected by a brain tumour, that all those diagnosed with a brain tumour should receive a consistently high standard of treatment and care throughout the UK and that there must be a significantly enhanced national programme of brain tumour research.","date":"2010-11-12","status":"o"},{"topic":"Diseases","id":"41991","proposer":"10527","edm":"1002","session":"2010-12","title":"Diabetes Care In Residential Care","text":"That this House welcomes Diabetes UK's report Awareness, screening, training in the care of people with diabetes in residential care; notes with concern the findings of the report that one person is admitted to hospital with diabetes every 25 minutes from residential care and that without urgent action to improve care for people with the condition the frequency of such admissions will increase to one every 10 minutes by 2051; is concerned that not all care homes are screening people on admission or at two-yearly intervals for diabetes, resulting in as many as 13,500 older people in care homes whose diabetes is undiagnosed and whose needs are not being met; believes that all people with diabetes living in care homes should have an individualised care plan to ensure their needs are met and that care home managers should put in place appropriate diabetes-specific training for all staff involved in the care of residents with the condition; and urges all care homes to adopt the Good Clinical Practice guidelines for care home residents with diabetes published by Diabetes UK to help improve care for people with diabetes in residential care.","date":"2010-11-12","status":"o"},{"topic":"Diseases","id":"41950","proposer":"11534","edm":"961","session":"2010-12","title":"Court Of Appeal Ruling On Mesothelioma Liability (No. 2)","text":"That this House is concerned that the implications of the decision by the Court of Appeal on 8 October 2010 will be that many victims of asbestos-related disease will die without the certainty that their families will be entitled to compensation; agrees thatit is the exposure to asbestos that can lead to the development of fatal diseases such as mesothelioma and that the trigger must therefore be the point of exposure and not, as challenged by the insurance industry, the point the disease develops, which can be many decades later; further agrees with the High Court ruling in 2008 that the insurers who should pay compensation are those who provided cover to the employer at the time of the asbestos exposure; notes this is the latest of many attacks by the insurance industry on compensation for working people who were negligently exposed to deadly asbestos; and calls on the Association of British Insurers to take action against any of its memberswho are challenging the established trigger that is the point of exposure and support the establishment of an Employers' Liability Insurance Bureau.","date":"2010-11-04","status":"o"},{"topic":"Diseases","id":"41927","proposer":"11707","edm":"940","session":"2010-12","title":"Prostate Cancer And Movember Charity","text":"That this House recognises that prostate cancer is the most common cancer amongst men with one man dying every hour from the disease in the UK; acknowledges that nine out of 10 men diagnosed with prostate cancer are over 60 years old and that those with a family history and men from an African or Caribbean background are at higher risk; supports the right of every man over 50, and young men at higher risk, to have access to balanced information about the prostate-specific antigen test, which can help diagnose prostate cancer; welcome the work carried out by the international charity Movember where men are encouraged to grow moustaches to raise awareness and funds for the prostate cancer charity in the UK, with the money raised by Movember going towards the development of programmes related to awareness, public education, advocacy, support of those affected and research into the prevention, detection, treatment and cure of prostate cancer; and calls on the Government to support Movember in raising vital awareness and funds for this terrible disease and to better last year's45,000 participants and 5 million raised in the UK.","date":"2010-11-02","status":"o"},{"topic":"Diseases","id":"41931","proposer":"10428","edm":"944","session":"2010-12","title":"British Lung Foundation","text":"That this House is aware that annually in Britain approximately eight millionUK citizens are affected by lung disease, respiratory health problems being the second biggest killer in the UK with annual death rates almost double the European average; notes that so far over 40 unhealthy lung conditions have been identified including chronic obstructive pulmonary disease (COPD) the umbrella term used to classify a number of related conditions which includes chronic bronchitis, emphysema and other small airway diseases, that themselves currently kill around 24,000 people every year, a figure higher than the death rates for bowel, breast and prostate cancers; is aware that17 November 2010 has been designated as World COPD Day, a date chosen also by the British Lung Foundation to launch its Missing Millions Get Tested campaign, aimed at encouraging the estimated 3.7 million in the UK with COPD to register and if necessary receive treatment for their condition; congratulates this excellent organisation for its work; and calls on the Government to give whatever help it can in support of its worthy endeavours.","date":"2010-11-02","status":"o"},{"topic":"Diseases","id":"41934","proposer":"10170","edm":"947","session":"2010-12","title":"Nice Recommendations For Alzheimer's Disease Drugs","text":"That this House notes that dementia is a devastating illness which affects over 800,000 people in the UK, two-thirds of them suffering from Alzheimer's disease and with only about a tenth receiving drug treatment; understands that for patients suffering in all stages of the disease some drug treatments can help to alleviate symptoms but that currently there are no National Institutefor Health and Clinical Excellence (NICE) recommended treatment options for mild or severe forms of the disease; believes that the current NICE technology appraisal of Alzheimer's diseease will allow drugs, which can improve the symptoms of Alzheimer's disease, to be more widely available; congratulates NICE on its recently published draft guidance on Alzheimer's disease, which recommends the use of donepezil, galantamine and rivastigmine for Alzheimer's patients suffering from a mild and moderate form of the disease as well as recommending memantine for use in patients suffering from severe Alzheimer's and some moderate Alzheimer's patients; welcomes that there will now be NICE recommended treatment options for patients suffering at all stages of Alzheimer's disease, which will help to alleviate the terrible symptoms for thousands of patients; further notes that NICE has recognised the benefits that memantine can have on patients suffering from behavioural symptoms of Alzheimer's disease, including aggression and agitation; further welcomes the contribution this could have towards reducing the prescriptions of anti-psychotic, chemical cosh, drugs; and looks forward to the current draft recommendations being finalised unchanged at the end of the consultation period.","date":"2010-11-02","status":"o"},{"topic":"Diseases","id":"41913","proposer":"24852","edm":"926","session":"2010-12","title":"Combined Seasonal And Swine Influenza Vaccine","text":"That this House acknowledges that the seasonal influenza vaccine is being administered in combination with the swine influenza vaccine, with no alternative single seasonal influenza vaccine available; is concerned that many patients are not being made aware of this by their surgeries; notes that this denial both of information and the ability to choose not to receive the swine influenza vaccination undermines the Government's promotion of patient choice; and urges the Government to call on health practitioners to provide full and transparent information about the composition, risks and benefits of such vaccinations.","date":"2010-11-01","status":"o"},{"topic":"Diseases","id":"41923","proposer":"11592","edm":"936","session":"2010-12","title":"Cancer-Related Hair Loss And Wig Services In The Nhs","text":"That this House recognises the often profound psychological and physical impact that hair loss can have on individuals undergoing treatment for cancer and on those with alopecia; notes with concern the variation in quality, access and equity of wig provision across the UK; further notes the significant impact that good quality wigs and wig services can have on the self-esteem and self-confidence of individuals following treatment for cancer or as a result of other medical hair loss; further recognises the vital work being undertaken by My New Hair in campaigning for an improvement in the quality and choice of wigs provided by the NHS; warmly welcomes My New Hair's work in providing a national helpline and online resource where patients and carers can access the information they need in order to make an informed choice about the services available to them, includingon choosing a wig, options for children, men and minority ethnic groups through to aftercare and styling; and calls on the Government to take action to reassess the current commissioning guidelines for NHS wig services in order to provide a high standard of care to all individuals sufferingfrom alopecia or medical hair loss.","date":"2010-11-01","status":"o"},{"topic":"Diseases","id":"41925","proposer":"10415","edm":"938","session":"2010-12","title":"Osteoporosis","text":"That this House notes that osteoporosis causes fragile bones, which can lead to painful and disabling fractures; is concerned that in the UK, one in two women and one in five men will suffer a fracture at some point after the age of 50, mainy because of poor bone health; is concerned about the increase in fragility fracture incidence that is predicted, partly as a result of the ageing population; welcomes the fact that comprehensive falls and fracture services have been proven to reduce fracture rates and could save 8.5 million for the NHS and social care in England during the coming five years; commends the Fracture Liaison Service in Greater Glasgow, where hospital admissions for hip fracture in older people fell by 7.3 per cent. between 1998 and 2008; and calls on the Government to ensure that a reduction in fragility fracture incidence becomes a key outcome measure for the NHS.","date":"2010-11-01","status":"o"},{"topic":"Diseases","id":"41906","proposer":"10428","edm":"919","session":"2010-12","title":"Chronic Obstructive Pulmonary Disease Nhs Priority","text":"That this House notes that Chronic Obstructive Pulmonary Disease is a health umbrella term used to cover illness including chronic bronchitis and emphysema which are responsible for 30,000 deaths per year, and is the UK's fifth larget set of killer diseases estimated to cost the NHS in England alone almost 500 million per annum and is the second largest cause of emergency hospital admissions in Britain; further notes that this group of illnesses has not been featured as a priority by the Government in its NHS White Paper, nor in the subsequent Transparency in Outcomes consultation document; further notes that this set of illnesses kills more women every year in the UK than breast cancer and more men than prostate cancer; and calls on the Government to add this group to its priority consideration.","date":"2010-10-28","status":"o"},{"topic":"Diseases","id":"41884","proposer":"10614","edm":"901","session":"2010-12","title":"Incidence Of Diabetes","text":"That this House notes with concern that the number of adult diabetics in the UK has soared by six per cent. since 2009 to 2.8 million; further notes that one in 10 adults are now being treated for obesity and that there is a high prevalence of Type 2 diabetes in those overweight or obese; recognises the importance of a healthy and active lifestyle to prevent the condition; and calls on the Government to work with diabetes charities and health professionals to raise awareness and prevent further increases in the number of sufferers.","date":"2010-10-26","status":"o"},{"topic":"Diseases","id":"41842","proposer":"10428","edm":"861","session":"2010-12","title":"Archer Report And Haemophilia","text":"That this House is aware that during the 1970s and 1980s NHS services infected more than 5,000 people with bleeding disorders and more than 1,200 others and their partners who were infected with HIV from which some died; cannot understand why successive administrations have refused to hold a public inquiry into these tragic events or provide full financial settlements to those involved at a level equivalent to that awarded to sufferers in the Republic of Ireland; and calls on the Government to give full legal effect to the recommendations of the Archer report so that justice may finally be granted to those involved.","date":"2010-10-19","status":"o"},{"topic":"Diseases","id":"41822","proposer":"11707","edm":"843","session":"2010-12","title":"Breakthrough Breast Cancer And Breast Cancer Awareness Month","text":"That this House recognises that breast cancer is the most common cancer in the UK with nearly 46,000 women diagnosed with the disease each year; accepts that although the number of breast cancer deaths in the UK has decreased considerably in recent years, survival rates still lag behind some other European countries; notes that there is evidence that being breast aware - knowing the signs and symptoms of breast cancer and the importance of early presentation - and regularly attending NHS breast screening appointments are two of the three most influential factors on breast cancer survival in the UK, the third being improved treatments; acknowledges that breast screening is a vital part of early diagnosis, with an estimated 1,400 lives saved in England each year thanks to the NHS breast screening programme; further notes that currently invitations for NHS breast screening are sent to women aged 50 to 70 years every three years, and that beyond this age women are still entitled to free breast screening but need to make their own appointments; and supports Breakthrough Breast Cancer's call for GPs to encourage all women to be breast aware, remind women over 50 years to attend their breast screening appointments and make their older patients aware that they can still attend breast screening.","date":"2010-10-18","status":"o"},{"topic":"Diseases","id":"41779","proposer":"10754","edm":"813","session":"2010-12","title":"Tuberculosis In London","text":"That this House notes with concern the significant rise in tuberculosis (TB) in the UK over the last 20 years to over 9,000 cases and 400 deaths annually; recognises that London accounts for nearly 40 per cent. of all cases and has a higher rate of TB than any other capital in western Europe; further notes that TB often affects the poorest and most vulnerable communities; welcomes the recently published London TB Service Review; and urges the Government seriously and urgently to consider implementing the recommendations made in the review including the establishment of a London Board of TB Control.","date":"2010-10-12","status":"o"},{"topic":"Diseases","id":"41761","proposer":"10527","edm":"795","session":"2010-12","title":"Support For People With Rheumatoid Arthritis","text":"That this House commends the work of the National Rheumatoid Arthritis Society in supporting people with rheumatoid arthritis; notes that there are around 690,000 people with the condition in the UK and that the overall burden of the condition on the UK economy due to losses in productivity is almost 8 billion; further notes reports from the National Audit Office and Committee of Public Accounts underlining the need for co-ordinated, national action to improve outcomes for people with rheumatoid arthritis; and calls on hon. Members to support the National Rheumatoid Arthritis Society's campaign to ensure that opportunities provided through the NHS reforms enable effective joint working between the NHS, public health and social care services and result in improved outcomes for people with rheumatoid arthritis.","date":"2010-10-11","status":"o"},{"topic":"Diseases","id":"41716","proposer":"24932","edm":"756","session":"2010-12","title":"Contaminated Blood","text":"That this House most warmly welcomes the Contaminated Blood (Support for Infected and Bereaved Persons) Bill [Lords] with its provisions for the relief of privation for those afflicted and bereaved through treatment with contaminated NHS blood and blood products; and calls on the Government and hon. Members of all parties and of none to ensure this humane Bill's passage into law in this session of Parliament.","date":"2010-09-16","status":"o"},{"topic":"Diseases","id":"41721","proposer":"10170","edm":"761","session":"2010-12","title":"Diabetes Drug Avandia","text":"That this House compliments BBC Panorama and reporter Shelley Jofre for exposing the dangers of GlaxoSmithKline's diabetes drug Avandia; regrets the heart attacks and strokes as side effects of Avandia suffered by thousands of patients; deplores the negligence of the Medicines and Healthcare Products Regulatory Agency (MHRA) in again withholding safety information from patients; requests Sir Alasdair Breckenridge, Chairman of MHRA and former member of a scientific advisory board at GlaxoSmithKline, to consider his position; and calls on the Department of Health to implement the recommendations of the 2004-05 Health Select Committee Report on the Influence of the Pharmaceutical Industry and in particular its recommendation for an independent review of the MHRA.","date":"2010-09-16","status":"o"},{"topic":"Diseases","id":"41573","proposer":"24966","edm":"616","session":"2010-12","title":"Screening For Abdominal Aortic Aneurysms","text":"That this House supports the Circulation Foundation's efforts to raise awareness of the planned national screening programme for abdominal aortic aneurysms (AAA); welcomes the work carried out by the NHS AAA screening programme team; notes that abdominal aortic aneurysms are the third most common cause of death for males aged over 65 and that each year nearly 7,000 people, almost all of them men, die suddenly and without symptoms; and urges the Government to reaffirm its support for the programme and its full implementation as quickly as possible.","date":"2010-07-26","status":"o"},{"topic":"Diseases","id":"41585","proposer":"10256","edm":"628","session":"2010-12","title":"Proposed Closure Of Woodlands Respite Home","text":"That this House is concerned that the Multiple Sclerosis (MS) Society intends to close Woodlands in York, a respite home for people suffering from multiple sclerosis; notes that the press and media were informed of the proposed closure before users and local authority social services departments; and calls on the MS Society to reconsider its decision to close Woodlands in the light of the distress which it will cause to users.","date":"2010-07-26","status":"o"},{"topic":"Diseases","id":"41589","proposer":"10383","edm":"632","session":"2010-12","title":"Bakers And Asthma","text":"That this House notes with concern that bakers are about 80 times more likely to develop occupational asthma than the average worker due to exposure to flour and other bakery dusts; believes that every worker has the right to work in a healthy and safe workplace and is extremely alarmed that thousands of bakers could be at risk of developing an incapacitating respiratory condition; urges employers to work with health and safety trades union representatives and the Bakers, Food and Allied Workers Union to implement appropriate control measures to protect bakers from developing asthma; and further urges the Government to ensure that the Health and Safety Executive has sufficient resources to take the necessary action to prevent work-related illnesses such as bakers' asthma.","date":"2010-07-26","status":"o"},{"topic":"Diseases","id":"41598","proposer":"10009","edm":"641","session":"2010-12","title":"Carotid Artery Surgery","text":"That this House welcomes the findings of the UK Audit of Vascular Surgical Services and Carotid Endarterectomy which states that patients with symptoms of a mini-stroke or transient ischemic attack are missing out on life-saving surgery of the carotid artery because they fail to recognise the symptoms, that patients who do not recognise the symptoms are treated as low priority in the NHS, and that if patients have surgeryof the carotid artery ideally within 14 days this will prevent them fromhaving a full stroke,saving approximately 500 lives a year; and calls on the Government to raise awareness of the symptoms of mini-stroke and reorganise vascular surgery services so that services are concentrated in fewer, larger centres to ensure adequate staffing and resources, enabling an extra 6,500 patients a year to benefit from surgery of the carotid arteryand preventing the debilitating effects of stroke.","date":"2010-07-26","status":"o"},{"topic":"Diseases","id":"41548","proposer":"24864","edm":"591","session":"2010-12","title":"Epilepsy Specialist Nurses","text":"That this House welcomes Epilepsy Action's report Best Care: the value of epilepsy specialist nurses; supports Epilepsy Action's campaign to preserve epilepsy specialist nurse (ESN) posts; recognises the invaluable contribution to patient care of the epilepsy specialist nurse; notes that ESNs save costs by reducing demand on consultants' time, reducing hospital admissions and reducing emergency readmissions; further recognises the increasing threat to ESNs of redundancy, reduced working hours or assignment to non-specialist duties as trusts seek short-term cost savings; and calls on the Government to ensure there is a national plan to enable all patients who are assessed as requiring access to an ESN to have that access.","date":"2010-07-22","status":"o"},{"topic":"Diseases","id":"41534","proposer":"24754","edm":"577","session":"2010-12","title":"Neuromuscular Services In The Nhs South East Coast Region","text":"That this House congratulates the NHS South East Coast Specialised Commissioning Group (SECSCG) on its publication of a draft report on neuromuscular services in July 2010; notes that the report follows an in-depth review of specialised neuromuscular services in the region; further notes that there are some 5,000 people living in the South East Coast NHS region affected by muscular dystrophy and related neuromuscular conditions; further notes that the report follows a 12 month campaign by the South East Coast Muscle Group, a coalition of local families, health professionals and experts in these conditions supported by the Muscular Dystrophy Campaign; calls on the SECSCGto implement the recommendation to appoint a vital neuromuscular care adviser, a post which provides invaluable support for families living with these rare and very rare conditions; recognises that neuromuscular care advisers provide cost-effective care by helping to save consultant time and, as part of a multidisciplinary team, help to prevent expensive and traumatic emergency hospital admissions for this group of patients; further notes that the cost of unplanned emergency admissions for patients with neuromuscular conditions in the NHS South East Coast region was 5.4 million last year; and calls on the Government to urge the Specialised Commissioning Group to implement the recommendations of the report to ensure that all families living with muscle disease in the region have access to specialist multidisciplinary care which improves quality of life and increases life expectancy.","date":"2010-07-21","status":"o"},{"topic":"Diseases","id":"41539","proposer":"10614","edm":"582","session":"2010-12","title":"Diabetes Research (No. 2)","text":"That this House welcomes recent research which has found that diabetes can be treated by rescuing insulin producing cells and transplanting them into the liver; believes that diabetes sufferers could benefit hugely from this new pioneering treatment; congratulates the work done by the University of Leicester, which is one of only 20 centres worldwide which are capable of harvesting the pancreatic islets; notes that diabetes and diabetes-related conditions cost the NHS 1 million per hour; and calls on the Government to increase research funding as this could prevent this huge expenditure in the future.","date":"2010-07-21","status":"o"},{"topic":"Diseases","id":"41531","proposer":"24900","edm":"574","session":"2010-12","title":"Chlamydia Screening In England","text":"That this House recognises that one in 14 of those aged between 15 and 24 who test for chlamydia is infected; notes that chlamydia often has no obvious symptoms; further notes that, if left untreated, it can lead to conditions including infertility, ectopic pregnancy and pelvic inflammatory disease as well as onward transmission of the infection to sexual partners; further recognises that chlamydia screening in England is now cost-effective according to the Health Protection Agency's modelling; welcomes the National Audit Office's review of the National Chlamydia Screening Programme which demonstrates how further savings could be made whilst increasing diagnosis and treatment of the infection; and calls on the Secretary of State for Health to reform and maintain the delivery of opportunistic chlamydia screening for young people in England to reverse the epidemic and instil good attitudes towards sexual health in young people.","date":"2010-07-20","status":"o"},{"topic":"Diseases","id":"41458","proposer":"24888","edm":"505","session":"2010-12","title":"Asthma UK And The Report On Fighting For Breath","text":"That this House welcomes Asthma UK's Fighting for Breath report which reveals the limiting impact of severe asthma; notes that there are5.4 million people with asthma in the UK, roughly five per cent. of whom have asthma so severe that it cannot be treated with the usual medicines; recognises that many people with severe asthma battle against a lack of understanding about the impact of their condition from employers, school staff and healthcare professionals; condemns the fact that lives are put at risk in accident and emergency departments becausehealthcare professionals are not appropriately trained in asthma management; further notes that the work of specialist nurses has reduced costly emergency admissions and unscheduled care; and calls on the Government to increase awareness of severe asthma and to maintain investment in specialist asthma nurses and training to achieve the best possible outcomes for people with severe asthma.","date":"2010-07-14","status":"o"},{"topic":"Diseases","id":"41444","proposer":"11592","edm":"491","session":"2010-12","title":"Treatment For Kidney Cancer","text":"That this House observes that between 7,000 and 8,000 people are diagnosed with kidney cancer in the UK each year, and that around 40 per cent. of patients have advanced cancer at the time of diagnosis; notes that everolimus is the only licensed treatment for patients with advanced and\/or metastatic renal cell carcinoma who have failed on first-line treatment; notes with concern that the National Institute for Health and Clinical Excellence (NICE) has not recommended funding for everolimus; is concerned by the number of clinically effective cancer drugs which are turned down by NICE despite additional guidance on end-of-life medicines issued by NICE to the appraisal committees; and calls on NICE to reconsider its recommendations so that patients may be able to access this drug on the NHS.","date":"2010-07-13","status":"o"},{"topic":"Diseases","id":"41410","proposer":"24825","edm":"458","session":"2010-12","title":"Neuromuscular Services In The Nhs West Midlands","text":"That this House congratulates the NHS West Midlands Specialised Commissioning Group on its decision to invest 400,000 in specialised neuromuscular services; notes that this will serve the 6,000 people living in the region affected by muscular dystrophy and related neuromuscular conditions; further notes that the investment is the result of a six month review commmissioned by the Specialised Commissioning Group in response to the publication of the Building on the Foundations report by the Muscular Dystrophy Campaign in April 2009 which highlighted the fact that half of all the children and adults with neuromuscular conditions in the West Midlands do not receive any specialised medical care; welcomes the commitment to reduce the 6.6 million spent annually on unplanned emergency admissions for people living with rare and very rare muscular dystrophy and related neuromuscular conditions; calls on specialised commissioning groups across the country to follow the lead of the West Midlands; and praises the campaign led by the Muscular Dystrophy Campaign and the West Midlands Muscle Group, a coalition of local families, health professionals and experts in these conditions who continue to work together to fight for fair access to clinically effective, first class, specialised neuromuscular services across the West Midlands.","date":"2010-07-12","status":"o"},{"topic":"Diseases","id":"41388","proposer":"10614","edm":"445","session":"2010-12","title":"Undiagnosed Diabetes","text":"That this House notes that 1.1 million people in the UK have undiagnosed diabetes and that the total diabetes population of the UK could rise to 5.5 million by 2030; further notes that an early diagnosis of the condition with regular management could reduce risks of complications such as retinopathy, heart disease and kidney failure; and calls on the Government to support organisations such as Diabetes UK and for assessment units tobe made available in a variety of locations.","date":"2010-07-08","status":"o"},{"topic":"Diseases","id":"41385","proposer":"24924","edm":"442","session":"2010-12","title":"Anthony Nolan","text":"That this House supports Anthony Nolan in its work to provide lift-saving transplants for people with leukaemia; is concerned that for every patient that receives a transplant, there is another for whom no match can be found; welcomes the news that saliva testing means that it is now even easier for people to join the bone marrow register to help save the lives of people with leukaemia; and applauds Anthony Nolan in its ambition to double the number of lives it can save and to increase the number of its donors to one million by 2004.","date":"2010-07-07","status":"o"},{"topic":"Diseases","id":"41346","proposer":"10292","edm":"405","session":"2010-12","title":"Chronic Fatigue Syndrome \/ Myalgic Encephalomyelitis","text":"That this House notes that around one in300 people in the UK is living with chronic fatigue syndrome (CFS)\/myalgic encephalomyelitis; further notes that many sufferers report the process of diagnosis can take many months or even yearsand that patients report backa lack of awareness among clinicians about the condition and possible treatments; further notes that many patients with CFS can, if they receive appropriate support, make considerable progress and live free of relapse; and calls on the Department of Health to ensure that clinical outcomes for patients with CFS form a part of its approach to reforming remuneration for healthcare commissioners and providers.","date":"2010-07-06","status":"o"},{"topic":"Diseases","id":"41326","proposer":"10428","edm":"386","session":"2010-12","title":"Duchenne Muscular Dystrophy (No. 2)","text":"That this House notes that people suffering from Duchenne Muscular Dystrophy who live in Denmark are living into their 30s and 40s, proof that with the relevant available care, children and young men suffering from this debilitating illness can live on average 10 to 15 years longer than under the medical regime adopted for sufferers in the UK; urges the Government to immediately investigate why authorities and institutions in Britain have not yet adopted the Danish model of care for sufferers of this illness; and further urges the Government to ensure delivery of the same level of quality of treatment for UK citizens.","date":"2010-07-01","status":"o"},{"topic":"Diseases","id":"41332","proposer":"10428","edm":"392","session":"2010-12","title":"Bowel Cancer","text":"That this House recognises that 37,500 people in the UK are diagnosed with bowel cancer each year, a condition from which almost half of those so diagnosed will eventually die; further recognises that over 90 per cent. of all bowel cancer cases can be successfully treated if diagnosed early and that over the past decade major developments in cancer policy and treatments have vastly improved the quality of life of patients; notes however that many challenges remain; and praises the excellent work of organisations such as Cancer Research UK, the National Cancer Intelligence Network and its latest excellent campaign to beat bowel cancer; and calls on the Government to ensure that every assistance is given to help such organisations in their quest.","date":"2010-07-01","status":"o"},{"topic":"Diseases","id":"41310","proposer":"10614","edm":"370","session":"2010-12","title":"Diabetes Research","text":"That this House recognises that type 2 diabetes represents one of the most signficant global challenges to health; notes that in the UK alone 2.6 million people have diabetes and that 95 per cent. of these have type 2 diabetes; congratulates Professor Mark McCarthy of the University of Oxford and his group of international scientists who have identified 12 new genes associated with type 2 diabetes; believes that a better understanding of type 2 diabetes will help to prevent people from developing the condition; and calls on the Government to encourage and support further research in this field.","date":"2010-06-30","status":"o"},{"topic":"Diseases","id":"41263","proposer":"24892","edm":"285A1","session":"2010-12","title":"Effect Of Homeopathic Remedies On Breast Cancer Cells","text":"leave out from `403' to end and insert `as an example of the failure of adequate scientific peer review because the paper provides no statistical analysis to support any conclusion, indicates that the experimental control, 87 per cent. alcohol solution, was itself toxic to the cell cultures, does not illustrate or explain the different chromatographic profiles of the solvent and the test substances, and does not provide sufficient data to allow proper evaluation of the study; notes that the lead author has retired and runs a homeopathy website which falsely claims that homeopathy is as effective as a conventional chemotherapy agent, Taxol, in treating breast cancer; further notes that one of the authors, Alison Pawlus, has publicly disowned the paper; regrets that isolated poor-quality studies are cited by proponents of homeopathy to endorse dangerous and exploitative cancer-curing claims in the face of overwhelming weight of scientific evidence against them; and agrees with the conclusions of the Science and Technology Select Committee's Fourth Report of Session 2009-10, Evidence Check 2: Homeopathy HC45 that putting patients through pointless further clinical trials, and the spending of scarce public sector funds on research into homeopathy cannot be justified.'.","date":"2010-06-24","status":"o"},{"topic":"Diseases","id":"41237","proposer":"10715","edm":"303","session":"2010-12","title":"Cancer Research UK Commit To Beat Cancer Campaign","text":"That this House applauds the international reputation of Cancer Research UK in its work to understand, prevent, detect and treat cancer; congratulates the charity for being at the heart of the tremendous progress made on cancer survival rates over the last 30 years; acknowledges that the money Cancer Research UK spends on research each year (\u00a3355 million in 2008-09) is funded entirely by the public; recognises that 90 per cent. of the population lives no more than 30 miles from a Cancer Research UK research centre; notes that UK cancer outcomes are not yet as good as those in the best performing European countries; commends the Cancer Research UK Commit To Beat Cancer campaign to make the UK's cancer outcomes among the best in Europe in the next 10 years; further applauds the five core elements of the campaign to prevent more cancers, detect cancer earlier, provide world-class cancer treatments, tackle cancer inequalities and protect the UK's research base; and further acknowledges that the support of the new Coalition Government and both Houses is needed for further progress on cancer.","date":"2010-06-23","status":"o"},{"topic":"Diseases","id":"41240","proposer":"24723","edm":"306","session":"2010-12","title":"Keep Leuchie House Open","text":"That this House regrets the decision to close Leuchie House in North Berwick; notes that Leuchie House is the only respite home for sufferers of multiple sclerosis (MS) operating in Scotland and Northern England and is one of a total of only four across the UK; recognises that the level of care given at Leuchie House is exceptional and that the facility has achieved maximum scores in every area of the Care Commission's inspection; further recognises that Leuchie House is much-valued by service users and the closure of such a specialised facility will cause a strain on families and other services, such as the NHS, as they struggle to cope with the needs of MS patients; and calls on the Government to work with the Scottish Government and the MS Society to ensure the continuation of the facility.","date":"2010-06-23","status":"o"},{"topic":"Diseases","id":"41247","proposer":"10222","edm":"313","session":"2010-12","title":"Support For Ankylosing Spondylitis Patients","text":"That this House supports the National Ankylosing Spondylitis Society (NASS) in its work for people with ankylosing spondylitis (AS), a form of inflammatory arthritis which affects around 200,000 people in the UK with symptoms usually starting in early adulthood; notes the NASS drive to raise awareness of this condition, which can have a major impact on quality of life and ability to work; is concerned that many people with AS in the UK do not receive optimum care because of delayed diagnosis and lack of access to appropriate expertise and therapies; welcomes the recent NASS report Looking Ahead, which highlights the barriers to people with AS receiving the best care; and calls on the Government to ensure access to the specialists and treatments necessary to achieve the best possible outcomes for people with AS.","date":"2010-06-23","status":"o"},{"topic":"Diseases","id":"41221","proposer":"12005","edm":"289","session":"2010-12","title":"Diagnosis Of Coeliac Disease","text":"That this House recognises that people with coeliac disease have an autoimmune disease for which the only treatment is a lifelong adherence to a gluten-free diet; acknowledges that one in 100 people have the condition but that only 12 to 15 per cent. of these people are diagnosed; urges the medical profession to improve diagnosis rates to reduce the time from onset of symptoms to diagnosis; and supports Coeliac UK and its campaign to help the half a million undiagnosed get a diagnosis of their condition which will significantly improve their quality of life and save the NHS money.","date":"2010-06-22","status":"o"},{"topic":"Diseases","id":"41229","proposer":"24784","edm":"214A1","session":"2010-12","title":"Breathe Easy Week 2010 Campaign","text":"after `(BLF)', insert `and further congratulates Breathe Easy in Harlow and Epping Forest for their dedicated public service and hard work,'.","date":"2010-06-22","status":"o"},{"topic":"Diseases","id":"41213","proposer":"10715","edm":"281","session":"2010-12","title":"Cancer Care And Outcomes","text":"That this House encourages the Government to implement the recommendations made by the All Party Parliamentary Group on Cancer (APPGC) in the report of its inquiry into cancer inequalities; welcomes the re-establishment of the APPGC; calls on members of both Houses to join the APPGC so it can maintain a high profile in Parliament for cancer reform and continue to highlight the fundamental issues affecting cancer patients and their families and carers; and further calls on the Government to address the unacceptable inequality which still exists in cancer care and outcomes in the UK.","date":"2010-06-21","status":"o"},{"topic":"Diseases","id":"41217","proposer":"10602","edm":"285","session":"2010-12","title":"Effect Of Homeopathic Remedies On Breast Cancer Cells","text":"That this House welcomes the study published in the International Journal of Oncology (2010 Feb; 36(2): 395-403) which revealed that homeopathic remedies have a beneficial effect on breast cancer cells; notes that researchers at the University of Texas conducted an in vitro study to determine whether products prescribed by a clinic in India have any effect on breast cancer cell lines; further notes that the researchers studied four ultra-diluted remedies (carcinosin, phytolacca, conium and thuja) against two human breast adenocarcinoma cell lines (MCF-7 and MDA-MB-231) and a cell line derived from immortalized normal human mammary epithelial cells (HMLE); observes that the remedies exerted preferential cytotoxic effects against the two breast cancer cell lines, causing cell cycle delay\/arrest and apoptosis; believes that the findings demonstrate biological activity of these natural products when presented at ultra-diluted doses; and calls for further research in this important area.","date":"2010-06-21","status":"o"},{"topic":"Diseases","id":"41188","proposer":"24789","edm":"265","session":"2010-12","title":"Champions For Childhood Epilepsy Campaign","text":"That this House congratulates in National Epilepsy Week the National Centre for Young People with Epilepsy (NCYPE) on its Champions for Childhood Epilepsy campaign to improve health and education services for young people with epilepsy; notes that 31 staff from 21 schools from the Tandridge Confederation in Surrey and from West Sussex collaborated with the NCYPE on a pilot epilepsy champions project; recognises that the resulting support programme includes a model of best practice that can be adopted by schools across the UK to improve the educational experience and outcomes for the near 60,000 young people living with epilepsy; appreciates that this work covered close to 7,000 students, including 55 with a diagnosis of epilepsy; further notes that on average there is one child with epilepsy in every primary school and five in every secondary school in the UK; welcomes the first phase of the NCYPE's Epilepsy 4 Education programme which will provide free, direct support for schools in London and the South East; and calls on the Government to recognise this significant contribution from the voluntary sector by encouraging all schools to join the NCYPE's Champions for Childhood Epilepsy campaign so that these practical, affordable and effective measures can make a difference to the lives of young people with epilepsy across the UK.","date":"2010-06-17","status":"o"},{"topic":"Diseases","id":"41199","proposer":"10001","edm":"276","session":"2010-12","title":"World Sickle Cell Day","text":"That this House celebrates the United Nations World Sickle Cell Day on 19 June 2010; notes that sickle cell disease is the most common genetic disease in England; believes that allocation of NHS resources should reflect this; recognises that some improvements have been made in the UK in treatment and screening for sickle cell and thalassaemia, but that care received by patients is still variable, leading to unnecessary deaths in the most extreme cases; calls on the Government to continue improving services for patients with these conditions; further recognises the need for better education of the medical, nursing and social care professions regarding the conditions; and further calls on the Government to support the work of the voluntary sector in improving awareness of the conditions within the communities affected, in schools and amongst the wider public.","date":"2010-06-17","status":"o"},{"topic":"Diseases","id":"41177","proposer":"24819","edm":"254","session":"2010-12","title":"National Strategy For Motor Neurone Disease","text":"That this House endorses the call by the Motor Neurone Disease Association for a national strategy for motor neurone disease (MND); believes that such a strategy would lead to enhanced cost-effectiveness and good practice; supports the implementation of the National Service Framework for long-term neurological conditions; is dismayed that no official national clinical guidance or approach exists in relation to MND; notes the extreme cruelty of motor neurone disease, which dramatically curtails lives and traps an often healthy mind in a failing and incapacitated body; and further believes that a national strategy is urgently needed in order to address the inequity of access to best practice in care for people with MND and to ensure as high a quality of life as possible and dignity in death.","date":"2010-06-16","status":"o"},{"topic":"Diseases","id":"41137","proposer":"24919","edm":"214","session":"2010-12","title":"Breathe Easy Week 2010 Campaign","text":"That this House congratulates the British Lung Foundation (BLF) on the launch of their Children's Charter during Breathe Easy Week 2010; praises the Charter for outlining what is required to make a substantial difference to the lung health of children in the UK; notes that the most commonly reported long-term illnesses in children and babies are conditions of the respiratory system; further notes that children with any respiratory problems have the right to have access to a professional who is suitably qualified and that all children and their parents and carers should be given the opportunity to learn how to keep young lungs healthy; further notes that the BLF's survey of mumsnet.com users found that 86 per cent. of respondents support a ban on smoking in cars, where minors are present, to protect the health of children; and urges an increase in awareness of the dangers of passive smoking to children's health.","date":"2010-06-14","status":"o"},{"topic":"Diseases","id":"41129","proposer":"11427","edm":"206","session":"2010-12","title":"Duchenne Muscular Dystrophy","text":"That this House commends the work of charity Action Duchenne in highlighting the need to deliver care levels that will extend by up to 15 years the lives of children living with the severe muscle-wasting disease Duchenne Muscular Dystrophy; endorses the recently agreed International Standards of Care guidelines for Duchenne published in the Lancet Neurology in March 2010; supports Duchenne families who are calling on the Government to ensure that levels of care for these vulnerable children are not cut in the forthcoming spending review; believes that recommendations in the new guidelines for multi-disciplinary care for Duchenne patients should be implemented for all, irrespective of where they live; and further believes that further funding should be made available to continue research and development of new medicines to cure this devastating condition.","date":"2010-06-10","status":"o"},{"topic":"Diseases","id":"41117","proposer":"10527","edm":"194","session":"2010-12","title":"Diabetes Week 2010","text":"That this House welcomes Diabetes Week 2010, 13 to 19 June; notes that there are 2.6 million people living with diabetes in the UK and up to 500,000 people who have the condition but who remain undiagnosed; regrets that despite its increasing prevalence a number of myths about the condition persist which can lead to discrimination and prejudice against people with diabetes; and congratulates Diabetes UK for the work it does to raise awareness about diabetes to dispel these myths and give people accurate information about the condition.","date":"2010-06-09","status":"o"},{"topic":"Diseases","id":"41038","proposer":"10527","edm":"122","session":"2010-12","title":"Type 1 Diabetes Research","text":"That this House supports the Juvenile Diabetes Research Foundation (JDRF) in its campaign to increase awareness and understanding about type 1 diabetes; notes that type 1 and type 2 diabetes are very separate and distinct conditions; acknowledges that type 1 diabetes is a chronic, life-threatening auto immune condition and is not caused by eating sugary food, by being overweight or by lifestyle choices; further notes with concern that type 1 is a leading cause of kidney failure, adult blindness, stroke, heart attacks and nerve damage and that incidence of the condition is increasing by four per cent. year on year; further notes that approximately five per cent. of the entire NHS budget is spent on treating type 1 diabetes; recognises that JDRF is the world's leading charitable funder of type 1 diabetes research and the only organisation dedicated solely to finding the cure for type 1; and believes that more funding for medical research will lead to the development of better treatments for type 1 diabetes, resulting in fewer complications and hospitalisations, improve cost efficiencies for the NHS budget and lead to a cure.","date":"2010-06-02","status":"o"},{"topic":"Diseases","id":"41042","proposer":"24872","edm":"126","session":"2010-12","title":"National Myeloma Awareness Week 2010","text":"That this House welcomes National Myeloma Awareness Week from 21 to 28 June 2010, which focuses on raising awareness of myeloma in primary care; further welcomes the recent Office for National Statistics' report showing that five year survival in myeloma is increasing at one of the fastest paces among all cancers; notes, however, that there is still much work to do to build on these significant improvements, particularly around achieving timely diagnosis and access to treatment; supports the TAKE 2 project of the Myeloma UK GP Pledge Campaign which this year aims to deliver the Myeloma Diagnosis Pathway to 4,000 more GPs across the UK and help reduce the likelihood of delays in diagnosis; recognises the importance of the Myeloma Diagnosis Pathway as a reference tool to raise awareness of the common signs and symptoms of myeloma and the steps to take if myeloma is suspected; encourages hon. Members to get involved in the TAKE 2 campaign and take a copy of the Myeloma Diagnosis Pathway with them the next time they have a GP appointment, encouraging their friends, family and colleagues to do the same; commends the progress of the National Awareness and Early Diagnosis Initiative; and calls on the Government to work in collaboration with the myeloma community to develop and deliver key messages on myeloma for primary care.","date":"2010-06-02","status":"o"},{"topic":"Diseases","id":"41035","proposer":"24889","edm":"119","session":"2010-12","title":"Hepatitis C Trust's Get Tested Campaign","text":"That this House notes that 19 May 2010 is World Hepatitis Day; is concerned that 500 million people worldwide have either chronic hepatitis B or C which is equivalent to one in 12 of the global population, including between 250,000 and 500,000 people infected with hepatitis C in the UK; welcomes the Hepatitis C Trust's Get Tested campaign aimed at diagnosing all those at risk of hepatitis C in the UK; is encouraged by news that early diagnosis and treatment could largely eradicate the virus within 30 to 40 years; and urges action to increase public and professional awareness of the disease and improve patient pathways in hepatitis C services.","date":"2010-05-27","status":"o"},{"topic":"Diseases","id":"41037","proposer":"10614","edm":"121","session":"2010-12","title":"Prevention Of Diabetes","text":"That this House recognises that diabetes is one of the biggest health challenges currently facing the UK with 5.1 per cent. of the population suffering; acknowledges the rise in sufferers of the condition from 1.4 million in 1996 to 2.6 million last year, with estimations of a further increase to four million by 2025; notes with concern the tremendous cost of the condition to the NHS with it utilising 10 per cent. of the 2007-08 budget, equivalent to \u00a3173 million per week, \u00a325 million per day or \u00a3286 per second; and calls on the Government to increase efforts to raise the public's awareness of diabetes, its complications and the ways in which it can be prevented.","date":"2010-05-27","status":"o"},{"topic":"Diseases","id":"40868","proposer":"11707","edm":"1208","session":"2009-10","title":"National Institute For Health And Clinical Excellence Ruling On Azacitidine","text":"That this House notes that patients with myelodysplastic syndromes (MDS) suffer from chronic and severe fatigue and are at risk of progressing to a more aggressive form of leukaemia (acute myeloid leukaemia); observes that the drug azacitidine is the first and only licensed drug available specifically to treat MDS and has the ability both to slow the progress of the disease and immeasurably improve patients' quality of life; is disappointed at the recent National Institute for Health and Clinical Excellence (NICE) recommendation that azacitidine is not sufficiently cost-effective; recognises that as few as 700 patients would require the drug each year, which translates to a diminutive portion of the NHS budget; and calls on NICE to reconsider its recommendation on use of the drug which is already widely available in other Western European and North American countries.","date":"2010-03-30","status":"o"},{"topic":"Diseases","id":"40707","proposer":"11377","edm":"1072","session":"2009-10","title":"World Tuberculosis Day","text":"That this House recognises the importance of World Tuberculosis Day on 24 March 2010; notes with concern the continued rise in tuberculosis (TB) cases globally, resulting in nearly 5,000 deaths a day and the increase of TB in the UK, particularly among vulnerable, marginalised populations; further notes that TB-HIV co-infection and TB drug resistance is fuelling the epidemic; and calls on the Government to ensure the maximum effectiveness is achieved through its efforts in the UK and overseas to combat this preventable and curable disease.","date":"2010-03-11","status":"o"},{"topic":"Diseases","id":"40696","proposer":"10261","edm":"1064","session":"2009-10","title":"World Kidney Day 2010","text":"That this House welcomes World Kidney Day 2010 which raises awareness of kidney disease among the general population and seeks to publicise the link between kidney disease and diabetes; is alarmed that kidney disease is common and increasing; notes that diabetic kidney disease remains the single most common cause of renal failure; further notes that kidney failure and diabetes can lead to an elevated risk of heart disease; further welcomes the introduction of the NHS Health Check which supports the early detection of kidney disease; urges the Government to build upon these measures through a public health campaign highlighting the importance of kidneys; applauds the efforts of kidney patients, their families and friends, clinicians and healthcare professionals who have worked hard to highlight the issues associated with kidney disease and spread the important message of World Kidney Day; expresses its concern that an estimated 13,000 people die from kidney disease annually in this country; further notes that in the UK numbers of adults receiving dialysis treatment for kidney failure is increasing every year by eight per cent.; strongly believes that patient choice is the key to ensuring the best possible quality of life for patients; and calls on the Government to investigate ways by which to improve levels of patient choice in renal services.","date":"2010-03-10","status":"o"},{"topic":"Diseases","id":"40634","proposer":"10013","edm":"1008","session":"2009-10","title":"Brain Cancer","text":"That this House recognises that one in five of all cancers spread to the brain; notes that the number of children dying from a brain tumour in 2007 was 33 per cent. higher than in 2001; further notes that five-year survival rates for brain cancer are low relative to most other cancers; and calls for brain tumour research to receive greater cancer funding from Government than the 0.7 per cent. of all cancer funding that it currently receives.","date":"2010-03-04","status":"o"},{"topic":"Diseases","id":"40620","proposer":"10527","edm":"998","session":"2009-10","title":"Diabetes UK Improving Lives Campaign","text":"That this House welcomes the Diabetes UK campaign Improving Lives; regrets that more than 2.5 million people in the UK have diabetes; further regrets that up to 500,000 people have Type 2 diabetes but do not know it; notes with concern that one person in the UK is diagnosed with diabetes every three minutes and that by 2025 it is estimated that over four million people will have diabetes; acknowledges that diabetes is one of the biggest health challenges facing the UK today which, including the treatment of serious complications, costs the NHS 10 per cent. of its annual resources; and urges hon. Members seeking re-election in 2010 to support the Improving Lives campaign and the important issues it highlights.","date":"2010-03-03","status":"o"},{"topic":"Diseases","id":"40621","proposer":"10780","edm":"999","session":"2009-10","title":"Ms Awareness Week","text":"That this House notes the forthcoming MS Awareness Week between 26 April and 2 May 2010; acknowledges that about 100,000 people throughout the UK are affected by the condition and that in some regions of the UK, such as the north coast of Northern Ireland, instances are among the highest throughout the country; and pays tribute to branches of the MS Society in Northern Ireland which have been lobbying elected representatives for more access to physiotherapy for people with MS given the benefits such treatment provides for sufferers.","date":"2010-03-03","status":"o"},{"topic":"Diseases","id":"40595","proposer":"11784","edm":"975","session":"2009-10","title":"Asbestos In Schools (No. 2)","text":"That this House is concerned by the recent report of the Asbestos Training and Consultancy Association, which highlights systemic failings in the management of asbestos in schools; notes with alarm that around 75 per cent. of schools contain this potentially deadly substance; further notes that at least 178 school teachers have died from the fatal disease mesothelioma, which is contracted from asbestos; welcomes the decision by the Department for Children, Schools and Families to set up a steering group to examine all aspects of risk, management and training for asbestos in schools; and calls on the Government to take further steps to tackle this problem and to ensure that adequate guidance and training is in place for the protection of staff and pupils.","date":"2010-03-02","status":"o"},{"topic":"Diseases","id":"40598","proposer":"10261","edm":"978","session":"2009-10","title":"International Rare Disease Day","text":"That this House welcomes the third International Rare Disease Day on 28 February 2010; notes that there are over 6,000 rare diseases, affecting approximately 3.5 million people in the UK; supports the focus of this year's Rare Disease Day on the importance of research into rare diseases for the millions of patients without a cure; believes that rare diseases should be seen as a public health priority; and joins Rare Disease UK in calling on the Government to act on its commitment to a strategy for rare diseases as demonstrated by the adoption of the European Council Recommendation on action for rare diseases in June 2009.","date":"2010-03-02","status":"o"},{"topic":"Diseases","id":"40585","proposer":"11245","edm":"965","session":"2009-10","title":"Diabetes UK Recommendations","text":"That this House notes with concern that diabetes is one of the biggest health challenges facing the UK today and now costs the NHS 10 per cent. of its resources; further notes with concern that every three minutes one person in the UK is diagnosed with diabetes; congratulates Diabetes UK on its Get Serious campaign which recommends prioritising action to solve day-to-day problems facing people living with diabetes; and calls on the Government and Her Majesty's Opposition to commit to acting on Diabetes UK's recommendations.","date":"2010-03-01","status":"o"},{"topic":"Diseases","id":"40563","proposer":"11651","edm":"944","session":"2009-10","title":"Ovarian Cancer Action Charity","text":"That this House welcomes Ovarian Cancer Awareness Month in March; notes with concern that only 38 per cent. of women diagnosed with ovarian cancer in the UK will survive five years; recognises that women who are diagnosed at an early stage with ovarian cancer have a 90 per cent. survival rate five years beyond diagnosis, as opposed to women diagnosed at a later stage with the disease where survival rates are much lower; further welcomes the all party commitment to improve access to diagnostic tools for cancers, including ovarian cancer; further recognises proposals aimed at increasing prompter diagnosis of ovarian cancer; acknowledges the good work of Ovarian Cancer Action to improve women's chances of surviving ovarian cancer by funding research and raising awareness of the disease by giving a voice to women with ovarian cancer and their families; and calls on the Government to support Ovarian Cancer Action's Remember the Symptoms campaign to raise awareness among health professionals and women alike of the symptoms of ovarian cancer to increase earlier diagnosis of the disease and improve survival rates.","date":"2010-02-25","status":"o"},{"topic":"Diseases","id":"40395","proposer":"10614","edm":"796","session":"2009-10","title":"Low Glucose Levels In Type 2 Diabetes Sufferers","text":"That this House commends research undertaken by Cardiff University into the dangers of letting blood glucose levels drop too low in type 2 diabetes sufferers; notes the health problems associated with letting blood glucose go too high or too low; further notes that it is essential that even levels of blood glucose are maintained in type 2 diabetes sufferers; supports the call for diabetes sufferers to undertake regular check-ups to ensure the most appropriate treatment is provided, alongside a healthy diet and regular exercise; is concerned that more than 145,000 new cases of diabetes, mostly type 2, were diagnosed in the past year; urges the Government to investigate further the overall effect of intensification of glucose control with insulin therapy and its link to a heightened risk of death; and encourages the Government to provide guidelines on regular check-ups and advice on managing diabetes to sufferers and their practitioners.","date":"2010-02-03","status":"o"},{"topic":"Diseases","id":"40314","proposer":"11427","edm":"724","session":"2009-10","title":"Breast Cancer Screening In The North East","text":"That this House applauds the tremendous progress made in recent years to increase access to cancer screening and to prevent premature deaths; congratulates the Government and dedicated staff for the fact that cases of breast cancer picked up by screening have already doubled in the North East over the last decade, which should provide further assurance to women that breast checks are effective; notes that 95,605 women were screened in 2009 and 731 cases of cancer were detected of which 589 were invasive; and further notes that the current target age range is between 50 and 70 years old, but that the widening of the screening programme from April 2008 included those aged between 47 and 73 years, with full coverage expected in 2015.","date":"2010-01-26","status":"o"},{"topic":"Diseases","id":"40291","proposer":"10240","edm":"701","session":"2009-10","title":"Ms Society","text":"That this House congratulates the MS Society on its campaign to uphold the rights of people living with multiple sclerosis, namely the right to quality health care including fair access to appropriate drugs and treatments, the right to personalised care and support, the right to wheelchairs and equipment to enable independent living and the right to support in and out of work, including support for carers; and commends the MS Society for its success in highlighting the impact of this unpredictable and incurable condition.","date":"2010-01-25","status":"o"},{"topic":"Diseases","id":"40245","proposer":"14137","edm":"641A1","session":"2009-10","title":"Prescription Charges In Scotland (No. 2)","text":"leave out from `England' to end and insert `but expresses disappointment that sufferers of other long-term conditions still have to pay prescription charges despite a commitment by the Prime Minister to help with those long-term conditions; and commends the Scottish government's decision to reduce prescription charges for all users before phasing them out completely in April 2011.'.","date":"2010-01-19","status":"o"},{"topic":"Diseases","id":"40219","proposer":"10428","edm":"635","session":"2009-10","title":"Alimta And Treatment For Mesothelioma Sufferers","text":"That this House is aware that the anti-cancer drug Alimta is enormously beneficial in the treatment of mesothelioma tumours; recalls that sufferers in Scotland and parts of England and Wales have had access to the drug via cancer networks and primary care trusts; is therefore alarmed that the National Institute of Health and Clinical Excellence (NICE) has indicated that it is not minded to recommend Alimta for prescription to patients despite its known efficacy; and calls on the Government to ignore such advice, which deals mainly with NICE's narrow definition of cost effectiveness rather than the clinical needs of sufferers.","date":"2010-01-18","status":"o"},{"topic":"Diseases","id":"40226","proposer":"10070","edm":"641","session":"2009-10","title":"Prescription Charges In Scotland (No. 2)","text":"That this House notes that since 1 April 2009, cancer patients have been exempt from prescription charges in England, whereas in Scotland they will be required to pay \u00a33 per prescription from 1 April 2010; congratulates the Government for this targeted and responsive measure; and is disappointed that the devolved Scottish administration is continuing to fail to provide the same support to those requiring prescription drugs to deal with cancer in Scotland, in a similarly timely manner.","date":"2010-01-18","status":"o"},{"topic":"Diseases","id":"40126","proposer":"10614","edm":"548","session":"2009-10","title":"Type 2 Diabetes And Visceral Fat","text":"That this House notes with concern that a recent study into diabetes by GlaxoSmithKline has revealed a link between visceral fat - fat accumulated around internal organs - and type 2 diabetes; is concerned that a survey of 12,000 Europeans found most had no idea that being overweight could be attributed to being at risk of type 2 diabetes; further notes that 90 per cent. of people diagnosed with pre-diabetes are overweight or obese; commends a diabetes study by the University of Oxford that explores the genetic roots of type 2 diabetes; and calls on the Government to increase its efforts to raise the public's awareness of the link between weight and diabetes and to support further research into the area.","date":"2010-01-06","status":"o"},{"topic":"Diseases","id":"40109","proposer":"10677","edm":"533","session":"2009-10","title":"National Lung Cancer Audit","text":"That this House notes the publication of the National Lung Cancer Audit 2009 which identifies wide regional variations in the active treatment of lung cancer and patients' access to specialist lung cancer nurses; is concerned by the Audit's findings that only half of lung cancer patients are currently seen by a lung cancer specialist nurse and that only a quarter of patients have a nurse specialist present to give them support when receiving their diagnosis; welcomes the publication of the United Kingdom Lung Cancer Coalition's Lung Cancer Review, which benchmarks progress and makes recommendations for change across important aspects of lung cancer, including prevention and awareness, diagnosis and treatment, workforce capacity, data collection and research; and calls on the Government to work with the UK Lung Cancer Coalition and its members to help deliver the ambitious but achievable aim of doubling lung cancer survival in the UK.","date":"2010-01-05","status":"o"},{"topic":"Diseases","id":"40112","proposer":"10442","edm":"537","session":"2009-10","title":"Under 18 Year Olds And Sunbeds","text":"That this House expresses concern that under 18 year olds are able to easily access unsupervised sunbed salons; further expresses strong concern that malignant melanoma, the most dangerous form of skin cancer, is increasing at an alarming rate across the UK; notes with concern that the International Agency for Research on Cancer has re-classified sunbeds into its highest cancer risk category alongside tobacco; further notes research commissioned by Cancer Research UK found that in 2008-09 six per cent. of 11 to 17 year olds have used sunbeds; further notes that the research also found that 50 per cent. of 15 to 17 year old girls in Liverpool and Sunderland have used a sunbed; recognises that 87 per cent. of the UK public believe under 18 year olds should not use sunbeds, with 90 per cent. supporting sunbed salons being staffed; welcomes the Private Member's Sunbed (Regulation) Bill which would make it an offence for an operator to allow under-18s to use sunbeds; and calls on hon. Members of both Houses to support legislation to protect children from sunbeds.","date":"2010-01-05","status":"o"},{"topic":"Diseases","id":"40113","proposer":"10462","edm":"538","session":"2009-10","title":"Contaminated Blood (Support For Affected And Bereaved Persons) Bill [lords]","text":"That this House most warmly welcomes the Contaminated Blood (Support for Infected and Bereaved Persons) Bill [Lords] with its provisions for the relief of privation for those afflicted and bereaved through treatment with contaminated NHS blood and blood products; and calls on the Government and hon. Members of all parties and of none to ensure this humane Bill's passage into law in this session of Parliament.","date":"2010-01-05","status":"o"},{"topic":"Diseases","id":"40036","proposer":"10614","edm":"464","session":"2009-10","title":"Incidence Of Diabetes In Children","text":"That this House notes with concern that a recent study into fructose by the University of California has revealed a link between high levels of fructose, a sweetener commonly found in children's products, and incidences of diabetes and weight gain; is concerned that there is an increase in children under 15 years with Type 1 diabetes across Europe from 94,000 in 2005 to a predicted 160,000 in 2020; states that 90 per cent. of people diagnosed with pre-diabetes are overweight or obese; and calls on the Government to increase its efforts to raise the public's awareness of diabetes in children, particularly the dangers of high levels of fructose, and how it can be prevented.","date":"2009-12-15","status":"o"},{"topic":"Diseases","id":"39911","proposer":"11489","edm":"351","session":"2009-10","title":"Colitis And Crohn's Disease","text":"That this House recognises the potentially debilitating nature of inflammatory bowel disease, and the effect this can have on carrying out everyday tasks; notes that Crohn's disease and colitis are not as well understood by the general public as some other conditions and is concerned that the Department for Work and Pensions and Jobcentre Plus policies do not always reflect the needs of these conditions; acknowledges that the conditions can change over time, and that it can be difficult to assess whether sufferers are fit for work on an ongoing basis; welcomes the publication of the Quality Care Standards for Inflammatory Bowel Disease, the first national framework on how to treat these conditions; and calls on the Government to ensure that health workers, Department for Work and Pensions staff and Jobcentre Plus staff are given adequate training to respond to the needs of people with colitis and Crohn's disease.","date":"2009-12-03","status":"o"},{"topic":"Diseases","id":"39912","proposer":"11489","edm":"352","session":"2009-10","title":"Essential Tremor Disorder","text":"That this House acknowledges the difficulties faced by those diagnosed with essential tremor, an involuntary shaking or trembling of part of the body; notes that it is one of the most common neurological diseases, affecting approximately four per cent. of those aged 40 years or over, and the most common form of tremor; further acknowledges that while many can live happy, healthy lives despite the disorder, it can cause significant problems for the remainder in carrying out their daily routine; welcomes the support given to sufferers by the National Tremor Foundation in the UK; further notes the lack of research into this condition; and believes that greater recognition of essential tremor would help to improve treatment and public understanding.","date":"2009-12-03","status":"o"},{"topic":"Diseases","id":"39815","proposer":"10262","edm":"272","session":"2009-10","title":"Myelodysplastic Syndromes","text":"That this House recognises that myelodysplastic syndromes (MDS) are a group of blood disorders affecting approximately 10,000 people in the UK in which around one third of cases progress to acute leukaemia, and that more than 90 per cent. of patients are over the age of 50 when they are diagnosed; notes that there is a lack of awareness of MDS by the public, Parliament and non-specialist healthcare professionals; welcomes the work of the MDS UK Patient Support Group in raising the profile of the conditions and in providing support to patients; calls for continued progress to be made in the diagnosis and treatment of MDS patients across the UK to minimise regional inequality of access to essential, specialist treatment and care through the NHS; calls for clinically effective pharmaceutical interventions to be made available to patients; and recommends that updated national guidelines for treatment are developed.","date":"2009-11-26","status":"o"},{"topic":"Diseases","id":"39780","proposer":"10351","edm":"237","session":"2009-10","title":"East Midlands Muscle Group","text":"That this House welcomes the launch of the East Midlands Muscle Group; notes that the group is led by local families and people affected by muscular dystrophy and related neuromuscular conditions who will campaign to improve access to essential specialist care and support; is concerned to learn of the serious problems affecting the 4,000 people with muscular dystrophy and related neuromuscular conditions living in East Midlands; further notes that access to multi-disciplinary specialist care improves overall health outcomes and survival for patients with muscular dystrophy and related neuromuscual conditions; is deeply concerned that some patients are being denied access to multi-disciplinary specialist care; calls on the East Midlands Specialised Commissioning Group, local primary care trusts and the Strategic Health Authority to take forward a review of neuromuscular services to identify areas of best practice and gaps in NHS service provision; and praises the campaign led by the Muscular Dystrophy Campaign, local families, health professionals and experts in these conditions who will work together to fight for good access to clinically effective, first class, specialised neuromuscular services across the East Midlands region.","date":"2009-11-25","status":"o"},{"topic":"Diseases","id":"39785","proposer":"10105","edm":"242","session":"2009-10","title":"Rights Of Those With Pleural Plaques","text":"That this House accepts expert evidence that pleural plaques represent a change to the anatomy of the sufferer evidenced by the abnormal scarring caused by the permanent physical penetration of asbestos fibres; believes the Law Lords ruling that physiological damage as well as anatomical damage is necessary for an injury to constitute actionable damage is clearly inconsistent with other areas of personal injury; notes that many sufferers of the condition would receive compensation if the scarring was on the outside of the body; and calls on the Secretary of State for Justice to restore the status quo ante to allay the strong sense of injustice felt by sufferers who have sustained asbestos exposure through their employers' negligence and have been unable to proceed with a court action since the Law Lords decision of October 2007.","date":"2009-11-25","status":"o"},{"topic":"Diseases","id":"39738","proposer":"10598","edm":"198","session":"2009-10","title":"National Strategy For Motor Neurone Disease","text":"That this House endorses the call by the Motor Neurone Disease Association for a national strategy for motor neurone disease (MND) and believes that such a strategy would lead to enhanced cost-effectiveness and good practice; supports the implementation of the National Service Framework for Long-Term Neurological Conditions; is dismayed that no official national clinical guidance or approach exists in relation to MND; notes the extreme cruelty of motor neurone disease, which dramatically curtails lives and traps an often healthy mind in a failing and incapacitated body; and further believes that a national strategy is urgently needed in order to address the inequity of access to best practice in care for people with MND and to ensure as high a quality of life as possible and dignity in death.","date":"2009-11-24","status":"o"},{"topic":"Diseases","id":"39655","proposer":"10295","edm":"118","session":"2009-10","title":"National Autism Society","text":"That this House commends the National Autism Society (NAS) for its work to increase and expand diagnosis and support services for those with autism and related developmental problems; recognises the importance of ensuring that diagnosis and support services are targeted and effective to eradicate the isolation and ignorance that those with autism are at risk of experiencing; further recognises that effective services can only be achieved by the Government working closely with the NAS, local authorities and primary care trusts to develop their knowledge and expertise of autism; and calls on the Government to pursue building these relationships in order to transform the lives of both adults and children with autism.","date":"2009-11-19","status":"o"},{"topic":"Diseases","id":"39674","proposer":"10027","edm":"137","session":"2009-10","title":"World Chronic Obstructive Pulmonary Disease Day 2009","text":"That this House celebrate World Chronic Obstructive Pulmonary Disease (COPD) Day on 18 November 2009; eagerly awaits the forthcoming clinical strategy for COPD; understands that if fully implemented this 10-year plan for the NHS will raise the quality of care for people living with COPD, address the lack of awareness of the condition and help to identify the millions of people with undiagnosed COPD; supports the aim of the British Lung Foundation to make COPD a disease of the past by ensuring that people are diagnosed during the early stages of their disease and are encouraged to take steps that will halt the disease progression; and endorses the award-winning Love Your Lungs campaign led by the British Lung Foundation which uses demographic data to identify where people with undiagnosed COPD are most likely to live and which through targeted campaigning encourages people most at risk to have a lung function test.","date":"2009-11-19","status":"o"},{"topic":"Diseases","id":"39565","proposer":"11245","edm":"28","session":"2009-10","title":"Tackling Malaria","text":"That this House notes that malaria still afflicts 40 per cent. of the world's population; calls on governments of malaria-endemic countries and international public and private organisations to work together to fight malaria worldwide and to raise awareness of malaria; further notes that, although preventable and curable, malaria continues to infect more than 500 million people each year in more than 90 countries of the world, killing betweenone and three million people, including a child every 30 seconds, and that it is especially lethal to children underfive and pregnant mothers;further notes that although the burden of malaria is heaviest in sub-Saharan Africa, it also afflicts Asia, Latin America, the Middle East and parts of Europe, and is spreading with climate change; congratulates all those engaged in the global campaign against malaria; further notes a number of countries have reduced malaria deaths by 50 per cent. in the last five years as theresources and implementation of preventative measures and treatments have been scaled up;further notes thatmalaria will only be defeated through collaboration and co-ordinated action of all relevant actors on local, national, regional and international levels; and therefore calls on the Government to maintain and enhance its international co-operation, collaboration and co-ordination of action towards the achievement of the UN 2010 and 2015 goals to end suffering and deaths from malaria, the world's most avoidable but devastating scourge.","date":"2009-11-18","status":"o"},{"topic":"Diseases","id":"39576","proposer":"11245","edm":"39","session":"2009-10","title":"Living With Autism","text":"That this House notes that there are over half a million people in the United Kingdom with autism who, to varying degrees, struggle to make sense of the world; further notes that this can cause them considerable anxiety, particularly in understanding and relating to other people and taking part in family, work and social life; further notes with concern that autism is still relatively unknown and misunderstood which means that many of those affected get nothing like the level of help, support and understanding they need; and congratulates the National Autistic Society for working with people living with autism to overcome social isolation,encourage independence and livelife with confidence so they can enjoy the same opportunities that the rest of us take for granted.","date":"2009-11-18","status":"o"},{"topic":"Diseases","id":"39636","proposer":"10258","edm":"99","session":"2009-10","title":"Variant Creutzfeldt-Jakob Disease","text":"That this House notes the 171 deaths and confirmed cases of variant Creutzfeldt-Jakob Disease (vCJD) and the four currently surviving victims of the disease in the UK, including four through blood transfusion compared with three in total in the US; congratulates and welcomes the work of Christine Lord, following the tragic death of her son Andy from vCJD at the age of 24, in establishing a website, www.justiceforandy.com, and producing a BBC South documentary Who Killed My Son; asks the BBC to screen the documentary nationwide; further asks the Government to commission further research to establish common factors, such as school catering and vaccines among vCJD victims in South Hampshire as well as elsewhere in the country including the cases of two young men from Eastleigh near Southampton who died of vCJD within weeks of each other, and who had both received polio vaccines from the same batch; further notes the Written Answer from the Minister of State for Health on 11 March 2008, giving a vCJD sub-clinical prevalence estimate of up to one in 1,400 of the population; and further asks that the Government completes its evaluation of screening for prions in blood supply and other possible measures to protect the blood supply, in light of the conclusions reported in the 15th annual report of the National Creutzfeldt-Jakob Disease Surveillance Unit, that blood transfusion is the most effective transmission route for vCJD.","date":"2009-11-18","status":"o"},{"topic":"Diseases","id":"39520","proposer":"10105","edm":"2258","session":"2008-09","title":"Restoring The Rights Of Pleural Plaque Sufferers","text":"That this House accepts expert evidence that pleural plaques represent a change to the anatomy of the sufferer evidenced by the abnormal scarring caused by the permanent physical penetration of asbestos fibres; believes the Law Lords ruling that physiological damage as well as anatomical damage is necessary for an injury to constitute actionable damage is clearly inconsistent with other areas of personal injury; notes that many sufferers of the condition would receive compensation if the scarring was on the outside of the body; and calls on the Secretary of State for Justice to restore the status quo ante to allay the strong sense of injustice felt by sufferers who have sustained asbestos exposure through their employers' negligence and have been unable to proceed with a court action since the Law Lords decision of October 2007.","date":"2009-11-09","status":"o"},{"topic":"Diseases","id":"39479","proposer":"10598","edm":"2219","session":"2008-09","title":"National Strategy For Motor Neurone Disease","text":"That this House endorses the call by the Motor Neurone Disease Association for a national strategy for motor neurone disease (MND) and believes that such a strategy would lead to enhanced cost-effectiveness and good practice; supports the implementation of the National Service Framework for Long-Term Neurological Conditions; is dismayed that no official national clinical guidance or approach exists in relation to MND; notes the extreme cruelty of motor neurone disease, which dramatically curtails lives and traps an often healthy mind in a failing and incapacitated body; and believes that a national strategy is urgently needed in order to address the inequity of access to best practice in care for people with MND and to ensure as high a quality of life as possible and dignity in death.","date":"2009-11-03","status":"o"},{"topic":"Diseases","id":"39393","proposer":"10296","edm":"2148","session":"2008-09","title":"Skydiving World Record And Breast Cancer Awareness","text":"That this House congratulates the British female skydiving team Brit Chicks on its successful contribution to achieving a new skydiving world record at Perris, California on 26 September 2009; commends Brit Chicks for being part of the international group of women skydivers achieving the record of 181-way freefall formation; and pays tribute to all the skydivers who took part in Jump for the Cause, raising over $900,000 for breast cancer research and promoting breast cancer research awareness worldwide.","date":"2009-10-26","status":"o"},{"topic":"Diseases","id":"39358","proposer":"10608","edm":"2124","session":"2008-09","title":"World Pneumonia Day","text":"That this House supports the first International World Pneumonia Day, on 2 November 2009; notes that the inaugural World Pneumonia Day is being marked by an event at the House of Commons in London on 28 October 2009; congratulates the organisers of events in New York, Bangladesh, Nigeria, Kenya, Uganda, Australia and other countries to highlight the scourge of pneumonia which kills more than four million people every year, half of whom are children under the age of five years; supports the Global Coalition Against Pneumonia, which includes the Global Alliance for Vaccines and Immunisations Alliance, PneumoADIP, Save the Children, Hedge Funds against Malaria and Pneumonia and other partners who have organised and helped promote World Pneumonia Day; hopes that World Pneumonia Day will encourage further support in the fight against pneumonia in the developing and developed world; further congratulates the Government for its role to date in supporting the Advanced Market Commitment for pneumococcal disease, the leading cause of pneumonia deaths; and calls on the Government to give continuing support to combat this terrible disease which claims the life of a child every 15 seconds.","date":"2009-10-21","status":"o"},{"topic":"Diseases","id":"39346","proposer":"10105","edm":"2114","session":"2008-09","title":"Pleural Plaques Protest 28 October 2009 (No. 2)","text":"That this House is aware that asbestos victims around the country were affronted by the 2007 Law Lords' judgement that people suffering with pleural plaques should no longer be compensated; and notes that on 28 October 2009 there will be a combined Union of Construction, Allied Trades and Technicians, GMB Unite, Unison, TUC and Asbestos Groups' lobby of Parliament to urge the Secretary of State for Justice to restore the rights of victims to seek compensation in the courts.","date":"2009-10-20","status":"o"},{"topic":"Diseases","id":"39306","proposer":"10021","edm":"2075","session":"2008-09","title":"World Osteoporosis Day, 20 October 2009","text":"That this House notes that 20 October 2009 is World Osteoporosis Day; is concerned that three million people in the UK have osteoporosis and are at risk of painful and debilitating fractures; is alarmed that an average of 21 hip fracture-related deaths occur in each constituency every year; congratulates the National Osteoporosis Society on its continuing efforts to eradicate needless fragility fractures throughout the UK; calls for the universal implementation of the Government's Prevention Package for Older People throughout England; further notes that this advises local health and social care communities to establish comprehensive fracture liaison services on the basis that they are cost-neutral and effective in reducing future fractures; and calls for primary care trusts to review their falls and fracture services against those provided by other trusts within their region.","date":"2009-10-19","status":"o"},{"topic":"Diseases","id":"39325","proposer":"10105","edm":"2094","session":"2008-09","title":"Pleural Plaques Protest 28 October 2009","text":"That this House is aware that asbestos victims around the country were affronted by the disgraceful 2007 Law Lords' judgement that people suffering with pleural plaques should no longer be compensated and notes that on 28 October 2009 there will be a combined Union of Construction, Allied Trades and Technicians, Unite, Unison, TUC and Asbestos Groups' lobby of Parliament to urge the Secretary of State for Justice to restore the rights of victims to seek compensation in the courts.","date":"2009-10-19","status":"o"},{"topic":"Diseases","id":"39303","proposer":"10144","edm":"2072","session":"2008-09","title":"Prescription Of Anti-Cancer Drugs","text":"That this House notes with concern the postcode lottery in the NHS in relation to the prescription of the anti-cancer drug, Cetuximab and the refusal of the Durham Primary Care Trust to prescribe this potentially life-saving drug to a constituent of the hon. Member for Easington; further notes with concern that the North of England Cancer Drugs Approval Group which was to have considered the prescribing of Cetuximab to patients who had already received both Oxaliplatin and Irinotecan containing regimes on 30 September 2009 has deferred its decision to a future meeting; and calls upon the Government to fund treatments using Cetuximab to patients where their consultant physician has recommended such use.","date":"2009-10-16","status":"o"},{"topic":"Diseases","id":"39274","proposer":"11641","edm":"2044","session":"2008-09","title":"London Muscle Group","text":"That this House welcomes the launch of the London Muscle Group; notes that the new group will campaign to improve access to essential specialist care and support for patients living with muscle disease; further notes that the Group is led by local families and people affected by muscular dystrophy and other related neuromuscular conditions; is concerned to learn of the serious problems that the 7,500 people with muscular dystrophy and related neuromuscular conditions face living in London; further notes that access to multi-disciplinary specialist care improves overall health outcomes and survival for patients with muscular dystrophy and related neuromuscular conditions; calls on the London Specialised Commissioning Group, local primary care trusts and the Strategic Health Authority to take forward a review of neuromuscular services which will identify areas of best practice and gaps in NHS service provision; and praises the campaign led by the Muscular Dystrophy Campaign, local families, health professionals and experts in these conditions who will work together to fight for good access to clinically effective, first class, specialised neuromuscular services across London.","date":"2009-10-14","status":"o"},{"topic":"Diseases","id":"39265","proposer":"11475","edm":"2010","session":"2008-09","title":"Breast Cancer Campaign Wear It Pink 2009","text":"That this House recognises that over 45,500 women and around 300 men in the United Kingdom will be diagnosed with breast cancer in 2009; endorses Breast Cancer Campaign's Wear It Pink on 30 October 2009; notes the importance of the event in promoting awareness of breast cancer among the general public; encourages hon. Members to participate in the initiative to help raise funds for innovative world-class breast cancer research at centres of excellence throughout the UK; and congratulates Breast Cancer Campaign and all of its supporters for having raised over \u00a33.5 million in 2008 through Wear It Pink.","date":"2009-10-13","status":"o"},{"topic":"Diseases","id":"39210","proposer":"10079","edm":"1980","session":"2008-09","title":"Muscular Dystrophy","text":"That this House welcomes the launch of the East of England Muscle Group; notes that the new group is led by local families and people affected by muscular dystrophy and related neuromuscular conditions who will campaign to improve access to essential specialist care and support; is concerned to learn of the serious problems affecting the 5,500 people with muscular dystrophy and related neuromuscular conditions living in the East of England; further notes that access to multi-disciplinary specialist care improves overall health outcomes and survival for patients with muscular dystrophy and related neuromuscular conditions; is deeply concerned that some patients are being denied access to multi-disciplinary specialist care; calls on the East of England Specialised Commissioning Group, local primary care trusts and the Strategic Health Authority to take forward a review of neuromuscular services which will identify areas of best practice and gaps in NHS service provision; and praises the campaign led by the Muscular Dystrophy Campaign, local families, health professionals and experts in these conditions who will work together to fight for good access to clinically effective, first class, specialised neuromuscular services across the East of England region.","date":"2009-10-12","status":"o"},{"topic":"Diseases","id":"39230","proposer":"11427","edm":"2001","session":"2008-09","title":"Access To Specialist Neuromuscular Care And The Walton Report","text":"That this House welcomes the All-Party Parliamentary Group for Muscular Dystrophy's publication Access to Specialist Neuromuscular Care: The Walton Report; is deeply concerned about the vulnerability of services for people with muscular dystrophy and related neuromuscular conditions in many parts of the UK; notes the urgent need to address gaps in service provision; expresses the hope that the recommendations put forward in the report will be implemented; calls for regional specialised commissioning groups to follow the lead of the South West and the West Midlands and conduct an urgent review of services; and further calls on the Department of Health, the National Specialised Commissioning Group and regional specialised commissioning groups to work with families living with muscle disease, health professionals and the Muscular Dystrophy Campaign to improve access to specialist care.","date":"2009-10-12","status":"o"},{"topic":"Diseases","id":"39109","proposer":"10022","edm":"1888","session":"2008-09","title":"Launch Of Muscle Group: South East Coast","text":"That this House welcomes the launch of Muscle Group: South East Coast; notes that the new group is led by local families and people affected by muscular dystrophy and related neuromuscular conditions who will campaign to improve access to essential specialist care and support; is concerned that a new report published by the Muscular Dystrophy Campaign illustrates serious problems affecting the 4,200 people with muscular dystrophy and related neuromuscular conditions living in Kent, Surrey and Sussex; further notes that access to multi-disciplinary specialist care improves overall health outcomes and survival for patients with muscular dystrophy and related neuromuscular conditions; is deeply concerned that some patients are being denied access to multi-disciplinary specialist care; calls on the Specialised Commissioning Group, local primary care trusts and the Strategic Health Authority to take forward a review of neuromuscular services to identify areas of best practice and gaps in NHS service provision; and praises the campaign led by the Muscular Dystrophy Campaign, local families, health professionals and experts in these conditions who will work together to fight for good access to clinically effective, first class, specialised neuromuscular services across the NHS South East Coast region.","date":"2009-07-14","status":"o"},{"topic":"Diseases","id":"39111","proposer":"10028","edm":"1890","session":"2008-09","title":"ARMLEY ASBESTOS DRAMA 'DUST' AND ASBESTOS-RELATED DISEASES","text":"That this House congratulates the playwright Kenneth Yates, Alex Chisholm the director and the cast of Dust, a dramatisation at the West Yorkshire Playhouse of June Hancock's legal struggle to prove that the JW Roberts' asbestos factory in Armley caused asbestos pollution in the neighbourhood, leaving a deadly local legacy of hundreds of mesothelioma victims; notes that the drama using the trial transcripts, testimonies and interviews brilliantly captures a story that is still not played out; and urges the Department of Health to devote more research resources to tackling mesothelioma and other asbestos-related diseases.","date":"2009-07-14","status":"o"},{"topic":"Diseases","id":"39071","proposer":"11427","edm":"1851","session":"2008-09","title":"Neuromuscular Support Services","text":"That this House welcomes the launch of the North East Muscle Group; notes that the new group is led by local families and people affected by muscular dystrophy and related neuromuscular conditions who will campaign to improve access to essential specialist care and support; is concerned to learn of the serious problems affecting the 2,500 people with muscular dystrophy and related neuromuscular conditions living in the North East region; further notes that access to multi-disciplinary specialist care improves overall health outcomes and survival for patients with muscular dystrophy and related neuromuscular conditions; calls on the North East Specialised Commissioning Group, local primary care trusts and the Strategic Health Authority to take forward a review of neuromuscular services which will identify areas of best practice and gaps in NHS service provision; and praises the campaign led by the Muscular Dystrophy Campaign, local families, health professionals and experts in these conditions who will work together to fight for good access to clinically effective, first class, specialised neuromuscular services across the North East region.","date":"2009-07-13","status":"o"},{"topic":"Diseases","id":"39032","proposer":"11869","edm":"1821","session":"2008-09","title":"PARKINSON'S DISEASE INQUIRY REPORT","text":"That this House welcomes the findings of the All Party Parliamentary Group for Parkinson's Disease inquiry into health and social care, which concludes that there are systemic problems with access to key services for people with Parkinson's and their carers throughout England, Wales and Northern Ireland; endorses its recommendations, including that the Department of Health should hold a five-year review of progress towards implementation of the National Service Framework for Long-term (Neurological) Conditions; believes that there is a pressing need for stronger national leadership on neurological services in England, Wales and Northern Ireland; and further welcomes the newly launched Fair Care for Parkinson's campaign by the Parkinson's Disease Society, which aims to improve services for people affected by the condition.","date":"2009-07-07","status":"o"},{"topic":"Diseases","id":"39019","proposer":"10224","edm":"1745A1","session":"2008-09","title":"HIV Treatment In The Developing World","text":"leave out from `2010' to `and' in line 9 and insert `notes that no company has yet agreed to sign up to putting drugs to treat HIV into the UNITAID or other patent pools, and urges pharmaceutical companies to do so;'.","date":"2009-07-02","status":"o"},{"topic":"Diseases","id":"38971","proposer":"10968","edm":"1773","session":"2008-09","title":"Young People With Autism","text":"That this House notes the recent publication of the All-Party Parliamentary Group on Autism's report on the transition from children's to adult services for young people with autism; further notes the report's conclusion that despite pockets of good practice across the UK transition services are still failing most young people with autism; recognises that these failings lead to a waste of talent, lives and money; further recognises the steps the Government has taken to address this situation; and calls on the Government to implement all the report's recommendations to improve outcomes for this vulnerable group.","date":"2009-06-29","status":"o"},{"topic":"Diseases","id":"38943","proposer":"10119","edm":"1745","session":"2008-09","title":"HIV Treatment In The Developing World","text":"That this House notes with concern that around the world 15 million children have lost one or more parents due to AIDS; notes that only 31 per cent. of adults and barely 10 per cent. of children in need of HIV treatment have access to it and that access to prevention is also limited; further notes that there is a lack of appropriate HIV treatments for children, and that the number of adults who have become resistant to basic HIV treatment and require more expensive medicines is increasing; recognises that pharmaceutical companies have a vital role to play in helping to achieve universal access to prevention, treatment, care and support by 2010; welcomes the fact that many companies have chosen voluntarily to sign up to new patent pool arrangements; and calls for governments, businesses and voluntary organisations to work together in tackling the epidemic.","date":"2009-06-24","status":"o"},{"topic":"Diseases","id":"38896","proposer":"11707","edm":"1704","session":"2008-09","title":"North West Muscle Group And Neuromuscular Services","text":"That this House welcomes the launch of the North West Muscle Group; notes that the new group is led by local families and people affected by muscular dystrophy and related neuromuscular conditions who will campaign to improve access to essential specialist care and support; is concerned to learn of the serious problems affecting the 6,500 people with muscular dystrophy and related neuromuscular conditions living in the North West; further notes that access to multi-disciplinary specialist care improves overall health outcomes and survival for patients with muscular dystrophy and related neuromuscular conditions; is deeply concerned that some patients are being denied access to multi-disciplinary specialist care; calls on the North West Specialised Commissioning Group, local primary care trusts and the Strategic Health Authority to take forward review of neuromuscular services which will identify areas of best practice and gaps in NHS service provision; and praises the campaign led by the Muscular Dystrophy Campaign, local families, health professionals and experts in these conditions who will work together to fight for good access to clinically effective, first class, specialised neuromuscular services across the North West region.","date":"2009-06-18","status":"o"},{"topic":"Diseases","id":"38880","proposer":"10001","edm":"1689","session":"2008-09","title":"World Sickle Cell Day","text":"That this House welcomes the United Nations' designation of 19 June 2009 as World Sickle Cell Day; congratulates the Sickle Cell Society on its 30th anniversary; recognises the achievements made by the society in raising awareness of, and improving care for, sickle cell disease in the UK; notes this recognition of sickle cell disease as both a global public health problem as well as a serious health problem in the UK; and calls on the Government to continue its funding of newborn and antenatal NHS screening for this disease and to increase support for the development of sickle cell care services.","date":"2009-06-17","status":"o"},{"topic":"Diseases","id":"38886","proposer":"11032","edm":"1695","session":"2008-09","title":"Diabetes Amputations","text":"That this House notes that there are around 100 lower-limb amputations among people with diabetes every week in England; is concerned that one in three people with diabetes do not realise that having the condition puts them more at risk of having an amputation; welcomes the publication of the Diabetes UK\/NHS Diabetes report, Putting Feet First, which calls for better joint working between primary care trusts and hospitals to ensure provision of high-quality specialist care for the management and prevention of diabetic foot disease; supports the top tips resource to inform people with diabetes of the foot care they should demand; and commends the work of Diabetes UK in improving the lives of people with diabetes.","date":"2009-06-17","status":"o"},{"topic":"Diseases","id":"38869","proposer":"11427","edm":"1682","session":"2008-09","title":"Beating Duchenne Muscular Dystrophy","text":"That this House recalls the statement from the Office of the Prime Minister on 31 October 2007 that `the Government fully accepts that everything possible needs to be done to bring an end to the tragic impact Duchenne Muscular Dystrophy has on individuals and their families'; acknowledges that in the intervening time period around 200 young men will have died from this disease; believes that experience from Denmark shows that much better outcomes are possible when resources are focused on supporting those hit by this disease; applauds those clinicians and researchers who, despite financial constraints, have made huge strides in recent years; and calls on the Government to implement the commitment given by the Prime Minister by meeting the clinicians, carers and campaigners involved in the Action Duchenne campaign in order to develop a strategy based on best practice.","date":"2009-06-16","status":"o"},{"topic":"Diseases","id":"38798","proposer":"10413","edm":"1615","session":"2008-09","title":"Arrhythmia Awareness Week","text":"That this House congratulates Arrhythmia Alliance, the Heart Rhythm Charity, a coalition of healthcare professionals, patients and carers to promote better understanding, diagnosis, treatment and quality of life of individuals with cardiac arrhythmias, or heart rhythm disorders, for organising Arrhythmia Awareness Week from 8 to 14 June 2009; welcomes the Know Your Pulse initiative which aims to encourage people to have their pulse checked; notes that more than one per cent. of the population is affected by atrial flutter (AF), the most common type of heart rhythm disturbance; recognises that people with AF have a dramatically reduced quality of life and face long-term serious complications including a high risk of having a stroke; further notes that 100,000 sudden cardiac deaths occur each year due to cardiac arrhythmias, and that 120,000 unexplained incidences of loss of consciousness occur due to cardiac arrhythmia; believes that the early identification of heart rhythm disorders is crucial in reducing the number of premature deaths from heartbeat disorders; and calls on the Government to make heart rhythm disorders a priority by ensuring pulse checks are taken during a routine visit to a GP surgery, to promote timely diagnosis and treatment of heart rhythm disorders.","date":"2009-06-09","status":"o"},{"topic":"Diseases","id":"38805","proposer":"10780","edm":"1622","session":"2008-09","title":"Breathe Easy Causeway Group","text":"That this House acknowledges that one in seven people across the United Kingdom are affected by lung disease; congratulates the many thousands of volunteers and professionals involved in raising awareness of the condition and treating it; notes that Breathe Easy Week takes place between 15 and 21 June 2009; and in particular recognises those involved at Breathe Easy Causeway Group where a national award for outstanding achievement was won against 200 other similar groups across the nation.","date":"2009-06-09","status":"o"},{"topic":"Diseases","id":"38762","proposer":"10166","edm":"1584","session":"2008-09","title":"KING'S FUND REPORT ON RHEUMATOID ARTHRITIS","text":"That this House recognises the findings of the King's Fund report Perceptions of patients and professionals on rheumatoid arthritis care, commissioned by the Rheumatology Futures Project Group; notes with concern wide variations in the standards of care for patients with rheumatoid arthritis, poor implementation of service redesign, insufficient clinical involvement in the commissioning process and a limited, understanding of the disease and the needs of patients; recognises the improvements in initial access to care for patients brought about by the introduction of the 18-week waiting time target, but notes that further improvements in access to care need to be made throughout the patient pathway; and calls on the Department of Health to take steps to encourage NHS organisations to improve education and training of primary healthcare professionals to ensure rapid referral for treatment and supportive care and to publish without delay a commissioning pathway for inflammatory arthritis, together with a supporting toolkit to ensure robust and consistent standards of care throughout the patient journey.","date":"2009-06-03","status":"o"},{"topic":"Diseases","id":"38767","proposer":"10288","edm":"1589","session":"2008-09","title":"Breathe Easy Week 2009","text":"That this House supports the British Lung Foundation's Love Your Lungs campaign for Breathe Easy Week 2009; praises the work of the Breathe Easy patient support network in providing help and information for people living with a lung condition and their carers; notes that less than a quarter of the estimated 3.7 million people in the UK with chronic obstructive pulmonary disease (COPD) have been diagnosed with the disease; calls on the Government to assess the benefits of incorporating spirometry testing into the new screening programme in order to ensure more people with a lung condition get an early diagnosis; recognises the importance of pulmonary rehabilitation for people with COPD, but observes that in many areas of the UK there is insufficient access to these courses and that they are not adequately funded; believes that more needs to be done to ensure that pulmonary rehabilitation is available to everyone who could benefit from it; eagerly awaits the publication of the clinical strategy for COPD; and urges the full implementation of the strategy in order to ensure an improved quality of life for all people with the disease.","date":"2009-06-03","status":"o"},{"topic":"Diseases","id":"38730","proposer":"10055","edm":"1553","session":"2008-09","title":"HIV Treatments And Children","text":"That this House notes with concern that globally most children who need treatment for HIV are not receiving it; further notes that there is a lack of appropriate HIV treatments for children and that the number of adults who have become resistant to basic HIV treatment and require more expensive medicines is increasing; recognises that the price of medicines and patents are closely linked; commends the Government's financial backing for UNITAID, the international drugs purchasing facility, and its support for the establishment of a patent pool; and calls on pharmaceutical companies to show their commitment to access to medicines for the world's poorest people by signing up to the UNITAID patent pool.","date":"2009-06-01","status":"o"},{"topic":"Diseases","id":"38735","proposer":"10089","edm":"1558","session":"2008-09","title":"Cancer Treatment","text":"That this House is concerned that the postcode lottery on cancer treatments is raising its ugly head again; notes that patients who are suffering from cancer and in need of the drug cetuximab, which has been proven to reduce tumours, are being refused because of that lottery; further notes that a constituent of the hon. Member for Blyth Valley, Mrs Mary Brewis, who is 53 years of age, has been informed by the local primary care trust that she cannot have the drug funded, effectively meaning she now awaits an early death sentence; and calls on the Government to fund all cancer treatments, no matter what the cost, to give cancer patients hope.","date":"2009-06-01","status":"o"},{"topic":"Diseases","id":"38679","proposer":"10021","edm":"1509","session":"2008-09","title":"National Osteoporosis Society Manifestos","text":"That this House welcomes the publication of the National Osteoporosis Society's Manifestos for England, Scotland, Wales and Northern Ireland; is concerned that osteoporosis is a long-term condition which is currently putting three million people in the UK at risk of painful fractures, which are costly for the NHS to treat; is further concerned that \u00c2\u00a32 billion is spent annually on treatment and care for people with hip fractures; notes that much can be done to prevent these fractures, through the proper identification, treatment and care for people who have osteoporosis; calls for a Fracture Liaison Service to be linked to every hospital that receives fragility fractures in the UK, to ensure that every fragility fracture patient gets the treatment and care they need; further calls for coherent clinical guidance for the prevention, diagnosis, treatment and care of falls, fragility fractures and osteoporosis; further calls for the quality and systems of care for people at risk of falls, and with, or at risk of, fragility fractures and osteoporosis to be measured on a regular basis, to stimulate best practice; further calls for healthcare professionals working in primary care to be offered meaningful incentives to find and treat those at a high risk of fragility fracture; and further calls for measures to improve understanding of bone health amongst individuals of all ages, with positive messages communicated in schools.","date":"2009-05-18","status":"o"},{"topic":"Diseases","id":"38613","proposer":"11923","edm":"1448","session":"2008-09","title":"Proton Therapy Treatment","text":"That this House notes with grave concern the increasing number of British cancer patients who are having to travel abroad to receive the life saving treatment proton therapy; further notes that unlike radiotherapy, most of the radiation used during proton therapy is concentrated on the tumour meaning that the amount of radiation affecting normal tissues can be reduced to half or even one tenth at the same time as delivering the same or higher dose to the cancer; accepts that the treatment has been found to be more effective at reducing collateral radiation which is particularly beneficial for patients whose cancers are close to the spinal cord, brain, heart, eye or ear; is appalled at the fact that treatment is not readily available within the UK; and calls on the Government to invest in a specialist treatment centre to allow cancer patients to receive proton therapy in the UK.","date":"2009-05-07","status":"o"},{"topic":"Diseases","id":"38608","proposer":"10004","edm":"1444","session":"2008-09","title":"Supplementary Charges For Oxygen By Airlines","text":"That this House recognises that patients with pulmonary hypertension, chronic obstructive pulmonary disease, muscular dystrophy and other conditions require supplemental oxygen when travelling by air; is dismayed that the vast majority of airlines operating in the UK currently charge passengers requiring supplemental oxygen on flights; applauds the work of the Pulmonary Hypertension Association, the British Lung Foundation and the Muscular Dystrophy Campaign to end the unfair financial impact of what is effectively a tax on the disabled; calls on all airlines flying from or through UK airports to allow passengers requiring in-flight supplemental oxygen to either bring personal oxygen equipment on board and use it, subject to necessary security checks, or to have supplemental oxygen provided for them by the airline, in both cases without charge; welcomes the recent decision by British Airways, Emirates and Cathay Pacific to drop all charges; notes that as of 1 May 2009 airlines in the United States of America will have to allow passengers requiring supplemental oxygen to be able to use their own portable oxygen concentrator free of charge; and urges all airlines operating in the UK to follow suit.","date":"2009-05-06","status":"o"},{"topic":"Diseases","id":"38592","proposer":"10526","edm":"1429","session":"2008-09","title":"South Central Muscle Group Launch","text":"That this House welcomes the launch of the South Central Muscle Group; notes that the new group is led by local families and people affected by muscular dystrophy and related neuromuscular conditions who will campaign to improve access to essential specialist care and support; is concerned that a new report published by the Muscular Dystrophy Campaign illustrates serious problems affecting the 4,000 people with muscular dystrophy and related neuromuscular conditions living in Berkshire, Buckinghamshire, Hampshire, Oxfordshire and the Isle of Wight; further notes that access to multi-disciplinary specialist care improves overall health outcomes and survival for patients with muscular dystrophy and related neuromuscular conditions; is deeply concerned that some patients are being denied access to multi-disciplinary specialist care; calls on the South Central Specialised Commissioning Group to meet with the Muscular Dystrophy Campaign and the leading clinicians in the area; and further calls on the Specialised Commissioning Group, local primary care trusts and the Strategic Health Authority to take forward a review of neuromuscular services which will identify areas of best practice and gaps in NHS service provision; and praises the campaign led by the Muscular Dystrophy Campaign, local families, health professionals and experts in these conditions who will work together to fight for good access to clinically effective, first class, specialised neuromuscular services across the NHS South Central region.","date":"2009-05-05","status":"o"},{"topic":"Diseases","id":"38524","proposer":"10754","edm":"1365","session":"2008-09","title":"BREAKTHROUGH BREAST CANCER'S LYMPHOEDEMA SERVICES CAMPAIGN","text":"That this House believes that people with breast cancer who develop symptoms of lymphoedema should be able to access services which enable them to manage their condition more effectively; notes that current service provision may not in all areas provide the specialist services and treatment needed by people with lymphoedema; further notes that local services are vital to ensuring that the pain and discomfort of lymphoedema can be reduced; further notes that healthcare policies and initiatives have been introduced which if delivered would provide much needed lymphoedema services to those areas where they currently may not exist; further notes that more effective data gathering on the incidence of lymphoedema should be implemented at local and national level to ensure that high quality services can be developed and delivered where needed; and supports Breakthrough Breast Cancer's campaign Constant Reminder? - Living with Lymphoedema, which seeks to improve services for people who develop lymphoedema after breast cancer.","date":"2009-04-28","status":"o"},{"topic":"Diseases","id":"38536","proposer":"11245","edm":"1377","session":"2008-09","title":"World Asthma Day 2009","text":"That this House notes there are over five million people in the UK with asthma and over one million of these are children; further notes that children with asthma may be excluded from academic, physical or social activity in schools; welcomes Asthma UK's upcoming initiatives, such as World Asthma Day on 5 May 2009, which will highlight the experiences of people with asthma; and calls on the Government to improve support for children with asthma.","date":"2009-04-28","status":"o"},{"topic":"Diseases","id":"38519","proposer":"11245","edm":"1341A1","session":"2008-09","title":"Breast Cancer Mortality","text":"leave out from `and' to `to' and insert `notes that the Government has promised'.","date":"2009-04-27","status":"o"},{"topic":"Diseases","id":"38520","proposer":"11245","edm":"1341A2","session":"2008-09","title":"Breast Cancer Mortality","text":"at end add `; and urges the Government to bring forward this date.'.","date":"2009-04-27","status":"o"},{"topic":"Diseases","id":"38496","proposer":"10141","edm":"1341","session":"2008-09","title":"Breast Cancer Mortality","text":"That this House welcomes the fact that the number of women dying from breast cancer has fallen to its lowest level since records began; recognises the Government commitment to the NHS and improvements in chemotherapy, radiotherapy and screening have all contributed to this; and congratulates the Government in promising to extend screening to include all women aged 47 to 73 years of age by 2012.","date":"2009-04-24","status":"o"},{"topic":"Diseases","id":"38466","proposer":"12016","edm":"1315","session":"2008-09","title":"40 YEARS OF THE PARKINSON'S DISEASE SOCIETY: FUNDING RESEARCH FOR A CURE","text":"That this House celebrates the 40th anniversary of the creation of the Parkinson's Disease Society; applauds the all-round support the society gives to the 120,000 people living with Parkinson's disease in the UK and in particular its contribution to advances in Parkinson's disease research; congratulates the society on the commitment of over 40 million of charitable funding into research to date, which has contributed to major breakthroughs such as the discovery of two of the genes associated with inherited Parkinson's disease and the development of highly effective drug treatments for Parkinson's disease; commends the society on opening one of the first Parkinson's disease-dedicated brain banks in the world which provides vital clues in understanding what goes wrong when nerve cells in the brain die; wholeheartedly supports its vision of continuing to fund research until the discovery of a cure for Parkinson's disease; and calls on the Government to continue its support for voluntary sector research grants through funds such as the Charity Research Support Fund.","date":"2009-04-22","status":"o"},{"topic":"Diseases","id":"38468","proposer":"10351","edm":"1317","session":"2008-09","title":"World Hepatitis Day 2009","text":"That this House notes that 19 May 2009 is World Hepatitis Day; is concerned that more than 500 million people worldwide have either chronic hepatitis B or C which is equivalent to one in 12 of the global population; is deeply concerned that these two diseases kill one million people annually; believes that worldwide action is needed in order to save millions of lives; hopes that World Hepatitis Day will increase public awareness of hepatitis B and C in the UK and internationally; and urges the Government to give its full backing to World Hepatitis Day and to support the resolution calling for a world day for the struggle against viral hepatitis at the 62nd meeting of the World Health Assembly in May 2009.","date":"2009-04-22","status":"o"},{"topic":"Diseases","id":"38473","proposer":"11823","edm":"1322","session":"2008-09","title":"West Midlands Muscle Group Launch","text":"That this House welcomes the launch of the West Midlands Muscle Group; notes that the new group is led by local families and people affected by muscular dystrophy and related neuromuscular conditions who will campaign to improve access to essential specialist care and support; is concerned that a new report published by the Muscular Dystrophy Campaign illustrates serious problems affecting the 5,500 people with muscular dystrophy and related neuromuscular conditions in the West Midlands; further notes that access to multi-disciplinary specialist care improves overall health outcomes and survival for patients with muscular dystrophy and related neuromuscular conditions; is deeply concerned that some patients are being denied access to multi-disciplinary specialist care; congratulates the West Midlands Specialised Commissioning Group, local primary care trusts and Strategic Health Authority on their plans to take forward a review of neuromuscular services which will identify areas of best practice and gaps in NHS service provision; and praises the campaign led by the Muscular Dystrophy Campaign, local families, health professionals and experts in these conditions who will work together to fight for good access to clinically effective, first class, specialised neuromuscular services across the West Midlands.","date":"2009-04-22","status":"o"},{"topic":"Diseases","id":"38483","proposer":"10240","edm":"1332","session":"2008-09","title":"Multiple Sclerosis","text":"That this House congratulates the MS Society, MS Trust, MS Resource Centre and MS Therapy Centre for their outstanding work in supporting people living with multiple sclerosis (MS) across the UK; but notes with concern the results of a recent YouGov survey that revealed common myths and misconceptions among the general public about how MS affects people's lives; regrets that only one in four people know that MS is most commonly diagnosed in people aged 25 to 34 years old and that 40 per cent. of the public were unable to name a single symptom associated with MS; but commends MS Awareness Week, taking place from 27 April to 3 May 2009, for helping to address these misconceptions about the often variable and fluctuating nature of multiple sclerosis.","date":"2009-04-22","status":"o"},{"topic":"Diseases","id":"38370","proposer":"10426","edm":"1246","session":"2008-09","title":"Year Of Rheumatoid Arthritis Campaign","text":"That this House congratulates the National Rheumatoid Arthritis Society (NRAS) on the launch of its Year of Rheumatoid Arthritis campaign; is concerned at recent research which revealed an alarming ignorance about the causes and impact of rheumatoid arthritis (RA); is particularly worried that 62 per cent. of people overall and 75 per cent. of younger people did not know the causes of RA or that it can affect other organs like the heart or lungs; and calls on hon. Members to support NRAS's campaign which aims to tackle misconceptions about this disabling and debilitating condition and to increase understanding of RA and its symptoms so that those affected can seek swift medical advice and treatment to halt the rapid progression of the disease and prevent long-term joint damage.","date":"2009-04-01","status":"o"},{"topic":"Diseases","id":"38375","proposer":"10333","edm":"1251","session":"2008-09","title":"Cervical Cancer Screening","text":"That this House welcomes the recent Written Ministerial Statement by the Parliamentary Under-Secretary of State at the Department of Health announcing that the Independent Advisory Committee on Cervical Screening will now formally review all available evidence relating to the issue of screening women under 25 years old and take evidence from interested parties; and congratulates families, individuals and the cervical charity Jo's Trust on their campaigning work; and hopes the results of the review will result in a reduction in the number of women who develop invasive cervical cancer and the number of women who die from it.","date":"2009-04-01","status":"o"},{"topic":"Diseases","id":"38312","proposer":"11863","edm":"1192","session":"2008-09","title":"Use Of Unsupervised Sunbeds By Under 18 Year Olds","text":"That this House expresses concern that under 18 year olds are able to easily access unsupervised sunbed salons; notes that unsupervised sunbed salons have no staff to prevent under 18 year olds using sunbeds; further notes that both the World Health Organisation and the European Union have expressed the view that under 18 year olds should not use sunbeds; further notes that sunbed use when young is associated with an increased risk of skin cancer; further notes with alarm the increase in incidence rates of malignant melanoma over the last 20 years; recognises the commitment in the Cancer Reform Strategy to review options for addressing sunbed consumer safety; and calls on the Government to prohibit use of sunbeds by under 18 year olds, provide evidence-based health information in sunbed salons and prohibit unsupervised sunbed salons.","date":"2009-03-25","status":"o"},{"topic":"Diseases","id":"38237","proposer":"12005","edm":"1125","session":"2008-09","title":"Eating Out With Coeliac Disease","text":"That this House recognises that people with coeliac disease have an autoimmune disease for which the only treatment is a lifelong adherence to a gluten-free diet; acknowledges that 58 per cent. of those diagnosed with coeliac disease are most concerned about the lack of safe gluten-free options offered in restaurants and similar places; urges chefs and caterers to improve the availability of gluten-free choices; and commends and supports Coeliac UK for its Eating Out campaign to make eating out possible for people with the condition which will significantly improve their quality of life and create more business for the hospitality sector.","date":"2009-03-18","status":"o"},{"topic":"Diseases","id":"38181","proposer":"11869","edm":"1073","session":"2008-09","title":"Muscular Dystrophy Services In The South West","text":"That this House congratulates the NHS South West Specialised Commissioning Group on their announcement of a new \u00c2\u00a31 million Neuromuscular Strategy; notes that this will serve the 5,000 people living in the South West affected by muscular dystrophy and related neuromuscular conditions; further notes that the investment is the result of a 12 month review in response to the publication of the Building on the Foundations report by the Muscular Dystrophy Campaign in December 2007 which highlighted that inadequate service provision for people affected by these progressive muscle-wasting conditions living in the South West of England was leading to premature deaths and poor standards of care; calls on specialised commissioning groups across the country to follow the lead of the South West; and praises the campaign led by the Muscular Dystrophy Campaign, local families, health professionals and experts in these conditions who worked together to fight for fair access to clinically effective, first class, specialised neuromuscular services across the South West.","date":"2009-03-12","status":"o"},{"topic":"Diseases","id":"38169","proposer":"10261","edm":"1065","session":"2008-09","title":"World Kidney Day 2009","text":"That this House notes with concern that whilst early detection and appropriate treatment can delay or stop chronic kidney disease, an estimated 13,000 people die from kidney failure annually in the UK; further notes that the number of people relying on kidney care services is increasing each year, including the 23,000 patients in the UK receiving dialysis for kidney failure; further notes and supports the ongoing work to develop and implement guidance and tools to improve patient care by increasing access to and by raising the quality of kidney services as set out in the National Service Framework for Renal Services; believes that the frequency and impact of kidney disease and its associated health problems can be reduced by a public health campaign focusing on the importance of kidneys; and welcomes, together with kidney patients, their families and friends, clinicians and healthcare professionals working in kidney care, World Kidney Day on 12 March 2009.","date":"2009-03-11","status":"o"},{"topic":"Diseases","id":"38123","proposer":"11245","edm":"1025","session":"2008-09","title":"INTERNATIONAL WOMEN'S DAY AND CERVICAL CANCER PREVENTION","text":"That this House welcomes International Women's Day on 8 March 2009; acknowledges that, on average, three women a day in the UK will die from cervical cancer; further acknowledges that the UK is one of the only countries in Europe not to provide human papilloma virus (HPV) testing to women routinely and not to follow the EU Quality Assurance Recommendations to use HPV testing as follow-up to borderline or mild smears and following treatment for cervical abnormalities; believes that making HPV testing available as a routine follow-up for all women would ultimately reduce the incidence of cervical cancer and save lives; highlights a Government-funded study published in 2006, Lifetime effects, costs and cost-effectiveness of testing for human papilloma virus to manage low grade cytological abnormalities: results of the NHS pilot studies, that predicts that using HPV testing in conjunction with the smear test for women with borderline or abnormal smear test results would be cost-effective; and calls on the Government to adopt HPV testing, instead of repeat smear tests, for follow-up of borderline and mild smear results and follow-up of women post-treatment for cervical abnormalities.","date":"2009-03-10","status":"o"},{"topic":"Diseases","id":"38143","proposer":"10214","edm":"1045","session":"2008-09","title":"Prostate Cancer Awareness Month","text":"That this House congratulates The Prostate Cancer Charity on launching the It Matters campaign during the first Prostate Cancer Awareness Month to highlight that more investment is needed in prostate cancer; notes that 35,000 men are diagnosed with prostate cancer every year in the UK and one man dies every hour of the disease; expresses concern that men living with prostate cancer report the worst NHS experience of all common cancers; calls on the Government to expedite its planned programme of national cancer patient experience surveys to assess whether this position has changed; further notes that in order to decrease mortality from prostate cancer there is a need to invest in more research to develop a new generation test for prostate cancer, capable of distinguishing between aggressive and slow-growing forms of prostate cancer; and calls on the Government to play an active role in providing leadership in the global search for such a test.","date":"2009-03-10","status":"o"},{"topic":"Diseases","id":"38100","proposer":"11245","edm":"1006","session":"2008-09","title":"World Glaucoma Day 2009","text":"That this House wholeheartedly welcomes the joint global World Glaucoma Day initiative of the World Glaucoma Association and the World Glaucoma Patient Association which takes place on 11 March 2009; supports the Royal National Institute of Blind People in its national campaign to raise awareness of glaucoma, including a parliamentary reception to mark World Glaucoma Day 2009; notes that in the UK some form of glaucoma affects hundreds of people in every constituency and that while four out of five people have heard of glaucoma, their understanding is limited, especially about the groups which are at higher risk; and calls on the Government to find new ways to raise awareness of the condition.","date":"2009-03-09","status":"o"},{"topic":"Diseases","id":"38112","proposer":"10261","edm":"1018","session":"2008-09","title":"Childhood Cancers In The UK","text":"That this House, in recognition of International Childhood Cancer Day on 15 February 2009 and Brain Tumour Awareness Month in March 2009, notes that 200,000 people each year develop a malignant form of primary brain tumour for which a cure is unlikely; further notes that in developed countries such as the US, Canada and the UK, brain tumours have overtaken leukaemia as the most prominent cause of childhood cancer mortality; and calls on the Government to ensure that there are no unnecessary barriers to medical research or clinical trials on brain tumours amongst children.","date":"2009-03-09","status":"o"},{"topic":"Diseases","id":"38084","proposer":"11923","edm":"992","session":"2008-09","title":"Progressive Supranuclear Palsy","text":"That this House notes that there are an estimated 10,000 people in the UK suffering from Progressive Supranuclear Palsy (PSP); recognises that this number is likely to be much higher due to the large percentage of PSP cases which are misdiagnosed; understands that three out of four PSP cases are misdiagnosed resulting in patients being given medication that has exacerbated their condition; expresses concern about the lack of awareness amongst the medical profession about the disease and is disappointed at the lack of appropriate palliative care and support given to sufferers of PSP; applauds the work of the PSP Association who are an organisation dedicated to the support of people with Progressive Supranuclear Palsy and those who care for them; and welcomes the forthcoming PSP Awareness Week starting on 4 April 2009 which aims to raise funding for research so that the possible causes of PSP are better understood and to find ways to achieve earlier and better diagnosis and to develop treatments that could potentially slow down, or even halt, the progression of this disease.","date":"2009-03-05","status":"o"},{"topic":"Diseases","id":"38051","proposer":"11923","edm":"967","session":"2008-09","title":"Ovarian Cancer Awareness Month","text":"That this House notes with concern that current awareness of ovarian cancer and its symptoms is low in the UK; recognises that research has demonstrated that of almost all women with the disease, 90 per cent. experience symptoms, even in the early stage of the disease, when survival rates can be as high as 90 per cent.; expresses concern that despite this fact, three out of every four women are only diagnosed with ovarian cancer after it has spread significantly, leading to a dramatic fall in survival rates; commends the work of Ovarian Cancer Action which is dedicated to advancing and supporting ovarian cancer research; and celebrates the beginning of Ovarian Cancer Awareness Month as a fantastic opportunity to raise awareness of ovarian cancer research as part of its mission to save women's lives.","date":"2009-03-04","status":"o"},{"topic":"Diseases","id":"38070","proposer":"10105","edm":"986","session":"2008-09","title":"Diabetes In The UK","text":"That this House is concerned by the latest research showing the number of new cases of diabetes rose by 74 per cent. between 1997 and 2003 and is increasing at a faster rate in the UK than in North America; welcomes the Government's introduction of the Reduce Your Risk and the Change4Life campaigns which aim to reduce rising disease rates by encouraging people to live healthily by helping them to make significant and sustained choices to behaviours around diet and physical activity; and calls on the Government to work with Diabetes UK to tackle this increase and ensure that diabetes services are able to fully support all those living with the condition.","date":"2009-03-04","status":"o"},{"topic":"Diseases","id":"37993","proposer":"10261","edm":"914","session":"2008-09","title":"Rare Disease Day 2009","text":"That this House acknowledges the second Pan-European Rare Disease Day on 28 February 2009, which successfully highlights rare diseases and the challenges faced by patients, carers, healthcare professionals and policy makers, working to ensure the highest quality of services and available treatments are accessible to often isolated and vulnerable people; notes that there are over 6,000 rare conditions identified, affecting more than 3.5 million people in the UK; further notes that 75 per cent. of those with a rare condition are children and 30 per cent. die before the age of five years; welcomes the newly-established campaign Rare Disease UK; and urges the Government to move forward with the European Commission's Communciation to create a National Plan for rare diseases.","date":"2009-02-26","status":"o"},{"topic":"Diseases","id":"37962","proposer":"10614","edm":"883","session":"2008-09","title":"Incidence Of Diabetes","text":"That this House notes with alarm the research published in the Journal of Epidemiology and Community Health showing an increase of 74 per cent. in new cases of diabetes between 1997 and 2003; further notes that the overall incidence of diabetes increased from 2.8 per cent. of the population in 1996 to 4.3 per cent. in 2005; acknowledges the author's assertion that the increases in Type 2 diabetes are directly linked to rising obesity rates; and encourages the Government to redouble its efforts to increase public awareness of diabetes and to take urgent action to tackle obesity rates.","date":"2009-02-25","status":"o"},{"topic":"Diseases","id":"37859","proposer":"11489","edm":"797","session":"2008-09","title":"Essential Tremor Disorder","text":"That this House acknowledges the difficulties faced by those diagnosed with essential tremor, an involuntary shaking or trembling of part of the body; notes that it is one of the most common neurological diseases, affecting approximately four per cent. of those aged 40 years or over and the most common form of tremor; acknowledges that while many can live happy, healthy lives despite the disorder, it can cause significant problems for the remainder in carrying out their daily routine; welcomes the support given to sufferers by the National Tremor Foundation in the UK; further notes the lack of research into this condition; and believes that greater recognition of essential tremor would help to improve treatment and public understanding.","date":"2009-02-12","status":"o"},{"topic":"Diseases","id":"37760","proposer":"10170","edm":"706","session":"2008-09","title":"Kidney Cancer Drugs","text":"That this House welcomes the National Institute for Health and Clinical Excellence (NICE) Final Decision Determination granting access to Sutent for first-time patients with kidney cancer and expresses the hope that the NHS will implement these recommendations swiftly; is concerned that NICE has issued draft recommendations rejecting the use of three other key drugs used in treating kidney cancer, Nexavar, Avastin and Torisel; recognises that these treatments are not interchangeable and that not all patients with kidney cancer are suitable for treatment with Sutent; notes with concern that this leaves many patients without access to the latest treatments, which have been recognised as clinically effective by NICE; seeks to ensure that primary care trusts are aware that this is not final guidance and that patients should still be able to access these treatments through exceptional case processes; further notes with concern that the additional guidance on end-of-life medicines issued by NICE to the appraisal committees does not appear to have supported the use of these four key treatments options for patients; and calls on NICE seriously to reconsider this guidance and allow access to all of these important, life-extending treatments as soon as possible.","date":"2009-02-05","status":"o"},{"topic":"Diseases","id":"37737","proposer":"10169","edm":"651A1","session":"2008-09","title":"Evening Chronicle Campaign On Pleural Plaques","text":"after `restored;', insert `supports the Damages (Asbestos-Related Conditions) Bill, introduced by the hon. Member for Hendon, listed for Second Reading on Friday 24 April; and urges all hon. Members to attend to support this Bill'.","date":"2009-02-03","status":"o"},{"topic":"Diseases","id":"37701","proposer":"10274","edm":"651","session":"2008-09","title":"Evening Chronicle Campaign On Pleural Plaques","text":"That this House warmly endorses the campaign by the respected Newcastle Evening Chronicle to urge the Government to end the compensation scandal which left a forgotten generation facing a bleak future following the House of Lords ruling which overturned a decades-old right for working folk to be compensated for industrial diseases; notes that this has left hundreds of desperately ill former workers suffering from the debilitating lung condition pleural plaques who are now not entitled to a penny in redress; further endorses the view of Ian McFall, head of asbestos policy at Thompsons Solicitors, that thousands of people in the North East negligently exposed to asbestos, have suffered harm and deserve to have their concerns recognised; joins with the Chronicle in calling on the Government to overturn the ruling and give sufferers of the asbestos-linked condition the help they deserve; urges support for the Chronicle's campaign calling for the right to compensation to be restored; and urges the Government to conclude its consultation process on this matter speedily.","date":"2009-02-02","status":"o"},{"topic":"Diseases","id":"37638","proposer":"10586","edm":"601","session":"2008-09","title":"Paroxysmal Nocturnal Haemoglobinuria","text":"That this House welcomes the Government's decision to nationally commission services for the treatment of the ultra-orphan disease Paroxysmal Nocturnal Haemoglobinuria (PNH); acknowledges that without treatment with eculizumab patients with this chronic life threatening disease are left only with the options of recurrent blood transfusions and, in a small number, bone marrow transplant; and congratulates the PNH Alliance of clinicians, industry and patients who are working to ensure PNH services continue to improve patient outcomes.","date":"2009-01-27","status":"o"},{"topic":"Diseases","id":"37622","proposer":"10292","edm":"588","session":"2008-09","title":"Blindness Prevention And People With Diabetes","text":"That this House regrets that diabetic retinopathy is the leading cause of blindness among the working age population in the UK; considers that all people with diabetes should have access to free annual retinal screening with a digital camera; welcomes the progress made by many primary care trusts across England in implementing retinal screening programmes for people with diabetes, but is concerned that the latest figures from the Department of Health show that 28 per cent. of people with diabetes are at risk of losing their sight because they have not received screening and 6.9 per cent. of these have not even been offered it; commends the ongoing campaign from Diabetes UK that calls for everyone with diabetes to have access to high quality, annual retinal screening and appropriate follow-up treatment as necessary; and calls on primary care trusts to do more to reduce the number of people who do not respond to screening invitations.","date":"2009-01-26","status":"o"},{"topic":"Diseases","id":"37539","proposer":"10571","edm":"514","session":"2008-09","title":"BEATING BOWEL CANCER'S BE LOUD! BE CLEAR! CAMPAIGN","text":"That this House notes that bowel cancer is the UK's second biggest cancer killer and that more than 36,500 people are diagnosed with bowel cancer every year; recognises that early detection and effective treatment of bowel cancer could save 90 per cent. of those people diagnosed; congratulates Beating Bowel Cancer on its Be Loud! Be Clear! campaign and the charity's 10th anniversary; further recognises its ongoing crucial work to improve disease awareness, as well as to support bowel cancer patients and their families; welcomes the publication of the charity's report, Turn up the Noise on Bowel Cancer, which highlights Government progress towards meeting the charity's Bowel Cancer Challenge for improving bowel cancer services by 2012; and calls on the Government to work with the charity to continue to improve public awareness, extend the bowel cancer screening programme and monitor uptake, ensure that clinically effective treatments are available at the right time and in the right setting for all patients, and recognise the value in prolonging quality of life for bowel cancer patients and their families.","date":"2009-01-20","status":"o"},{"topic":"Diseases","id":"37490","proposer":"10214","edm":"466","session":"2008-09","title":"Implementation Of Improving Outcomes Guidance By Cancer Networks","text":"That this House notes the findings of the audit of Improving Outcomes Guidance carried out by the Prostate Cancer Charter for Action, to what outcome?; expresses concern that fewer than one in four cancer networks is fully on course to implement items of Improving Outcomes Guidance across all cancer types; further expresses concern that 11 cancer networks have failed to meet the December 2007 deadline of implementing Improving Outcomes in Urological Cancers; further notes that 2,500 deaths from cancer a year could potentially be prevented if all cancer networks were fully on course to implement items of Improving Outcomes Guidance across all cancer types; further notes that 300 deaths from prostate cancer a year could potentially be saved if all cancer networks implemented Improving Outcomes in Urological Cancers; and calls on the Government to ensure both that all cancer networks implement Improving Outcomes in Urological Cancers as soon as possible, and that all cancer networks are on course to have implemented all items of Improving Outcomes Guidance in line with the timetables set out in the Department of Health's Cancer Reform Strategy.","date":"2009-01-15","status":"o"},{"topic":"Diseases","id":"37464","proposer":"10378","edm":"441","session":"2008-09","title":"Epilepsy In England","text":"That this House notes the Epilepsy Action survey of January 2009; agrees that it is time for change for people with epilepsy; recognises that the majority of primary care trusts and acute trusts in England are failing to meet National Institute for Health and Clinical Excellence (NICE) Guidelines of 2004 for adults and children with epilepsy; congratulates Epilepsy Action for highlighting these issues in its campaign Epilepsy in England: time for change; believes that all health commissioners should carry out a review of their implementation of the NICE epilepsy guidelines and develop plans to ensure these are met; and calls on the Government to take a lead in driving improvements in epilepsy service provision and appoint a national clinical director to review service provision in England and lead change.","date":"2009-01-14","status":"o"},{"topic":"Diseases","id":"37466","proposer":"10351","edm":"443","session":"2008-09","title":"National Liver Reform Strategy","text":"That this House notes that the increasing prevalence of viral hepatitis, alcohol misuse and obesity is increasing the incidence of, and mortality from, liver disease; further notes that liver disease is the fifth most common cause of death in the UK with over 14,000 people dying from liver disease every year and is the only one of the top five killer diseases still increasing; believes that tackling liver disease, through improved prevention, diagnosis and treatment should be made a health service priority; welcomes the publication of the All-Party Parliamentary Hepatology Group's report, Divided Nations: Tackling the hepatitis C challenge across the UK; expresses concern at the report's findings that the Hepatitis C Action Plan for England has been poorly implemented; calls for urgent action to tackle the weaknesses of the Action Plan; and urges the Government to commit to developing a liver strategy and appoint a national clinical director for liver services to co-ordinate this vital work.","date":"2009-01-14","status":"o"},{"topic":"Diseases","id":"37445","proposer":"10428","edm":"425","session":"2008-09","title":"Prescribed Diseases And The Use Of Pneumatic Percussion Tools","text":"That this House is aware that UK legislation covering access to industrial injuries disablement benefits and appropriate compensation for noise induced hearing loss is currently woefully inadequate, a factor proven by the exemption from valid claims of thousands of workers whose health has been damaged directly because of their employer's use of pneumatic percussion tools to drill stone or other solid substances other than in the severely restricted confines of a quarry, underground coalmine, shaft or tunnelling works; believes such blatantly unfair legal discrimination should not be countenanced; and calls upon the Government immediately to take all necessary steps to bring forward amendments to the Social Security Contribution and Benefits Act 1992 and thereafter accordingly to bring forward all necessary changes to the Social Security (Industrial Injuries) Prescribed Diseases Regulations.","date":"2009-01-13","status":"o"},{"topic":"Diseases","id":"37449","proposer":"10455","edm":"429","session":"2008-09","title":"BRITISH CARDIAC PATIENTS ASSOCIATION'S CARDIOVASCULAR PATIENTS BILL OF RIGHTS","text":"That this House welcomes the launch of the Cardiovascular Patients Bill of Rights by the British Cardiac Patients Association; applauds the progress made to date on tackling cardiovascular disease, including heart disease, stroke and peripheral arterial disease leading to a 40 per cent. reduction in deaths since 1997; notes the serious cost of cardiovascular disease in the UK both in terms of ill health and economic impact; further notes the need to ensure that health services provide the best possible standards of care for cardiovascular patients throughout their patient journey, from emergency care to treatment and rehabilitation; and calls on the Government and health professionals to endorse and implement through the National Health Service the five fundamental rights for cardiovascular patients as set out in the Cardiovascular Patients Bill of Rights.","date":"2009-01-13","status":"o"},{"topic":"Diseases","id":"37359","proposer":"10258","edm":"348","session":"2008-09","title":"Prevention Of Healthcare Associated Infections","text":"That this House regrets that the best estimate the Government has provided for the cost to the NHS of treating and preventing healthcare associated infections (HCAIs) is based on data that is 14 years old; notes that recent reductions in superbug infection rates are modest drops from record high levels; understands that the NHS is considering providing infection-control packs to only those patients who already have MRSA; regrets that such measures are designed to deal with infection rather than prevent it; further notes that it costs up to \u00c2\u00a310,000 more to treat each patient that contracts an HCAI, which affect an estimated one in 10 patients, and that in consequence the NHS spends up to \u00c2\u00a31,000 per in-patient on treating HCAIs irrespective of whether the in-patient contracts an infection; believes that, in order to prevent HCAIs, it is essential that the NHS provides a comprehensive range of proven personal antimicrobial products and a guide to infection control to every NHS in-patient; calls upon the Government to, at the very least, undertake widespread trials of such an initiative, report the findings to the House and extend the initiative throughout the NHS if the trial is successful; and recognises that this preventative scheme, if implemented, would cost a small fraction of the amount spent on HCAI treatment.","date":"2008-12-17","status":"o"},{"topic":"Diseases","id":"37367","proposer":"11245","edm":"356","session":"2008-09","title":"Superbugs","text":"That this House is concerned that, despite recent falls, infection rates of MRSA, C. difficile, Norovirus and other superbugs remain high, and there is considerable public anxiety about this issue; notes that as everyone can carry and spread superbugs, patients and visitors as well as hospital staff have a part to play in helping to tackle infection; believes that patients should individually be provided with the means and information to protect themselves and others when they go into hospital; and calls upon the Government to provide a comprehensive range of personal antimicrobial products that are proven to kill superbugs and a hygiene guide to every NHS in-patient prior to admission, or as soon after admission as possible as this will help reduce infection rates, empower patients and instil good hygiene practices at a fraction of the financial cost of treating those who contract superbugs.","date":"2008-12-17","status":"o"},{"topic":"Diseases","id":"37255","proposer":"10105","edm":"254","session":"2008-09","title":"Pleural Plaques","text":"That this House is increasingly concerned by the delays in announcing the Government's response to the consultation on pleural plaques and the proposed actions that will deliver justice to pleural plaques sufferers; is also alarmed at statements from representatives of the insurance industry such as Nick Starling from the Association of British Insurers who has claimed that pleural plaques were benign and that there are no symptoms associated with them other than in the most exceptional cases and Pamela Abernathy from the Forum of Insurance Lawyers who said plaques are a good thing and do not cause harm; and believes now is the time to reverse the Law Lords decision of October 2007 that has deprived pleural plaques sufferers of much needed compensation and prior to the Law Lords decision worked in establishing liability at a stage prior to the onset of a fatal asbestos-related disease.","date":"2008-12-11","status":"o"},{"topic":"Diseases","id":"37256","proposer":"11427","edm":"255","session":"2008-09","title":"Muscular Dystrophy All-Party Parliamentary Group Inquiry","text":"That this House welcomes the launch of an inquiry into neuromuscular services by the All-Party Parliamentary Group for Muscular Dystrophy; notes that the inquiry seeks to identify areas of best practice and gaps in service provision; acknowledges the importance of an inquiry after the publication of recent reports by the Muscular Dystrophy Campaign revealing unacceptably wide geographical variations in the quality of and access to service provision; further notes that access to multi-disciplinary specialist care improves overall health outcomes and survival for patients with neuromuscular conditions; is deeply concerned that some patients are being denied access to essential health and social care services; and encourages the Department of Health to provide evidence to the inquiry.","date":"2008-12-11","status":"o"},{"topic":"Diseases","id":"37267","proposer":"10557","edm":"266","session":"2008-09","title":"Support For Children With Diabetes","text":"That this House congratulates the 225 children who came to Westminster on 18 November 2008 to mark World Diabetes Day and to inform hon. Members about their experiences of living with diabetes; welcomes the Diabetes UK report Making All Children Matter which calls for the 20,000 children in the UK who have Type 1 diabetes to receive appropriate support in managing their condition at school; is concerned that the UK has the lowest percentage of children attaining good diabetes control in Europe, with 83 per cent. failing to achieve recommended blood glucose levels; is further concerned that many children are still not getting the support they need in school to administer their medication and are still having to rely on parents visiting the school because the school cannot or will not provide the necessary assistance; and calls on the Government to ensure that local authorities, primary care trusts and schools take immediate steps to make this assistance available so that all children with diabetes are supported to play a full part in school life.","date":"2008-12-11","status":"o"},{"topic":"Diseases","id":"37272","proposer":"10258","edm":"271","session":"2008-09","title":"Variant Creutzfeldt-Jakob Disease","text":"That this House notes the 167 confirmed cases of variant Creutzfeldt-Jakob Disease (vCJD) in the UK, including three through blood transfusion, compared with three in total in the USA; congratulates and welcomes the work of Christine Lord, following the tragic death of her son Andy from vCJD at the age of 24, in establishing a website, www.justiceforandy.com, and producing a BBC South documentary Who Killed My Son which can be watched on www.justiceforandy.com; asks the BBC to screen the documentary nationwide; notes the death from vCJD of another six young people living within 25 miles of Portsmouth; further asks the Government to commission further research to establish common factors, such as school catering, among vCJD victims in South Hampshire as well as elsewhere in the country; further notes the Written Answer from the Minister of State for Health on 11 March 2008, giving a vCJD sub-clinical prevalence estimate of up to one in 1,400 of the population; and further asks that the Government completes its evaluation of screening for prions in blood supply and other possible measures to protect the blood supply as soon as possible, in light of the conclusions reported in the 15th annual report of the National Creutzfeldt-Jakob Disease Surveillance Unit, that blood transfusion is beyond reasonable doubt a possible transmission route for vCJD.","date":"2008-12-11","status":"o"},{"topic":"Diseases","id":"37274","proposer":"11784","edm":"273","session":"2008-09","title":"Diabetes Management In Schools","text":"That this House notes that the UK has the highest number of children with diabetes in Europe with 20,000 children below the age of 15 years diagnosed; urges the Government to ensure that children suffering from diabetes receive vital checks required for good diabetes management; further notes with concern the recent Diabetes UK campaign highlighting the lack of support for children at school in the management of their diabetes; further urges the Government to aid schools in ensuring children with diabetes have a safe environment and are able to receive full access to medication and health monitoring in schools; and concludes that all schools should have trained staff to deal with medical emergencies concerning children suffering from diabetes to assist with and if required administer insulin injections and blood glucose tests.","date":"2008-12-11","status":"o"},{"topic":"Diseases","id":"37224","proposer":"10614","edm":"226","session":"2008-09","title":"Leicester Royal Infirmary Diabetes Text Service","text":"That this House welcomes the first scheme in the country where diabetes sufferers can have their daily blood sugar levels monitored daily and can text their daily blood sugar level tests to a special number and have this information placed on a secure website which patients, parents and doctors can access; notes that it is vital that diabetics are aware of their blood sugar levels and can be assured by doctors through this service that they are within the normal boundaries; further notes that the aim of the pioneering project is to familiarise diabetics with how to effectively manage their condition; congratulates the Leicester Royal Infirmary for initiating the project; celebrates the use of technology in informing patients of their current health status; recognises that 2.2 million people in the UK are diabetes sufferers and that 750,000 diabetic people in the UK are undiagnosed; and further recognises that by 2010 there will be 66,000 people in Leicestershire alone with undiagnosed diabetes.","date":"2008-12-10","status":"o"},{"topic":"Diseases","id":"37233","proposer":"10105","edm":"235","session":"2008-09","title":"Coalminers And Industrial Injuries Advisory Council Recommendations","text":"That this House calls on the Government to implement without further delay the Industrial Injuries Advisory Council's recommendations and declare osteoarthritis of the knee a prescribed disease in relation to coal mining making it possible for this group of mainly elderly disabled workers to claim industrial injury disablement benefit.","date":"2008-12-10","status":"o"},{"topic":"Diseases","id":"37246","proposer":"10261","edm":"195A1","session":"2008-09","title":"Nhs Cervical Cancer Screening Programme","text":"leave out from `if' to end and add `the available evidence shows that this would save lives in a cost-effective manner.'.","date":"2008-12-10","status":"o"},{"topic":"Diseases","id":"37189","proposer":"10333","edm":"195","session":"2008-09","title":"Nhs Cervical Cancer Screening Programme","text":"That this House believes that the NHS Cervical Cancer Screening Programme, which aims to reduce the number of women who develop invasive cervical cancer and the number of women who die from it, should review its current policy of only screening women over the age of 25 years old; and considers that the programme should examine the figures for cervical cancer incidences in women under 25 years old and offer routine cervical screening to women under 25 years old if such figures could be reduced by routine screening.","date":"2008-12-09","status":"o"},{"topic":"Diseases","id":"37155","proposer":"10626","edm":"163","session":"2008-09","title":"Meningitis Awareness And National Immunisation Programme","text":"That this House welcomes the Meningitis Research Foundation's Winter Awareness campaign; notes that meningitis is a disease that affects nine people every day, of whom one will die and two more will suffer life-altering after-effects, such as brain damage, deafness and multiple amputations; further notes that babies and children are most at risk and that more young lives can be saved through raising awareness among clinical practitioners and the public of early warning signs; therefore welcomes the fact that in the 18 months since the Universal Infant Pneumococcal Vaccination was introduced there has been a marked fall in the number of invasive pneumococcal infections in children, and in associated deaths and disease, enabling some 470 children to avoid serious illness like meningitis, septicaemia and pneumonia; further notes however that between January and March 2008, 74 per cent. of children in England had received the vaccine booster dose as compared to 91 per cent. of children in Scotland; and calls on the Government to set in place measures to improve the uptake in England of both the primary vaccination and booster dose which both need to be given to ensure the fullest protection from pneumococcal disease.","date":"2008-12-08","status":"o"},{"topic":"Diseases","id":"37171","proposer":"11489","edm":"179","session":"2008-09","title":"Lymphoedema","text":"That this House notes that at least 100,000 people in the UK suffer from lymphoedema, a chronic swelling which can affect any part of the body; is aware that the condition can be a distressing side effect of cancer and its treatments, but also occurs far more commonly in people who have not suffered from cancer; further notes that, with access to a lymphoedema clinic and the support of a lymphoedema practitioner, patients can do much to manage and control their condition; notes with great concern that there is a postcode lottery in the treatment of lymphoedema; is disappointed that in Ceredigion and in many other areas, patients do not have access to an NHS-funded lymphoedema clinic; is concerned that often treatment is only available for patients who have lymphoedema following treatment for cancer; recognises the excellent work of the Lymphoedema Support Network, a charitable organisation that battles to raise the profile of this condition with insufficient access to public funds; and calls on the Government, in co-operation with the Scottish Executive and the Welsh Assembly Government, to do more to recognise this condition, and on local health boards and primary care trusts to give full recognition to lymphoedema in all its forms, and make sure treatment is available for all patients at a local level.","date":"2008-12-08","status":"o"},{"topic":"Diseases","id":"37177","proposer":"11489","edm":"185","session":"2008-09","title":"British Heart Foundation In Wales","text":"That this House congratulates the British Heart Foundation for the work it does in Wales in funding 31 nurses, funding research on heart disorders, providing information and fund-raising; notes that 12,000 people a year die from heart or circulatory disease in Wales, killing more than any other disease; further notes that in Wales there are nearly 250 Heartstart UK schemes, training 19,000 school children to save lives between June 2006 and June 2007; applauds the outstanding contribution to local and national heart services made by the British Heart Foundation; and wishes the charity well in its future work.","date":"2008-12-08","status":"o"},{"topic":"Diseases","id":"37006","proposer":"11420","edm":"14","session":"2008-09","title":"Hospital-Acquired Infection","text":"That this House recognises the trauma caused to patients and families by hospital-acquired infections such as MRSA and clostridium difficile; believes that there are examples the United Kingdom can learn from in other countries such as the Netherlands; recognises that this involves having sufficient beds to keep some empty and keep infected patients isolated from others; recognises that having medical staff travel in their work clothes also gives a risk of infection; requests that the tendency to blame patients for the spread of infection be resisted; and calls for an urgent review of whether reductions in bed numbers and planning for over 70 per cent. bed occupancy and other cost-saving measures are resulting in increased risk of hospital-acquired infection.","date":"2008-12-03","status":"o"},{"topic":"Diseases","id":"37022","proposer":"11245","edm":"30","session":"2008-09","title":"Tackling Malaria","text":"That this House notes that malaria still afflicts 40 per cent. of the world's population; calls on governments of malaria-endemic countries and international public and private organisations to work together to fight malaria worldwide and to raise awareness of malaria; further notes that, although preventable and curable, malaria continues to infect more than 500 million people each year, killing over one million; further notes that although the burden of malaria is heaviest in sub-Saharan Africa, it also afflicts Asia, Latin America, the Middle East and parts of Europe; further notes that it will only be defeated through collaboration and co-ordinated action of all relevant actors on local, national, regional and international levels; and therefore calls on the Government to review its efforts to collaborate with its international partners in tackling malaria.","date":"2008-12-03","status":"o"},{"topic":"Diseases","id":"37023","proposer":"11245","edm":"31","session":"2008-09","title":"New Treatment For Prostate Cancer","text":"That this House welcomes reports of the success of early trials of Abiraterone in treating an aggressive and often fatal form of prostate cancer; notes that eight out of 10 patients who have advanced prostate cancer may see their tumours shrink and be relieved of pain simply by taking a daily pill; further notes that full trials will be undertaken and that the drug may be generally available in three or four years; further notes that this drug, if it proves its potential during full trials, could help 10,000 men who die from aggressive prostate cancer each year; and therefore calls on the Government to ensure all possible support is given to accelerate the trials and ensure that the drug is available at the earliest possible moment.","date":"2008-12-03","status":"o"},{"topic":"Diseases","id":"37070","proposer":"10527","edm":"78","session":"2008-09","title":"Access To Inhaled Insulin Products For Diabetics","text":"That this House disagrees with the National Institute for Health and Clinical Excellence's technology appraisal document which proposes the restriction of access to inhaled insulin products on the NHS to patients with a proven injection phobia diagnosed by a psychiatrist or psychologist; is concerned that diabetes sufferers often delay treatment for as long as four years due to a fear of injections, risking the complications of heart disease, blindness and kidney failure, a situation that will only be compounded by attaching the unfortunate stigma of mental illness to those with a phobia of needles; expresses concern at the additional workload that will be placed on already overstretched NHS psychiatric services; and believes that the judgement of expert clinicians should be trusted in managing each individual patient's condition.","date":"2008-12-03","status":"o"},{"topic":"Diseases","id":"37094","proposer":"10608","edm":"104","session":"2008-09","title":"Heart Care For Patients With Diabetes","text":"That this House recognises that coronary heart disease (CHD) is the leading cause of death in people with type 2 diabetes - affecting 75 per cent. of patients; further recognises that people with diabetes have up to a fivefold increased risk of CHD due to prolonged, poorly controlled blood glucose levels; notes that patients are not receiving the optimal medical treatment as cardiovascular disease is not being properly identified; welcomes the willingness of cardiologists and diabetologists across the UK to assess and adopt the best treatment options for patients with diabetes; and calls on the Government to consider expanding its collaboration with healthcare professionals to ensure all patients with diabetes are screened for CHD and receive the most suitable medical and revascularisation therapy.","date":"2008-12-03","status":"o"},{"topic":"Diseases","id":"36908","proposer":"10626","edm":"2500","session":"2007-08","title":"Meningitis Awareness And National Immunisation Programme","text":"That this House welcomes Meningitis Research Foundation's Winter Awareness campaign; notes that meningitis is a disease that affects nine new people everyday, of whom one will die and two more will suffer life-altering after-effects, such as brain damage, deafness and multiple amputations; further notes that babies and children are most at risk and that more young lives can be saved through raising awareness among clinical practitioners and the public of the early warning signs; therefore welcomes that in the 18 months since the Universal Infant Pneumococcal Vaccination was introduced there has been a marked fall in the number of invasive pneumococcal infections in children, and in associated deaths and disease, enabling some 470 children to avoid serious illness like meningitis, septicaemia and pneumonia; further notes however that between January and March 2008, 74 per cent. of children in England had received the vaccine booster dose as compared to 91 per cent. of children in Scotland; and calls on the Government to set in place measures to improve the uptake in England of both the primary vaccination and booster dose which both need to be given to ensure the fullest protection from pneumococcal disease.","date":"2008-11-13","status":"c"},{"topic":"Diseases","id":"36901","proposer":"10304","edm":"2494","session":"2007-08","title":"Screening For Abdominal Aortic Aneurysms (No. 2)","text":"That this House supports the Circulation Foundation's efforts to raise awareness of the planned national screening programme for abdominal aortic aneurysms; recognises that work is being carried out to support the establishment of a nationwide screening programme; notes that abdominal aortic aneurysms are the third most common cause of death for males aged over 65 and that each year nearly 7,000 people, almost all of them men, die suddenly and without symptoms; and urges Government to announce a firm timetable for the programme's introduction.","date":"2008-11-12","status":"c"},{"topic":"Diseases","id":"36905","proposer":"11923","edm":"2498","session":"2007-08","title":"World Diabetes Day 2008","text":"That this House notes 14th November 2008 will be World Diabetes Day; expresses concern that some 250 million people worldwide, including two million in England, are living with diabetes; recognises the increasing number of children and teenagers currently suffering from the condition; and welcomes World Diabetes Day and its efforts to raise awareness and improve education about the disease.","date":"2008-11-12","status":"c"},{"topic":"Diseases","id":"36876","proposer":"10274","edm":"2470","session":"2007-08","title":"Turner And Newall And Sir Cyril Smith","text":"That this House notes that for decades the asbestos industry covered up the fatal health threat posed by the carcinogenic mineral; further notes that some 4,000 people a year die from incurable asbestos-related diseases; expresses disquiet over letters revealing that on 5th August 1981 the then hon. Member for Rochdale, Sir Cyril Smith, asked Turner and Newall, a major asbestos corporation, to supply a speech to make in the Chamber of the House in a debate on asbestos controls; is disturbed that the letter of 5th August 1981 stated `could you please, within the next eight weeks, let me have the speech you would like to make (were you able to!) in the debate?'; believes such action was dishonourable and not in the interests of the public nor in the finest tradition of this House; and expresses its support for those now demanding that the former hon. Member for Rochdale be stripped of his knighthood.","date":"2008-11-11","status":"c"},{"topic":"Diseases","id":"36863","proposer":"10258","edm":"2459","session":"2007-08","title":"Superbugs And Personal Antimicrobial Products","text":"That this House is concerned that, despite recent falls, infection rates of MRSA, clostridium difficile, norovirus and other superbugs remain high and there is considerable public anxiety about this issue; notes that as everyone can carry and spread superbugs, patients and visitors, as well as hospital staff, have a part to play in helping to tackle infection; believes that patients should be provided with the means and information to protect themselves and others when they go into hospital; and calls on the Government to provide personal antimicrobial products that are proven to kill superbugs to every NHS in-patient as this will help reduce infection rates, empower patients and instil good hygiene practices at a small fraction of the financial cost of treating those who do contract superbugs.","date":"2008-11-10","status":"c"},{"topic":"Diseases","id":"36790","proposer":"10226","edm":"2398","session":"2007-08","title":"Rarer Cancers Forum Reports","text":"That this House welcomes the investigations by the Rarer Cancers Forum into the processes used by the NHS to determine exceptional funding requests for treatment; congratulates the Rarer Cancers Forum on the reports resulting from its investigations, Taking Exception and Exceptional England?; expresses concern at the large variation in assessing applications for exceptional funding between different NHS organisations identified in the reports; expresses further concern that a patient is less likely to make an exceptional funding request if they live in a deprived area; notes the finding in Exceptional England? that the average cost to a cancer patient of paying privately for a top-up treatment is in excess of \u00c2\u00a320,000; and calls on the Government to investigate the viability of implementing each of the recommendations in the reports so that all patients with cancer are provided with clinically-effective cancer treatments on the NHS if they have been recommended by their doctor.","date":"2008-11-03","status":"c"},{"topic":"Diseases","id":"36784","proposer":"11032","edm":"2395","session":"2007-08","title":"Photo Dynamic Therapy","text":"That this House notes the remarkable work of University College Hospital, London and other UK hospitals in developing photo dynamic therapy for the treatment of a range of cancers and other conditions; further notes that the treatment is much less invasive and less traumatic for the patient compared to surgery, radiotherapy and chemotherapy, that evidence points to impressive survival rates and that treatment is highly cost-effective; nevertheless notes that photo dynamic therapy is only available in a very small number of NHS hospitals, and that availability is falling; further notes that the Richards' Cancer Review recommended a systematic review of photo dynamic therapy with a view to promoting and extending the use of the therapy across the NHS; expresses regret that progress on this review appears to be moving very slowly; and calls on the Government to take urgent steps to develop the potential for this therapy in the NHS.","date":"2008-10-30","status":"c"},{"topic":"Diseases","id":"36762","proposer":"10027","edm":"2375","session":"2007-08","title":"Lung Cancer Specialist Nurses","text":"That this House applauds the vital work of specialist lung cancer nurses in caring for patients with lung cancer, providing families with the information and support that they need and sharing their expert knowledge; notes that lung cancer remains the UK's largest killer cancer, resulting in more than 33,500 deaths every year; further notes with concern that on average there is one lung cancer nurse in England for every 132 lung cancer patients, compared to one breast cancer nurse for every 82 breast cancer patients, and that many thousands of lung cancer patients do not have access to a specialist nurse at all; supports the United Kingdom Lung Cancer Coalition (UKLCC)'s campaign to double lung cancer survival; welcomes the voices of the UKLCC and the National Forum for Lung Cancer Nurses in calling for equal and improved access to lung cancer services across the country, including access to a specialist lung cancer nurse for every patient; and calls on the Government to take action to deliver access to a lung cancer specialist nurse for every patient as recommended in the Department of Health's Cancer Reform Strategy and NICE's Improving Outcomes Guidance.","date":"2008-10-29","status":"c"},{"topic":"Diseases","id":"36748","proposer":"10557","edm":"2367","session":"2007-08","title":"Food Labelling","text":"That this House is concerned by the dramatic rise in obesity and diet-related disease across the UK; recognises a major contributing factor to be excessive consumption of foods high in fat, sugar and salt; acknowledges the need for simple front of pack labelling with information about the levels of fat, sugar and salt in foods to enable consumers to make healthier choices; welcomes the Food Standards Agency's current evaluation of all front of pack labelling schemes to identify which system performs best to give consumers the information they need; and calls on food retailers and manufacturers to end the confusion caused by the proliferation of different schemes and to commit to adopting whichever single labelling approach is found by the Food Standards Agency to perform best for consumers.","date":"2008-10-28","status":"c"},{"topic":"Diseases","id":"36639","proposer":"10571","edm":"2272","session":"2007-08","title":"National Service Framework For Asthma","text":"That this House calls on the Government to develop a National Service Framework for asthma; urges it to improve standards of care and treatment for the 4.5 million people with asthma in England; notes that caring for people who experience an asthma attack costs over three and a half times more than for those whose asthma is well-managed; and is concerned by Asthma UK's research showing that 69 per cent. of people with asthma do not have their symptoms under control and their recent Wish you were here? report, highlighting that children in the primary care trust (PCT) area with the highest emergency admissions ratio are eight times as likely to be admitted to hospital for asthma as children in the PCT with the lowest admissions ratio.","date":"2008-10-16","status":"c"},{"topic":"Diseases","id":"36647","proposer":"10021","edm":"2280","session":"2007-08","title":"World Osteoporosis Day, 20th October 2008","text":"That this House marks World Osteoporosis Day on 20th October 2008; welcomes the publication by the National Osteoporosis Society of Your Bones and Osteoporosis: What Every Man, Woman and Child Should Know, a major report that shows almost half of 18 to 24 year olds do not know that there are steps they can take to keep their bones healthy, with more than half unaware that exercise can help to reduce the risk of osteoporosis and one in three unaware about the positive role that diet can play; notes that these are alarming statistics in view of the fact that the teens and early twenties are the most important time in terms of taking action to prevent osteoporosis in later life; and supports the recommendations in the report, including taking nationwide measures to improve the public's knowledge of bone health across all ages including that of school age children through the teaching of bone health within the classroom.","date":"2008-10-16","status":"c"},{"topic":"Diseases","id":"36651","proposer":"10021","edm":"1726A1","session":"2007-08","title":"Pulmonary Rehabilitation And Follow-On Exercise Classes","text":"at end add `, and congratulates the Bexley Care Trust on its pioneering community-based service led by respiratory physiotherapist Tracey Birch at Northumberland Heath, Erith.'.","date":"2008-10-16","status":"c"},{"topic":"Diseases","id":"36587","proposer":"10333","edm":"2237","session":"2007-08","title":"Nhs Cervical Screening Programme","text":"That this House believes that the NHS Cervical Screening Programme, which aims to reduce the number of women who develop invasive cervical cancer and the number of women who die from it, should review its current policy of only screening women over the age of 25 years; and considers that the programme should examine the figures for cervical cancer incidences in women under 25 years and offer routine cervical screening to women under 25 years if such figures could be reduced by routine screening.","date":"2008-10-14","status":"c"},{"topic":"Diseases","id":"36560","proposer":"10166","edm":"2212","session":"2007-08","title":"Lupus Awareness Month","text":"That this House notes that October is Lupus Awareness Month; recognises the impact lupus has on over 50,000 people in the UK alongside their families, friends and carers; congratulates LUPUS UK for its work as the only national charity dedicated to raising awareness of the condition, as well as providing support and advice for lupus sufferers and raising funds for the sufferers; further notes that lupus is an auto-immune disease which can cause many and varied symptoms affecting different organs of the body, including the kidneys, heart, lungs, brain and the skin and is often misdiagnosed; further notes that the phasing out of incandescent light bulbs by 2011 is likely to have serious consequences for some lupus sufferers with light sensitivity; welcomes the Government's commitment to work with the lighting industry to seek a solution to this problem; and further urges the Government to raise public awareness of lupus and to encourage research into effective treatment of the disease.","date":"2008-10-08","status":"c"},{"topic":"Diseases","id":"36533","proposer":"10226","edm":"2182","session":"2007-08","title":"Seasonal Influenza","text":"That this House is concerned about the terrible impact of seasonal influenza each year on the health of the UK population; recognises the huge burden of influenza on NHS resources; notes that between 3,000 and 4,000 people die each year from influenza-related illnesses; congratulates the Department of Health on the success of its seasonal influenza vaccination campaign, particularly for those people aged 65 years and over, where vaccination coverage rates have reached over 73 per cent.; supports the Department in its decision to focus this year's campaign on those at risk under 65 years old; and calls for the Joint Committee on Vaccination and Immunisation to review the case for reducing the age for influenza vaccination to 50 years and above, and to introduce influenza vaccinations for all children between six months and two years of age to increase the overall uptake rates and to meet the World Health Organisation's target for population coverage.","date":"2008-10-07","status":"c"},{"topic":"Diseases","id":"36508","proposer":"11475","edm":"2158","session":"2007-08","title":"Breast Cancer Wear It Pink Day Campaign","text":"That this House recognises that over 45,500 women and almost 300 men will be diagnosed with breast cancer in 2008 in the UK; endorses Breast Cancer Campaign's organisation of Wear it Pink on 31st October 2008; notes the importance of the event in promoting awareness of breast cancer among the general public; encourages hon. Members to participate in the initiative to help raise funds for innovative world-class breast cancer research at centres of excellence throughout the UK; and congratulates Breast Cancer Campaign and all of its supporters for having raised over \u00c2\u00a33.2 million in 2007 through Wear it Pink.","date":"2008-10-06","status":"c"},{"topic":"Diseases","id":"36476","proposer":"11245","edm":"2127","session":"2007-08","title":"New Treatment For Prostate Cancer","text":"That this House welcomes reports of the success of early trials of Abiraterone in treating an aggressive and often fatal form of prostate cancer; notes that eight out of 10 patients who have advanced prostate cancer may see their tumours shrink and be relieved of pain simply by taking a daily pill; further notes that full trials will be undertaken and that the drug may be generally available in three or four years; further notes that this drug, if it proves its potential during full trials, could help 10,000 men who die from aggressive prostate cancer each year; and therefore calls on the Government to ensure all possible support is given to accelerate the trials and ensure that the drug is available at the earliest possible moment.","date":"2008-07-22","status":"c"},{"topic":"Diseases","id":"36447","proposer":"11245","edm":"2100","session":"2007-08","title":"Rheumatoid Arthritis Treatment","text":"That this House congratulates the National Rheumatoid Arthritis Society on its caring activities; notes the recent National Institute for Health and Clinical Excellence (NICE) Final Appraisal Document; is aware of the pain, and the medical and social problems, suffered by people suffering from rheumatoid arthritis; further notes that effective treatment can save the NHS significant sums in the longer term; further notes that the NICE decision would deny 60,000 people with rheumatoid arthritis access to a range of anti-TNF drugs and could leave them facing high levels of pain, the possibility of more surgery and long-term disability; and therefore calls on the Government to ensure that anti-TNF drugs are available to rheumatoid arthritis sufferers according to their clinical needs.","date":"2008-07-21","status":"c"},{"topic":"Diseases","id":"36470","proposer":"10521","edm":"2123","session":"2007-08","title":"LYMPHOMA ASSOCIATION SURVEY OF PATIENTS' EXPERIENCE OF DIAGNOSIS","text":"That this House notes the findings of the Lymphoma Association's survey of patients' experiences of their diagnosis of lymphoma; expresses concern that although lymphoma is one of the most common cancers in the UK and that there are clear symptoms indicating that a person may have the condition, there is a lack of awareness of these symptoms amongst both members of the public and GPs, with consequent and unnecessary delays in prompt and accurate diagnosis; is disappointed by the survey results showing that more than one in 10 lymphoma sufferers had to visit their GP after their initial visit on a further five occasions before being referred to a specialist; is encouraged by the results showing that pressure from families is a key factor in persuading patients to seek a diagnosis; welcomes the work of the Lymphoma Association in raising awareness of the symptoms of lymphoma and supporting patients and their families with the disease; and urges the Government to work with the lymphoma community through the National Awareness and Early Diagnosis Initiative to increase awareness of the condition and encourage its early diagnosis.","date":"2008-07-21","status":"c"},{"topic":"Diseases","id":"36437","proposer":"10431","edm":"2090","session":"2007-08","title":"Bovine Tuberculosis And Badger Culling","text":"That this House congratulates the Secretary of State for Environment, Food and Rural Affairs for his principled stand in rejecting calls for a widespread cull of badgers; notes that the evidence shows that such a cull would do nothing to help eradicate bovine tuberculosis and would be likely to make matters worse; considers that he is right to take his decision in accordance with science; and hopes that the Minister for Rural Affairs in the National Assembly for Wales will set aside her intention to allow a cull, and return to an evidence-based approach.","date":"2008-07-17","status":"c"},{"topic":"Diseases","id":"36375","proposer":"11971","edm":"2033","session":"2007-08","title":"Trailblazers And The Muscular Dystrophy Campaign","text":"That this House welcomes the launch of Trailblazers, the Muscular Dystrophy Campaign's new exciting v-funded volunteering project, which will turn the aspirations of young disabled people into action; notes that this follows the Muscular Dystrophy Campaign's Bridging the Gap campaign, which highlighted the difficulties young people with muscle disease face in accessing education, employment and making their views heard; is concerned that disabled 16 year olds are twice as likely to be out of work, education or training as their non-disabled peers; recognises that people with impairments and long-term health conditions form 40 per cent. of all people out of work; expresses concern that disabled people form 35 per cent. of the total number of people without any formal qualifications; further recognises the vital contribution young disabled people can make to their local communities; acknowledges the positive role Trailblazers will have in providing opportunities and experiences to young disabled people enabling them to make informed decisions about their future and their local communities; and calls on the Government to support the work of Trailblazers to ensure that the views of young disabled people are heard.","date":"2008-07-15","status":"c"},{"topic":"Diseases","id":"36379","proposer":"11032","edm":"2037","session":"2007-08","title":"Sickle Cell Disease","text":"That this House observes that sickle cell disease is one of the most common genetic diseases in the country and affects over 12,500 people in the UK; notes that knowledge of the condition is still low and welcomes the start of Sickle Cell Awareness Month; recognises that access to care and support for patients with sickle cell disease varies widely across the UK; welcomes the publication by the Sickle Cell Society of the Standards for the Clinical Care of Adults with Sickle Cell Disease in the UK; and recommends that the standards be implemented and services audited in an attempt to raise levels of care and reduce the health inequalities which many sickle cell patients currently face.","date":"2008-07-15","status":"c"},{"topic":"Diseases","id":"36365","proposer":"10258","edm":"2024","session":"2007-08","title":"Research Into Variant Creutzfeldt-Jakob Disease","text":"That this House notes the 167 confirmed cases of variant Creutzfeldt-Jakob disease (vCJD) in the UK, including three through blood transfusion, compared with three in total in the USA; congratulates and welcomes the work of Christine Lord, following the tragic death of her son Andy from vCJD at the age of 24, in establishing a website, www.justiceforandy.com, and producing a BBC South documentary Who Killed My Son which can be watched on www.justiceforandy.com; asks the BBC to screen the documentary nationwide; notes the death from vCJD of another six young people living within 25 miles of Portsmouth; further asks the Government to commission further research to establish common factors, such as school catering, among vCJD victims in South Hampshire as well as elsewhere in the country; further notes the written answer from the Minister of State for Health on 11th March 2008, giving a vCJD sub-clinical prevalence estimate of up to 1 in 1,400 of the population; and further asks that the Government completes its evaluation of screening for prions in blood supply and other possible measures to protect the blood supply as soon as possible, in light of the conclusions reported in the 15th annual report of the National Creutzfeldt-Jakob Disease Surveillance Unit that blood transfusion is beyond reasonable doubt a possible transmission route for vCJD.","date":"2008-07-14","status":"c"},{"topic":"Diseases","id":"36351","proposer":"11923","edm":"2014","session":"2007-08","title":"Bluetongue Protection Zone","text":"That this House expresses concern that as of the beginning of July, Cumbria and other counties in the north of England have not been placed in the bluetongue protection zone or received bluetongue vaccine; is particularly concerned about the effect that late administration of the vaccine may have on the ability of livestock farmers in Cumbria to move their animals to sale later in the summer, given that this would cause enormous hardship for farming communities; and calls on the Government to ensure that animals in Cumbria and other affected counties are vaccinated as a matter of urgency.","date":"2008-07-10","status":"c"},{"topic":"Diseases","id":"36344","proposer":"10378","edm":"2011","session":"2007-08","title":"Human Papilloma Virus Vaccine","text":"That this House notes the recent Department of Health decision to purchase a bivalent, rather than quadrivalent, Human Papilloma Virus (HPV) vaccine for the national HPV immunisation programme; recognises that, as well as preventing cervical cancer, a quadrivalent vaccine would protect against a wider range of conditions, including genital warts, reducing sexually-transmitted infections and costs for the NHS; understands that the UK will be the only country in the world to opt for a bivalent rather than quadrivalent vaccine for a national programme; shares the disappointment of fpa, the Terrence Higgins Trust, Brook and the British Association of Sexual Health and HIV at this decision; and urges the Government to reconsider.","date":"2008-07-09","status":"c"},{"topic":"Diseases","id":"36286","proposer":"10226","edm":"1962","session":"2007-08","title":"Peripheral Arterial Disease And The Dragging Their Feet Report","text":"That this House welcomes the Dragging Their Feet report, produced by Target PAD, an expert group of clinicians with an interest in tackling peripheral arterial disease (PAD); notes with concern the serious health, social and economic costs to the 720,000 individuals diagnosed with PAD in the UK, caused by sub-optimal treatment of the disease; further notes the wider costs to these patients' families, and to UK plc; and calls on the Government and health professionals to take action to improve the management of peripheral arterial disease, particularly through supporting the inclusion of measures to manage PAD in primary care through the quality and outcomes framework of the General Medical Services contract and the Government's cardiovascular risk management programme.","date":"2008-07-07","status":"c"},{"topic":"Diseases","id":"36298","proposer":"10614","edm":"1974","session":"2007-08","title":"Care Provisions For People With Diabetes","text":"That this House recognises the report published on 7th July by Diabetes UK which warns that 100 people a week lose a limb due to complications as a result of diabetes and that there is an urgent need for greater awareness of the impact of the condition; notes that diabetes can also lead to heart attacks, stroke, blindness and kidney failure; and calls on the Government to provide diabetes sufferers with better access to high-quality integrated specialist foot care services and to regular foot checks as part of their annual medical review to prevent amputations.","date":"2008-07-07","status":"c"},{"topic":"Diseases","id":"36269","proposer":"10190","edm":"1946","session":"2007-08","title":"Duchenne Muscular Dystrophy","text":"That this House notes that Duchenne Muscular Dystrophy (DMD) is a severe and progressive muscle wasting disease; recognises that DMD is caused by variations in the dystrophin gene on the X chromosome that results in a loss of the protein dystrophin in muscle cells and primarily affects boys; realises that most boys with DMD are confined to a wheelchair by the age of 11 and that the average life expectancy for DMD sufferers is early to mid twenties; understands that DMD occurs in one in every 3,500 male births worldwide and that 100 children a year are born in the UK with DMD; further notes that there is currently no cure for DMD which means that two children per week die in the UK from DMD and that it is the biggest genetic killer in the UK; further recognises that there are only two specialist DMD centres in the UK in Newcastle and London; and calls on the Government to increase funding into research projects and existing clinical trials and to improve the translational network of DMD specialist centres across the UK so that families have access to the best possible care.","date":"2008-07-02","status":"c"},{"topic":"Diseases","id":"36187","proposer":"10571","edm":"1869","session":"2007-08","title":"7 Out Of 10 Prostate Cancer Campaign","text":"That this House welcomes the launch of the 7 out of 10 campaign to raise awareness of the variations in treatment of prostate cancer patients; notes with particular concern that 7 out of 10 men with metastatic hormone refractory prostate cancer are missing the opportunity to receive chemotherapy; further notes that prostate cancer is the commonest male cancer, killing 10,000 men every year; believes eligible men should be given access to chemotherapy where appropriate; and calls on the Government to ensure ideal patient pathways are locally implemented as recommended in the National Institute for Health and Clinical Excellence prostate cancer guidelines published in 2008, first, to ensure that multi-disciplinary team meetings occur at appropriate times and second, to ensure patients are referred to oncologists at the first opportunity.","date":"2008-06-24","status":"c"},{"topic":"Diseases","id":"36193","proposer":"11427","edm":"1875","session":"2007-08","title":"Chronic Obstructive Pulmonary Disease -\u0000 Finding The Missing Millions Campaign","text":"That this House notes that an estimated 3.7 million people in the UK have chronic obstructive pulmonary disease (COPD) but that only 900,000 people have been diagnosed with the disease; recognises that COPD is the UK's fifth biggest killer and that the direct cost of providing care in the NHS for people with COPD is almost \u00c2\u00a3500 million per year; welcomes the Invisible Lives report from the British Lung Foundation (BLF), which identifies the hotspots in the UK where people with undiagnosed COPD are most likely to live; understands that improving rates of early diagnosis for COPD would help patients to slow down the progression of their disease, live a healthy life for longer and avoid expensive emergency care; supports efforts by the BLF, Breathe Easy groups and primary care trusts to raise awareness and the rates of early diagnosis of COPD in the hotspot areas; and calls on the Government urgently to carry out an assessment of the economic and health benefits of incorporating spirometry testing into the recently announced health screening programme.","date":"2008-06-24","status":"c"},{"topic":"Diseases","id":"36167","proposer":"10029","edm":"1857","session":"2007-08","title":"NELSON MANDELA'S 90th BIRTHDAY","text":"That this House warmly congratulates Nelson Mandela on the occasion of his 90th birthday; recognises that his life and work have been an inspiration and example for millions throughout the world; appreciates the work of The Nelson Mandela Foundation, The Nelson Mandela Children's Fund and The Mandela Rhodes Foundation in working to raise awareness of AIDS and to promote HIV prevention measures; and welcomes the 46664 concert to London on 27th June to celebrate the occasion and to continue to generate support for such a worthy cause.","date":"2008-06-23","status":"c"},{"topic":"Diseases","id":"36139","proposer":"10226","edm":"1831","session":"2007-08","title":"Bone Cancer","text":"That this House supports Bone Cancer Awareness Week from 21st to 28th June 2008, co-ordinated by the Bone Cancer Research Trust which promote research into the causes and treatment of primary bone cancer; notes that primary bone cancers take longer to diagnose than any other type of cancer in young people; recognises the vital and urgent importance of raising the level of awareness of the symptoms of primary bone cancer amongst medical professionals, in particular GPs, and the general public; and congratulates the Bone Cancer Research Trust which is working to raise awareness of primary bone cancer which affects over 400 children and young people every year in the UK.","date":"2008-06-18","status":"c"},{"topic":"Diseases","id":"36144","proposer":"11817","edm":"1836","session":"2007-08","title":"Bovine Tuberculosis In France And The UK","text":"That this House sincerely congratulates the French Ministry of Agriculture and Fish for almost totally eradicating bovine tuberculosis in France; sadly reflects on the British Government's total failure in dealing with the crisis of bovine tuberculosis in the UK; and urges the Secretary of State for Environment, Food and Rural Affairs to meet his French counterpart as soon as possible to learn from French experience.","date":"2008-06-18","status":"c"},{"topic":"Diseases","id":"36145","proposer":"10586","edm":"1821A1","session":"2007-08","title":"Centre Of Excellence For Diabetes In Leicester","text":"after `Leicester', insert `and Leicestershire'.","date":"2008-06-18","status":"c"},{"topic":"Diseases","id":"36119","proposer":"11607","edm":"1815","session":"2007-08","title":"Healthcare Champions For Rheumatoid Arthritis","text":"That this House congratulates the 20 winners of the National Rheumatoid Arthritis Society's Healthcare Champions awards for their dedicated support and care of people living with rheumatoid arthritis (RA); notes that specialist multi-disciplinary rheumatology teams across the UK provide crucial support and a high standard of care for 400,000 people in the UK living with this extremely painful and disabling condition; notes with concern that many specialised rheumatology teams and services are under threat from NHS reforms, funding restrictions, proposed clinic closures and cuts in services; and calls upon the Government to ensure that the very special support and care that specialists, multi-disciplinary rheumatology teams provide to RA patients and their carers is maintained and not undermined by Lord Darzi's review of the NHS, the World Class Commissioning Initiative and other ongoing or planned NHS reforms.","date":"2008-06-17","status":"c"},{"topic":"Diseases","id":"36125","proposer":"10614","edm":"1821","session":"2007-08","title":"Centre Of Excellence For Diabetes In Leicester","text":"That this House notes that the week commencing 9th June is marked National Diabetes Week; acknowledges that there could be approximately half a million people in the country who are unaware they have diabetes including 66,000 people in Leicestershire; believes that it is important that the Government's strategy is directed towards prevention of diabetes; welcomes the statements made by the Minister for Health, the hon. Member for Exeter, on the proposal to establish a Diabetes Centre of Excellence in Leicester on the site of Leicester General Hospital; commends Leicester City Primary Care Trust, its Chief Executive, Tim Rideout, and experts in the field, including Professor Melanie Davies and Professor Azhar Farooqi OBE, for their commitment and dedication in the prevention and treatment of diabetes and their proposal for a Diabetes Centre of Excellence to be established as soon as possible; and further notes that the Centre for Excellence will serve not just the people of Leicester but act as a template for the rest of the United Kingdom.","date":"2008-06-17","status":"c"},{"topic":"Diseases","id":"36059","proposer":"11093","edm":"1759","session":"2007-08","title":"NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE'S GUIDANCE ON ANTI-TNF TREATMENT","text":"That this House welcomes the publication of National Institute of Health and Clinical Excellence (NICE) Guidance on anti-TNF treatment options for adults with severe active ankylosing spondylitis (AS); supports the decision of NICE's Appeal Panel to uphold the NICE Final Appraisal Determination recommendation; notes that the impact of AS is extensive, affecting some 90,000 people across the UK, and that the effects on employment and work disability are considerable; and believes that implementation of this Guidance will markedly improve the quality of life for those AS patients eligible to receive anti-TNF therapy.","date":"2008-06-11","status":"c"},{"topic":"Diseases","id":"36008","proposer":"10428","edm":"1722","session":"2007-08","title":"Action Duchenne","text":"That this House notes the publication of research carried out by members of the Action Duchenne organisation on consultation with parents, patients and clinicians connected with the illness highlighting the need for higher levels of Government funding in areas such as extra clinical trials, access to new drugs and treatments for sufferers, together with the establishment of specialist centres manned by multidisciplinary teams throughout the UK; and calls on the Government to take seriously this cry for support from those in the front line of medical need.","date":"2008-06-09","status":"c"},{"topic":"Diseases","id":"36012","proposer":"10288","edm":"1726","session":"2007-08","title":"Pulmonary Rehabilitation And Follow-On Exercise Classes","text":"That this House supports the British Lung Foundation's (BLF) Breathe Easy Week from 16th to 22nd June 2008; welcomes the British Lung Foundation Charter, which sets out 12 priorities for improving lung health in the UK and is to be delivered to 10 Downing Street on 19th June 2008; acknowledges that respiratory disease is the second biggest killer in the UK and that it affects one person in every seven; recognises that pulmonary rehabilitation classes are particularly important for improving the quality of life for people with chronic obstructive pulmonary disease; understands that the benefits of these classes are only maintained if patients continue to exercise after their course finishes; further welcomes the BLF Active initiative from the BLF which aims to ensure a better standard of health for people with lung disease by helping them to keep up their specially tailored programme of exercises; and calls on the Government to improve access to pulmonary rehabilitation and follow-on exercise classes throughout the UK for all people with lung disease who can benefit from them.","date":"2008-06-09","status":"c"},{"topic":"Diseases","id":"35961","proposer":"10331","edm":"1677","session":"2007-08","title":"Arrhythmia Awareness Week 2008","text":"That this House welcomes Arrhythmia Awareness Week 2008 from 9th to 15th June; notes that cardiac arrhythmia claims the lives of 100,000 people each year, making it the UK's single biggest killer, and that it is also an independent risk factor for strokes; congratulates organisations, such as Arrhythmia Alliance, which are working to raise awareness of this cardiac condition which affects one million people in the UK; supports the placement of medical devices such as automated external defibrillators in the community to save lives; and calls upon the Government to continue to support the implementation of Chapter 8 (Arrhythmias and Sudden Cardiac Death) of the National Service Framework for Coronary Heath Disease.","date":"2008-06-03","status":"c"},{"topic":"Diseases","id":"35929","proposer":"10614","edm":"1647","session":"2007-08","title":"Diabetes Specialist Nurses","text":"That this House welcomes the research undertaken at the University Hospitals of Leicester NHS Trust into the effectiveness of diabetes specialist nurses in cutting the cost of treating sufferers of diabetes by around \u00c2\u00a3100 million; further welcomes the findings that these specialist nurses would be able to improve the treatment of accident and emergency patients allowing them to leave hospital sooner; notes that the number of people diagnosed with diabetes is continually rising, which requires greater long-term care plans; and calls on the Government to consider the regular employment of more diabetes specialist nurses in all accident and emergency wards in all hospitals in Britain.","date":"2008-06-02","status":"c"},{"topic":"Diseases","id":"35942","proposer":"10226","edm":"1660","session":"2007-08","title":"Fit To Eat Guidelines On Hospital Food For Children With Cancer","text":"That this House is concerned that children and young people with cancer are sometimes offered food in hospital which is unappetising and unresponsive to their needs; considers food and nutrition to be vital to these children and young people who need to keep up their immunity from infection, whose taste buds change as a result of chemotherapy, and who will be in hospital for some time; notes with concern that a survey of families by the children's cancer charity CLIC Sargent shows that a majority of families saw their food spending increase while their child was undergoing cancer treatment and that 77 per cent. of respondents described hospital food negatively; welcomes CLIC Sargent's new Fit to Eat guidelines for hospitals; and calls on the Government to renew its commitment to improve hospital food and ensure that all children with cancer are served food in hospital which is fit to eat.","date":"2008-06-02","status":"c"},{"topic":"Diseases","id":"35955","proposer":"10465","edm":"782A1","session":"2007-08","title":"Clinics For People With Neuromuscular Conditions","text":"after second 'Dystrophy', insert `Motor Neurone Disease'.","date":"2008-06-02","status":"c"},{"topic":"Diseases","id":"35926","proposer":"11589","edm":"1644","session":"2007-08","title":"UK Government Aids Strategy And Commitment For Children","text":"That this House recalls the Government's 2005 pledge to place children at the heart of its strategy to tackle HIV\/AIDS in the developing world; notes that this involved a cornerstone commitment of 10 per cent. of its \u00c2\u00a31.5 billion HIV\/AIDS budget for 2005-08 to children affected by HIV\/AIDS; believes that this earmark commitment helped Ministers to galvanise the international response to children affected by HIV\/AIDS; and calls for this level of commitment to children to be sustained in the Government's forthcoming HIV\/AIDS strategy.","date":"2008-05-22","status":"c"},{"topic":"Diseases","id":"35883","proposer":"10557","edm":"1605","session":"2007-08","title":"Patient Information On Clinical Research In Diabetes","text":"That this House recognises the importance of the UK as a world leader in clinical research; commends the work of the UK Diabetes Research Network in developing and strengthening NHS infrastructure to support the delivery of diabetes clinical research; further recognises that it is vital that patients, carers and members of the public are made more aware of the opportunities presented by clinical trials in diabetes in order to be able to make informed choices about participation in such research; welcomes the launch of the Clinical Research in Diabetes: A Patient Perspective DVD and its associated website, which aim to inform people about diabetes and diabetes research; and calls for the Government to make the DVD and details of the website widely available across the NHS in order to support research that will tackle the emerging global epidemic of diabetes.","date":"2008-05-19","status":"c"},{"topic":"Diseases","id":"35842","proposer":"12016","edm":"1566","session":"2007-08","title":"National Thrombosis Week","text":"That this House welcomes and supports National Thrombosis Week; recognises that 25,000 people in the UK die each year of deep vein thrombosis (DVT), many due to hospital-acquired DVT; notes that a report by the All Party Parliamentary Thrombosis Group in 2007 revealed that only one third of NHS trusts were following best practice, as recommended by the National Institute for Health and Clinical Excellence and the Chief Medical Officer, to risk assess all patients for DVT on admission to hospital; fully supports the campaign by the thrombosis charity, Lifeblood, to expose the existing NHS postcode lottery in risk-assessing potentially fatal blood clots; and calls upon all NHS trusts to ensure that all in-patients are risk assessed for DVT.","date":"2008-05-14","status":"c"},{"topic":"Diseases","id":"35848","proposer":"10518","edm":"1572","session":"2007-08","title":"British Heart Foundation","text":"That this House supports the vital work of the British Heart Foundation in tackling heart disease, the biggest cause of premature death in the UK and its pioneering research and efforts in encouraging preventative activity such as the North Wales Bike Ride, which is taking place in Rhyl on 8th June; and urges everyone across North Wales and North West England to get on their bikes and take part.","date":"2008-05-14","status":"c"},{"topic":"Diseases","id":"35825","proposer":"10431","edm":"1553","session":"2007-08","title":"Muscular Dystrophy","text":"That this House welcomes the publication of a new report by leading neuromuscular physiotherapists and clinicians as part of the Muscular Dystrophy Campaign's Building on the Foundations campaign; recognises that for many adults and children living in Wales with muscular dystrophy and related neuromuscular conditions physiotherapy is essential in maintaining the best quality of life, for the longest time possible; is concerned that many patients in Wales with neuromuscular conditions are being denied timely and ongoing physiotherapy on the NHS; notes that young adults often have their physiotherapy withdrawn when they reach adulthood; further notes the serious concerns raised in the Muscular Dystrophy Campaign's oral evidence to the Welsh Affairs Select Committee regarding cross-border arrangements; urges the Welsh Assembly Government to undertake a review of neuromuscular services; and calls on the Welsh Assembly Government to recognise neuromuscular services as a specialist service best delivered as part of a multidisciplinary team, to ensure improved standards of care for all patients with neuromuscular conditions.","date":"2008-05-13","status":"c"},{"topic":"Diseases","id":"35797","proposer":"10261","edm":"1337A1","session":"2007-08","title":"TERRY PRATCHETT AND ALZHEIMER'S RESEARCH FUNDING","text":"after `research', insert `, including research using animals'.","date":"2008-05-08","status":"c"},{"topic":"Diseases","id":"35766","proposer":"11427","edm":"1498","session":"2007-08","title":"Improving Provision For Those With Neuromuscular Conditions","text":"That this House welcomes the publication of a new report on physiotherapy by leading neuromuscular physiotherapists and clinicians as part of the Muscular Dystrophy Campaign's Building on the Foundations campaign; recognises that for many adults and children with neuromuscular conditions physiotherapy is essential in maintaining the best quality of life, for the longest time possible; is concerned that many patients with chronic conditions are being denied ongoing physiotherapy on the NHS; notes that young adults often have their physiotherapy withdrawn when they reach adulthood; further notes that specialist physiotherapy services are vulnerable where they rely on charitable sector funding; urges specialised commissioning groups to follow the lead of the South West and undertake reviews of neuromuscular services; and calls on the Department of Health to recognise neuromuscular services as a specialist service best delivered as part of a multidisciplinary team and to ensure improved standards of care for all patients with neuromuscular conditions.","date":"2008-05-07","status":"c"},{"topic":"Diseases","id":"35773","proposer":"10105","edm":"1505","session":"2007-08","title":"PLEURAL PLAQUES AND THE LAW LORDS' DECISION (No. 2)","text":"That this House is concerned that proposals to overturn the decision of the Law Lords made on 17th October 2007 that pleural plaque is not a compensatable medical condition have not yet been forthcoming; and calls on the Secretary of State for Justice speedily to introduce legislative proposals to reverse the judgement.","date":"2008-05-07","status":"c"},{"topic":"Diseases","id":"35751","proposer":"10571","edm":"1485","session":"2007-08","title":"Unnecessary Hospital Admissions For Asthma","text":"That this House is concerned that children in some primary care trusts are eight times more likely than children in other primary care trusts to have a hospital admission for their asthma; notes that respiratory conditions are the second most common cause of hospital admissions in the UK and that 75 per cent. of emergency asthma admissions are thought to be avoidable; supports Asthma UK's Wish You Were Here? campaign launched on World Asthma Day 2008 which draws attention to shocking disparities in hospital admission rates for asthma across the country; and calls on the Government to prioritise the effective diagnosis, treatment and management of asthma, to develop and implement clear and consistent national quality standards for asthma services, to encourage primary care trusts to adopt Asthma UK's Good Asthma Services Checklist and to work with primary care trusts and other healthcare providers, employers, people with asthma, carers and patient organisations to identify and reduce risk factors for asthma and asthma attacks.","date":"2008-05-06","status":"c"},{"topic":"Diseases","id":"35755","proposer":"10569","edm":"1489","session":"2007-08","title":"Nhs Allergy Services","text":"That this House welcomes the newly established All Party Parliamentary Group on Allergy and its aim to raise awareness in Parliament of the need to improve the provision of, and access to, NHS allergy services across the country; expresses concern that despite the recommendations made in reports by the Health Select Committee and the Lords Science and Technology Committee on allergy and a recent review of allergy services by the Department of Health, there is still an unacceptable gap between patient need and service provision because there is only a vestigial allergy service in the UK and too few posts across the country are being funded for allergist specialists; acknowledges the National Allergy Strategy Group's estimates that around 18 million people in the UK live with a disease where allergy may be involved and that around seven million of those have allergy severe enough to require specialist care; and calls for more allergy specialist posts to be created and funded in the NHS, the greater prioritisation and effective commissioning of allergy services to take place at the local level, and adequate training to be provided to enable effective referral and management of less severe allergies in primary care.","date":"2008-05-06","status":"c"},{"topic":"Diseases","id":"35734","proposer":"10009","edm":"1469","session":"2007-08","title":"World Hepatitis Day 2008","text":"That this House notes that 19th May 2008 will be the first World Hepatitis Day; is concerned that more than 500 million people worldwide have either chronic hepatitis B or chronic hepatitis C which is equivalent to one in 12 of the global population; is deeply concerned that these two diseases kill 1.5 million people annually; believes that worldwide action is needed in order to save millions of lives; hopes that World Hepatitis Day will increase public awareness of hepatitis B and C in the UK and internationally; and urges the Government to support World Hepatitis Day and to help put it on the World Health Organisation agenda.","date":"2008-05-01","status":"c"},{"topic":"Diseases","id":"35719","proposer":"11592","edm":"1457","session":"2007-08","title":"10th Anniversary Of The Lavender Trust","text":"That this House congratulates the Lavender Trust at Breast Cancer Care on its 10th anniversary; notes that the Lavender Trust was co-founded by Beth Wagstaff and Justine Picardie and is the only fund in the UK dedicated to addressing the particular needs of younger women with breast cancer; acknowledges that over one-fifth of breast cancer patients are women under 50 years of age who often face an uncertain future, early menopause and child care issues; further notes the variety of free support funded by the Lavender Trust including publications, workshops and telephone support; pays tribute to the dedication of all involved with the Lavender Trust over the last 10 years; and wishes them every success for the future.","date":"2008-04-29","status":"c"},{"topic":"Diseases","id":"35692","proposer":"11333","edm":"1431","session":"2007-08","title":"Sudden Cardiac Arrest Syndrome In Athletes","text":"That this House notes with concern that young, fit people are dying of sudden cardiac death syndrome; and praises the Scottish Government's investment in a \u00c2\u00a3100,000-a-year pilot programme, in co-operation with the Scottish Football Association, which will offer free screening to amateur athletes from the Hampden sports medicine facility.","date":"2008-04-28","status":"c"},{"topic":"Diseases","id":"35694","proposer":"11963","edm":"1433","session":"2007-08","title":"Rotary Club And The Eradication Of Polio","text":"That this House congratulates the work of Rotary International in helping to reduce the number of polio cases by 99 per cent. over the last 20 years; further congratulates Rotary members' efforts in raising more than \u00c2\u00a3430 million to fund polio immunisation activities over 20 years of humanitarian activity; notes that 2008 is the 50th anniversary of the Rotary Club of Largs which will be continuing its fundraising activities throughout the year to help eradicate polio; and hopes that due to the tireless work of Rotary Club members and many others that polio will soon be stamped out for good.","date":"2008-04-28","status":"c"},{"topic":"Diseases","id":"35677","proposer":"10586","edm":"1352A1","session":"2007-08","title":"Ms Week","text":"leave out `including' and insert `excluding'.","date":"2008-04-24","status":"c"},{"topic":"Diseases","id":"35658","proposer":"10619","edm":"1408","session":"2007-08","title":"Registration Of Adult Health And Social Care Providers","text":"That this House welcomes the Government's Health and Social Care Bill; recognises the importance of preventing and controlling healthcare-acquired infections; notes the publication on 25th March of the draft consultation document which closes on 17th June; and urges the Government, in the interests of consistency of healthcare standards, to include non-emergency patient transport services within the regulatory framework of the Care Quality Commission.","date":"2008-04-23","status":"c"},{"topic":"Diseases","id":"35665","proposer":"10647","edm":"1415","session":"2007-08","title":"TAIWAN'S PARTICIPATION IN THE WORLD HEALTH ORGANISATION","text":"That this House regrets that the World Health Organisation (WHO) has opposed including Taiwan's participation as an observer to the World Health Assembly (WHA) on its agenda since 1997; notes that the 61st WHA will convene between 19th and 24th May 2008; recognises that disease knows no boundaries or politics and there should be no gap or weak spot in the world's disease prevention network; contends that Taiwan should not become the only gap in the global public health network; applauds Taiwan's strong desire to work with international health institutions through medical co-operation and emergency humanitarian work; further applauds the valuable medical assistance and humanitarian aid provided by Taiwan's public and private sectors worldwide exceeding US$450 million over the last decade; further notes that Palestine, the Holy See, the Sovereign Military Order of Malta, the International Red Cross, the International Federation of Red Cross and Red Crescent Societies, and the Inter-Parliamentary Union have been granted observer status to the WHA; regrets that the Government has not supported Taiwan's WHA observer status or WHO membership; welcomes the fact that Taiwan would be willing to accept an arrangement to be a WHA observer so as to engage in direct access to and communication with the WHO before attaining WHO membership; strongly encourages the UK Government to support Taiwan's justifiable bids for WHO membership and preliminary WHA observer status; and urges the WHO Director-General to invite Taiwan as a WHA observer before granting WHO membership to ensure no gap in the global public health network.","date":"2008-04-23","status":"c"},{"topic":"Diseases","id":"35635","proposer":"10527","edm":"1388","session":"2007-08","title":"Five Year Anniversary Of The National Service Framework For Diabetes","text":"That this House recognises the five year anniversary of the National Service Framework (NSF) for Diabetes; regrets that although good practice exists it is not universal and there are significant numbers of people with diabetes who do not have access to the best possible treatment and care; further notes that failure to deliver on the standards in the NSF will mean that people with diabetes face a higher risk of complications such as heart disease, stroke, blindness and lower-limb amputation; and therefore welcomes Diabetes UK's report Five years - half way there? that highlights some of the gaps; and calls on Her Majesty's Government to conduct a national review of what has been achieved to date and what needs to be prioritised in the next five years.","date":"2008-04-22","status":"c"},{"topic":"Diseases","id":"35589","proposer":"10040","edm":"1345","session":"2007-08","title":"Brain Cancer","text":"That this House welcomes the new focus on child health announced by Department of Health Ministers on 17th March in Brain Tumour Awareness Month, but draws attention to the significantly increased numbers of childhood cancers registered annually since 1962 (up 35 per cent.); notes that some 300 children a year are found to be suffering from brain cancer, and that it is believed that brain cancers now account for more deaths among children and the under 40 year olds than any other cancer; further notes that the five year survival rate of all cancers now stands at 50 per cent. but that the comparative survival rates for males and females with brain cancer are 12 per cent. and 15 per cent. respectively; and urges the Government to encourage more laboratory research into brain cancer and to study the reasons why certain other EU countries achieve significantly better survival rates for children and adults suffering from brain cancer so that the NHS can adopt best treatment practice.","date":"2008-04-21","status":"c"},{"topic":"Diseases","id":"35596","proposer":"10240","edm":"1352","session":"2007-08","title":"Ms Week","text":"That this House supports the 2008 MS week which runs from 21st to 27th April 2008; recognises that the UK has one of the highest prevalence rates of multiple sclerosis (MS) in the world and that the condition impacts on all aspects of a person's life; notes the current shortage of effective treatments or a cure for MS; supports the exploration of important new avenues of research into MS and other conditions such as Parkinson's disease and motor neurone disease, including potential developments in the use of hybrid embryos as part of research; and welcomes the MS Society's growing investment in essential research.","date":"2008-04-21","status":"c"},{"topic":"Diseases","id":"35577","proposer":"11672","edm":"1337","session":"2007-08","title":"TERRY PRATCHETT AND ALZHEIMER'S RESEARCH FUNDING","text":"That this House applauds Terry Pratchett, who is donating $1 million to the Alzheimer's Research Trust; notes that there are 700,000 people with dementia in the UK, a number forecast to double within a generation; notes that for every person with Alzheimer's, \u00c2\u00a311 is spent each year on UK research compared with \u00c2\u00a3289 for each cancer patient; supports the work of the UK's leading scientists, who recently met at the Alzheimer's Research Trust's Network Conference in Bristol, in researching better treatments and possible cures for dementia; welcomes the campaign by Terry Pratchett and the Alzheimer's Research Trust to increase funding and promote further research into the diagnosis, treatment and a possible cure for Alzheimer's and other forms of dementia.","date":"2008-04-03","status":"c"},{"topic":"Diseases","id":"35553","proposer":"10378","edm":"1314","session":"2007-08","title":"Epilepsy And Special Educational Needs","text":"That this House congratulates the Joint Epilepsy Council on its campaign to ensure that the Department for Children, Schools and Families recognises epilepsy as a condition that causes special educational needs (SEN); notes with concern that children and young people with epilepsy routinely experience potential health, learning, behavioural and emotional needs as a direct result of their epilepsy; regrets that around two-thirds of children and young people with epilepsy who attend mainstream schools are believed to underachieve academically; further notes that this equates to 40,000 affected children, given that there are 60,000 children with epilepsy in UK schools; and urges the Government to consider the needs of children and young people with epilepsy when enacting the Children's Plan commitment to improve SEN data collection.","date":"2008-04-02","status":"c"},{"topic":"Diseases","id":"35546","proposer":"10586","edm":"1277A1","session":"2007-08","title":"End Of Life Care","text":"at end add `or in specialist local hospices.'.","date":"2008-04-01","status":"c"},{"topic":"Diseases","id":"35512","proposer":"10385","edm":"1277","session":"2007-08","title":"End Of Life Care","text":"That this House notes that, according to a leading expert, for 90 per cent. of cancer patients pain can be managed equally well at home as in hospital; and calls on the Government to increase funding to enable end of life care to be provided at home.","date":"2008-03-31","status":"c"},{"topic":"Diseases","id":"35507","proposer":"11032","edm":"1272","session":"2007-08","title":"Nice Guidelines On Sickle Cell And Thalassaemia Screening","text":"That this House notes the National Institute for Health and Clinical Excellence (NICE) guidelines, published on 26th March, and particularly welcomes the recognition of the importance of offering screening for Sickle Cell and Thalassaemia before 10 weeks of pregnancy; further notes that the majority of women access primary care services early in their pregnancy; believes that there is an urgent need to develop dialogue between primary care and maternity care services to capitalise on this early access by providing timely information, counselling and screening; and calls for the recommendations, as set out by NICE, to be adopted and for discussions to take place in primary care to identify ways to meet this ambitious target.","date":"2008-03-27","status":"c"},{"topic":"Diseases","id":"35440","proposer":"10256","edm":"1214","session":"2007-08","title":"Interstitial Lung Disease","text":"That this House notes the growing number of cases of interstitial lung disease over the last two decades; recognises that investment in respiratory research in the UK has been disproportionately low in comparison with the massive burden of lung disease; calls on the Government to increase from six the number of interstitial lung disease specialist nurses nationwide and to increase resources for respiratory research and NHS palliative and support services for those diagnosed; and further calls upon the Government to provide an improved financing framework that better reflects the number of professionals involved and the processes and time required for the diagnosis of the disease.","date":"2008-03-18","status":"c"},{"topic":"Diseases","id":"35446","proposer":"10527","edm":"1220","session":"2007-08","title":"Diabetes-Induced Miscarriage And Stillbirths In South Asian Women","text":"That this House recognises that South Asian women have over twice the risk of losing a baby in the early stages of pregnancy, compared to European women, due to complications caused by type 2 diabetes; notes that poor social conditions, language barriers and an unhealthy diet all contribute to these poor pregnancy outcomes; recognises that those of Asian background are up to six times more likely to develop diabetes and that diabetes affects this community five to 10 years earlier than the general population; understands insulin, which can provide a solution to many of the problems associated with diabetes during pregnancy, unfortunately carries a stigma within the South Asian community; congratulates local initiatives such as the Apnee Sehat social enterprise which has developed a targeted educational DVD to provide guidance and practical information for pregnant women; commends such educational resources being tailored to raise health risk awareness in South Asian communities and promoting lifestyle changes to prevent this disease; and urges the Department of Health to use this beacon DVD as a best practice tool and calls for this to be made available to primary care trusts across the UK.","date":"2008-03-18","status":"c"},{"topic":"Diseases","id":"35394","proposer":"10004","edm":"1173","session":"2007-08","title":"National Institute For Health And Clinical Excellence Appraisal Of Treatment For Pulmonary Arterial Hypertension","text":"That this House expresses its concern at the Appraisal Consultation Document regarding treatment for pulmonary arterial hypertension published by the National Institute for Health and Clinical Excellence (NICE); notes that NICE's recommendation to no longer use intravenous epoprostenol and inhaled iloprost would have a direct impact on existing and future patients with this life threatening disease; further notes that the effective combination, dual and triple therapies which 25 per cent. of patients receive will be withdrawn without an alternative; further notes that there will be no therapies available for the most severely ill patients; acknowledges that NICE currently considers therapies which exceed a cost of \u00c2\u00a330,000 per quality adjusted life year not to be cost-effective, which is inappropriate in the assessment of rare conditions like pulmonary arterial hypertension; further notes that NICE has not followed the principles laid out in its own position paper when considering very rare conditions; and therefore calls on NICE to carefully consider representations made in response to its preliminary recommendations by stakeholder groups such as the Pulmonary Hypertension Association UK, clinical experts and patient groups, and allow the continued prescribing of effective drug therapies by expert clinicians in the seven designated specialist treatment centres in the UK, in accordance with the consensus document published in March.","date":"2008-03-12","status":"c"},{"topic":"Diseases","id":"35371","proposer":"10571","edm":"1151","session":"2007-08","title":"Prostate Cancer Countdown To Equality","text":"That this House notes that prostate cancer is now the most commonly diagnosed form of cancer in men and that its incidence is set to rise still further; further notes that the deaths from prostate cancer have remained relatively stable at approximately 10,000 per year; recognises that progress has been made in improving prostate cancer services but that significant inequalities remain in awareness, quality of services, patient experience and patient outcomes; welcomes the Prostate Cancer Charter for Action's new policy calls which are intended to tackle these inequalities; and urges the Government to take immediate action to implement them.","date":"2008-03-11","status":"c"},{"topic":"Diseases","id":"35372","proposer":"11626","edm":"1152","session":"2007-08","title":"Prostate Cancer Awareness Week Poll","text":"That this House congratulates The Prostate Cancer Charity, the largest UK voluntary organisation focused on prostate cancer, on commissioning and publishing during Prostate Cancer Awareness Week a poll on the state of public awareness of the basics of the prostate gland and prostate cancer; notes with concern that two thirds of UK men do not understand the crucial role the gland plays in a man's sexual function, almost three quarters of African Caribbean men do not know the function of the prostate gland and 85 per cent. of African Caribbean men are unaware of their heightened risk of prostate cancer; recognises the vital importance of raising urgently the level of public awareness of prostate cancer, particularly amongst African Caribbean communities; calls on the Government to launch in partnership with the voluntary sector a prostate cancer awareness campaign; and welcomes The Prostate Cancer Charity's innovative awareness programmes, its high quality website, its printed literature and its nurse led helpline designed to equip men to make informed choices about prostate health and prostate cancer treatment options.","date":"2008-03-11","status":"c"},{"topic":"Diseases","id":"35390","proposer":"10105","edm":"1170","session":"2007-08","title":"Controls On Asbestos","text":"That this House notes that it is some time since the Interim Chemical Review Committee (ICRC), a part of the United Nations Environmental Programme, recommended that all forms of asbestos should be subject to strict international controls to eliminate the risk associated with the material; is shocked that although white asbestos was nominated by the ICRC for inclusion in the Prior Informed Consent (PIC) list of the Rotterdam Convention its entry on the list was stalled in 2006 by national governments led by Canada; is concerned that some international trades unions have reported an increase in asbestos diseases in Latin America and Asia particularly India; believes that parliaments and their members have a responsibility to ensure that decent work for a fair globalisation includes the right not to be exposed to hazardous materials; and calls on the UK Government to take the lead in pressing for white asbestos to be included in the Rotterdam Convention PIC list as a prelude to a global ban of what has been called the most pervasive environmental hazard in the world.","date":"2008-03-11","status":"c"},{"topic":"Diseases","id":"35340","proposer":"10063","edm":"1121","session":"2007-08","title":"WORLD'S BIGGEST COFFEE MORNING","text":"That this House congratulates Macmillan Cancer Support for organising the World's Biggest Coffee Morning, which this year is taking place on 26th September, in which groups of people all over the country will be preparing morning drinks and snacks and raising funds for the fight against cancer; recognises the fantastic achievements of the coffee mornings of other years, in particular last year's which saw 50,000 separate coffee morning community events; notes that such publicity campaigns are key to raising funds and generating awareness in the fight against cancer; and further congratulates all those organising and taking part in the events this year.","date":"2008-03-05","status":"c"},{"topic":"Diseases","id":"35347","proposer":"10105","edm":"1128","session":"2007-08","title":"Coroners Bill And The Treatment Of Mesothelioma Patients","text":"That this House urges the Government to make the passing of the draft Coroners Bill a priority; calls for the needs of the bereaved families to be put at the centre of the coroners' system and for a chief coroner to be able to set national standards; expresses concern at the British Lung Foundation's report An Unnatural Death, which highlights that when a death from mesothelioma occurs outside of the coroner's working hours the bereaved are often visited by uniformed police in a marked police car, sometimes in the middle of the night; and suggests that in cases of mesothelioma, clinicians should follow the guidance jointly published by the British Thoracic Society and the British Lung Foundation which recommends that the inquest procedure should be discussed with the patient and their family at an appropriate time and that information should be collected that may later be helpful to the coroners in their enquiries.","date":"2008-03-05","status":"c"},{"topic":"Diseases","id":"35328","proposer":"10105","edm":"1113","session":"2007-08","title":"Colliery Screen Workers And The Industrial Injuries Advisory Council Recommendation","text":"That this House welcomes the Industrial Injuries Advisory Council recommendation of November 2007 that the prescribed disease chronic obstructive pulmonary disease be extended to include those exposed to coal dust during screen work on the colliery surface for a minimum period of 40 years to 1983; and calls on the Department of Work and Pensions to complete its assessment of the recommendation as soon as possible so that the few survivors who are eligible to claim an industrial injuries disablement benefit award can do so and discussions can begin with the Department for Business, Enterprise and Regulatory Reform for a full and final compensation payment.","date":"2008-03-04","status":"c"},{"topic":"Diseases","id":"35296","proposer":"10226","edm":"1087","session":"2007-08","title":"Twentieth Anniversary Of Nhs Breast And Cervical Screening","text":"That this House notes that 2008 marks the 20th anniversary of the introduction of the NHS breast and cervical screening programmes; commends the programmes for the thousands of lives saved through the early detection of cancer; thanks all those NHS staff who have made these achievements possible; and hopes that the screening programmes continue to build on this success over the next 20 years.","date":"2008-03-03","status":"c"},{"topic":"Diseases","id":"35280","proposer":"10677","edm":"1079","session":"2007-08","title":"Wet Age Related Macular Degeneration","text":"That this House welcomes the announcement by the National Institute for Health and Clinical Excellence (NICE) of a review of its earlier appraisal consultation document regarding anti-VEGF treatments for wet age related macular degeneration (wet AMD); acknowledges that allocation of treatment according to the latest appraisal consultation document could potentially save the sight of as many as 26,000 patients per annum; welcomes the level of co-operation between NICE, the Royal National Institute for the Blind and members of the pharmaceutical industry in bringing about a satisfactory solution; looks forward to full guidance on anti-VEGF treatments for patients with wet AMD being published by NICE; and hopes that this guidance will be implemented as swiftly as possible by local primary care trusts.","date":"2008-02-28","status":"c"},{"topic":"Diseases","id":"35199","proposer":"10105","edm":"1001","session":"2007-08","title":"Pleural Plaque Post Card Campaign","text":"That this House supports the Union of Construction Allied Trades and Technicians post card campaign launched outside the Ministry of Justice on 20th February 2008 protesting about the decision of the Law Lords made on 17th October 2007 that `pleural plaques' are not a compensatable medical condition; notes that prior to this judgement compensation had been paid for the last 20 years; is aware that expert medical opinion judges that pleural plaques only develop after prolonged asbestos exposure and that they indicate an increased risk of developing a more serious complication in later life; and calls on the Government to bring forward legislative proposals to allow compensation for pleural plaques, recognising the condition as a permanent and irreversible structural change to the lining of the lung caused by negligent exposure to asbestos.","date":"2008-02-21","status":"c"},{"topic":"Diseases","id":"35151","proposer":"11581","edm":"958","session":"2007-08","title":"Lyme Disease","text":"That this House acknowledges that Lyme disease, also known as Lyme borreliosis, is a serious and potentially chronic disease which is becoming more widespread across the United Kingdom; notes the growing body of evidence which suggests patients with the disease are frequently subject to misdiagnosis and under-treatment; is concerned that the disease appears to be under-reported and inadequately investigated; and calls upon the Government to put in place a national strategy for reducing the growing toll of ill-health caused by this disease, including the development of clinical guidelines specific to the UK for the use of all medical professionals dealing with patients with this disease.","date":"2008-02-19","status":"c"},{"topic":"Diseases","id":"35154","proposer":"10428","edm":"961","session":"2007-08","title":"Screening Matters Campaign","text":"That this House congratulates Cancer Research UK, Beating Bowel Cancer, Bobby Moore Fund, Bowel Cancer UK, Breakthrough Breast Cancer, Breast Cancer Campaign, Breast Cancer Care and Jo's Trust on coming together to celebrate the Screening Matters campaign; notes that screening matters because it saves lives; notes that 2008 marks the 20th anniversary of the introduction of breast screening; further notes that breast screening saves an estimated 1,400 women's lives a year in England, that early detection through cervical screening together with treatment can prevent 75 per cent. of cervical cancers from developing and that bowel cancer screening, currently at different stages of being rolled out across the UK, is projected to save at least 20,000 lives over the next 20 years if just 60 per cent. of those eligible undertake the procedure; encourages right hon. and hon. Members to find out how they can support the campaign at www.cancercampaigns.org.uk and by writing to their primary care trust and promoting the importance of screening in their constituencies; and urges the Government to work with the NHS to screen at least three million more people over the next five years, reduce the variation in screening across the UK, reach out to people eligible for screening who are not taking part and provide the best possible screening programmes through funding, staffing and measuring success.","date":"2008-02-19","status":"c"},{"topic":"Diseases","id":"35162","proposer":"11573","edm":"969","session":"2007-08","title":"The Anthony Nolan Trust And The National Cord Blood Programme","text":"That this House salutes the pioneering work of the Anthony Nolan Trust in establishing and maintaining a national database of bone marrow donors for which they recruit and tissue-type more than 20,000 new entrants each year, giving around 6,000 children and adults a chance of new life since 1974; notes with interest that the Trust, with the support of the East Midlands Development Agency, has begun the establishment of a new Cord Blood Bank which could become a National Cord Blood Programme of a scale to provide a truly national resource for access to umbilical blood stem cells for future treatment and research; believes that this development offers great hope for the future treatment of a wide range of serious medical conditions; and invites the Secretary of State for Health to take a lead in welcoming the Trust's five year aim to collect 50,000 cord blood units with 30,000 able to be used for research purposes.","date":"2008-02-19","status":"c"},{"topic":"Diseases","id":"35163","proposer":"10105","edm":"970","session":"2007-08","title":"Action Mesothelioma Day 2008","text":"That this House welcomes Action Mesothelioma Day on 27th February; recognises that the asbestos-related cancer mesothelioma kills someone every five hours in the United Kingdom; expresses alarm at the results of a recent survey by the British Lung Foundation that shows worryingly few tradespeople have received training on how to deal with asbestos or are aware that asbestos exposure can cause cancer; supports initiatives by the Health and Safety Executive in partnership with trades unions, trade associations, charities and suppliers to raise awareness amongst tradespeople of the risks from asbestos and to encourage them to find out about the precautions they should be taking; is encouraged by the results of a British Lung Foundation audit of cancer networks in England showing that most have adopted the Mesothelioma Framework; but also recognises that more effort is needed to improve treatment and care for people with mesothelioma by establishing more specialist multi-disciplinary teams.","date":"2008-02-19","status":"c"},{"topic":"Diseases","id":"35129","proposer":"10428","edm":"948","session":"2007-08","title":"Cancer UK Screening Matters Campaign","text":"That this House is aware of Cancer Research UK's important new campaign, Screening Matters, which highlights the fact that thousands of women in Britain today are alive thanks to breast and cervical cancer screening they undertook; believes that the lives of many more men and women will be extended thanks to the new bowel cancer screening programme, provided greater numbers of eligible people are encouraged to participate; and calls upon the Government to issue strict guidelines to local primary care trusts on what is expected of them in respect of take up and frequency levels, the promotion of any new initiatives they may be introducing to increase participation and the plans they have to recruit and retain breast screening radiographers, radiologists and achieve the necessary accreditation of bowel screening colonoscopists.","date":"2008-02-18","status":"c"},{"topic":"Diseases","id":"35089","proposer":"10014","edm":"912","session":"2007-08","title":"Women And Girls And Hiv\/aids","text":"That this House recognises that around the world women and girls are being disproportionately affected by HIV and AIDS; notes that gender inequality, violence and discrimination are driving the feminisation of the pandemic; recognises that many HIV and AIDS programmes do not adequately address the specific needs and rights of women and girls; and therefore calls on the Government to show international leadership by placing them at the centre of its revised HIV and AIDS strategy, ensuring men are actively involved as part of the solution.","date":"2008-02-07","status":"c"},{"topic":"Diseases","id":"35093","proposer":"10378","edm":"916","session":"2007-08","title":"Human Papilloma Virus Infection And Genital Warts","text":"That this House welcomes the Prime Minister's statement that preventing ill health is a priority for the Government and notes the opportunity that now exists to prevent future generations suffering from a range of conditions, in addition to cervical cancer, caused by the human papilloma virus (HPV); further notes that genital warts is caused by HPV types six and 11 and is a significant burden on sexual health services costing the NHS an estimated \u00c2\u00a322.5 million per year and causing misery for over 80,000 men and women per annum who receive a new diagnosis, and many others who require repeat treatment; and calls for support for the British Association for Sexual Health and HIV, the Terrence Higgins Trust, the Faculty of Sexual and Reproductive Healthcare and the Family Planning Association's request that the Government does not miss the opportunity that now exists and acts to prevent both genital warts and cervical cancer by HPV immunisation.","date":"2008-02-07","status":"c"},{"topic":"Diseases","id":"35073","proposer":"10439","edm":"897","session":"2007-08","title":"Turn On The Tap Campaign","text":"That this House welcomes World Water Day on 22nd March; notes with great concern that over one billion people in the developing world do not have access to safe water, that water-related disease is the second biggest killer of children worldwide and that the average distance walked by women in Africa and Asia to collect water is four miles; encourages participation in Samaritan's Purse's Turn on the Tap walks in Westminster on 18th March and parliamentary constituencies on 10th May to highlight the issue; and supports the work of Samaritan's Purse and others who are contributing towards achieving Millennium Development Goal 7.3 to reduce by half the proportion of people without sustainable access to safe drinking water.","date":"2008-02-06","status":"c"},{"topic":"Diseases","id":"35047","proposer":"12005","edm":"871","session":"2007-08","title":"Food Without Fear Campaign","text":"That this House recognises the importance of the proper handling of allergens in loose foods in hospitals, schools and eating establishments by chefs and caterers; notes the recent publication of guidance by the Food Standards Agency (FSA) to increase understanding with chefs and caterers and to protect consumers with a food intolerance; further notes that 700 people in a constituency of 70,000 people have coeliac disease, equating to one in 100 people across the UK; further notes that people with coeliac disease have an autoimmune disease and the only medication possible is a life-long adherence to a gluten-free diet; further notes that for people with coeliac disease eating in hospital is restrictive and at times unsafe; urges the Department of Health to improve gluten-free choices in hospitals, and urges chefs and caterers in all eating establishments to improve gluten-free choices through specific training; calls for the monitoring of the impact of the new FSA guidance on the handling of allergens in loose foods to achieve greater understanding, awareness and gluten-free choices on menus; and supports Coeliac UK in its Food Without Fear campaign to raise awareness and understanding of coeliac disease with chefs and caterers to ensure that eating out through pleasure or need is freed from restrictions.","date":"2008-02-04","status":"c"},{"topic":"Diseases","id":"34980","proposer":"11221","edm":"815","session":"2007-08","title":"Asbestosis Pleural Plaques","text":"That this House calls on the Government to explore every avenue possible to reverse the recent decision of the Law Lords which has denied compensation to the victims of asbestosis pleural plaques.","date":"2008-01-29","status":"c"},{"topic":"Diseases","id":"34946","proposer":"11489","edm":"782","session":"2007-08","title":"Clinics For People With Neuromuscular Conditions","text":"That this House is concerned that across England and Wales there are significant geographical inequalities in access to health services for patients with neuromuscular conditions; notes with concern that many areas of Wales have no clinics for managing conditions such as Duchenne Muscular Dystrophy, Becker Muscular Dystrophy and Myasthenia Gravis; further notes that patients need access to specialist diagnosis, treatment and ongoing care as both children and adults, and that outcomes are improved by care from a specialist multi-disciplinary team; and calls on governments in Westminster and Cardiff to draw up a strategy to ensure that patients across England and Wales have equal access to specialist services through a network of local clinics.","date":"2008-01-24","status":"c"},{"topic":"Diseases","id":"34923","proposer":"10224","edm":"760","session":"2007-08","title":"YOUNG PEOPLE'S SEXUAL AND REPRODUCTIVE HEALTH","text":"That this House notes that young people across the world are disproportionately affected by problems relating to sexual and reproductive health and that they are suffering and dying because of a lack of access to sexual and reproductive health information, services and supplies; recognises that this leads to cycles of poverty and hunger and reduced school enrolment and education; further recognises that sexual and reproductive health education and rights are essential to reducing child mortality, improving maternal health, combating HIV\/AIDS and sexually transmitted diseases, and empowering women; believes that the achievement of the Millennium Development Goals is impossible without focusing specifically on the needs of young people; and asks that the Government includes a specific focus on young people in its development plans by guaranteeing funding for research into young people's sexual and reproductive health, services and programmes.","date":"2008-01-23","status":"c"},{"topic":"Diseases","id":"34899","proposer":"10571","edm":"737","session":"2007-08","title":"BEATING BOWEL CANCER'S BE LOUD! CAMPAIGN","text":"That this House notes that bowel cancer is the UK's second biggest cancer killer resulting in the deaths of around 45 people everyday; further notes that 90 per cent. of people diagnosed could be saved by early detection and effective treatment of bowel cancer; congratulates Beating Bowel Cancer on the Be Loud! campaign and their ongoing work with bowel cancer patients; welcomes the publication of the Cancer Reform Strategy and the Government's focus on improving cancer care and services for patients; and calls on the Government to make explicit its commitment to address specific issues raised in Beating Bowel Cancer's Bowel Cancer Challenge including to improve public awareness, extend the bowel cancer screening programme, ensure that clinically effective treatments are available at the right time and in the right setting for all patients, and recognise the value of prolonged quality life these can have for bowel cancer patients and their families.","date":"2008-01-21","status":"c"},{"topic":"Diseases","id":"34865","proposer":"10009","edm":"708","session":"2007-08","title":"Hepatitis B And The Rising Curve Report","text":"That this House is alarmed by the figures exposed in the Rising Curve report published by the Hepatitis B Foundation UK, revealing that chronic hepatitis B in the UK has doubled since 2002, rising from 180,000 people to 325,000; calls on the Department of Health to revise figures on chronic hepatitis B to ensure trusts receive the full funding necessary for hepatitis B prevention and treatment; further calls upon the Government to implement urgently a hepatitis B strategy and preventative public health measures on hepatitis B, including a reappraisal of the current vaccination policy; and further calls upon Government to introduce an effective GP and public education plan on hepatitis B in the UK.","date":"2008-01-16","status":"c"},{"topic":"Diseases","id":"34868","proposer":"10442","edm":"711","session":"2007-08","title":"European Cervical Cancer Prevention Week","text":"That this House calls on the Government to support the European Cervical Cancer Association and Jo's Trust Pearl of Wisdom campaign to raise awareness of cervical cancer prevention and advocate the implementation of prevention programmes across Europe; commends the STOP cervical cancer petition at www.cervicalcancerpetition.eu; notes the importance of women attending cervical screening; urges women everywhere to encourage friends, family and colleagues to accept their invitation to be screened; further notes the recent report on the lack of screening in England for women between 20 and 25 years of age; and urges the Government to take action to offer these women access to cervical screening or human papilloma virus vaccination.","date":"2008-01-16","status":"c"},{"topic":"Diseases","id":"34842","proposer":"10428","edm":"687","session":"2007-08","title":"NATIONAL ASSOCIATION FOR COLITIS AND CROHN'S DISEASE","text":"That this House records its thanks for the outstanding work of the National Association of Colitis and Crohn's Disease, the voluntary organisation working to improve the lives of people affected by inflammatory bowel conditions; notes its campaign to highlight, amongst other things, the importance of the provision and training of specialist nurses to help care for sufferers of such diseases; recalls that the Department of Health is currently reviewing its strategy on managing chronic illnesses; and calls upon the Government to deliver the necessary financial and technical support needed for the effective management of such illnesses.","date":"2008-01-14","status":"c"},{"topic":"Diseases","id":"34814","proposer":"10571","edm":"661","session":"2007-08","title":"Screening For Abdominal Aortic Aneurysms","text":"That this House welcomes the announcement of a national screening programme for abdominal aortic aneurysms; notes the Men's Health Forum's campaign on this issue, supported by the All-Party Parliamentary Group on Men's Health and hon. Members of all parties; further notes both that in spring 2007 the National Screening Committee recommended screening for older men and that a successful screening programme has run for many years in Gloucestershire; and calls on the Government to announce a firm timetable for the programme's introduction without further delay.","date":"2008-01-09","status":"c"},{"topic":"Diseases","id":"34790","proposer":"10043","edm":"637","session":"2007-08","title":"Disability Poverty In The UK","text":"That this House notes that the Leonard Cheshire Disability report Disability Poverty in the UK finds that disabled people are twice as likely as non-disabled people to live in poverty; further notes that disabled people can experience poverty in a number of ways including financial poverty, poverty of aspiration and poverty of opportunity; further notes that average basic living costs are much higher for disabled people; further notes that disabled people are twice as likely to be unemployed and seeking work than non-disabled people and that disabled people who are not expected to work are often trapped in inescapable poverty; believes that the extent of disability poverty in the UK today is unacceptable; and calls on the Government to make tackling disability poverty a priority.","date":"2008-01-07","status":"c"},{"topic":"Diseases","id":"34745","proposer":"11791","edm":"594","session":"2007-08","title":"Dementia Care In Care Homes","text":"That this House welcomes the publication of the Alzheimer's Society report Home from Home which highlights large variations in the quality of care experienced by people with dementia in care homes; believes that good quality care improves quality of life for individuals living in care homes; notes that 420,000 people live in care homes in the UK and two thirds of care home residents have dementia; further notes that the primary function of care homes is now caring for people with dementia, many of whom will have complex needs; further notes that Government policy in recent years has focused on supporting people in their own homes; further believes that it is important that Government policy also considers the needs of the care home population; further notes that caring for residents with dementia is a highly skilled task; is concerned that only a minority of care home staff have adequate dementia training; believes the formation of the Commission for Quality Care should be used as an opportunity to ensure the new regulation and inspection systems focus on outcomes that matter to people with dementia, including access to outside space and activities; and urges the Government to ensure the National Dementia Strategy addresses the needs of the care home population.","date":"2007-12-17","status":"c"},{"topic":"Diseases","id":"34728","proposer":"10176","edm":"583","session":"2007-08","title":"Coronary Vascular Disease","text":"That this House recognises that medical science has identified the key risk factors associated with coronary vascular disease - including increasing age, family history of heart disease, diabetes and elevated cholesterol - and is concerned that significant local variation exists in cholesterol measurement of at-risk patients in primary care with cover ranging from 90 per cent. of patients with heart disease in some to only 10 per cent. in others; and, in view of the UK's annual productivity losses owing to coronary disease running at \u00c2\u00a32.9 billion, calls for best current clinical practice to be available to all, irrespective of their home address, and for the Joint British Society Guidelines on the prevention of cardiovascular disease to be adopted as the clinically-driven NHS standard, and for GPs' contracts and rewards through the Quality and Outcomes Framework to be linked to the attainment of targets derived from these standards.","date":"2007-12-13","status":"c"},{"topic":"Diseases","id":"34675","proposer":"10226","edm":"534","session":"2007-08","title":"Childhood Cancer Awareness Month","text":"That this House marks Childhood Cancer Awareness Month, celebrating survivors of childhood cancer; notes that children and young people stand a better chance than ever of surviving cancer, but can suffer physical and emotional effects of cancer or treatment throughout their lives; welcomes the announcement of the new National Cancer Survivorship Initiative; notes that children and young people should receive the educational support they need during treatment for cancer, and in transition back to school; notes that survivors of childhood cancer can suffer late effects which impact on their learning capacity and educational attainment and which demand timely and effective special educational needs support from schools; hopes that plans to raise the school leaving age to 18 years will be extended to include out of school education support for young people with cancer; and congratulates CLIC Sargent on its work to help survivors of childhood cancer to get their lives back.","date":"2007-12-11","status":"c"},{"topic":"Diseases","id":"34699","proposer":"11312","edm":"532A1","session":"2007-08","title":"PLEURAL PLAQUES AND THE LAW LORDS' DECISION","text":"after `fibre', insert `further notes the swift action taken by the SNP Scottish Government in announcing that they will bring forward a bill in the Scottish Parliament to reverse the effect of the ruling in Scotland.'.","date":"2007-12-11","status":"c"},{"topic":"Diseases","id":"34672","proposer":"10105","edm":"532","session":"2007-08","title":"PLEURAL PLAQUES AND THE LAW LORDS' DECISION","text":"That this House is gravely concerned by the decision of the Law Lords on pleural plaques caused by exposure to asbestos delivered on 17th October 2007; notes that Professor Newman Taylor and Professor Mark Britton, world-renowned experts on asbestos-related diseases, have dispelled the myth held in some quarters that pleural plaques are widespread amongst the general population; considers that pleural plaques caused by the negligent exposure to asbestos make obvious that the body of a sufferer has been polluted by asbestos particles; believes that the polluter should pay compensation to those negligently contaminated by the fatal fibre; and calls on the Secretary of State for Justice to introduce legislative proposals to reverse the Law Lords' decision and avoid the development of a postcode lottery for those negligently exposed to asbestos.","date":"2007-12-10","status":"c"},{"topic":"Diseases","id":"34673","proposer":"10129","edm":"207A1","session":"2007-08","title":"Lords Ruling On Pleural Plaques","text":"at end add `, and furthermore to take careful note of the Scottish Cabinet's decision to introduce a Bill to reverse the House of Lords' judgment and enable those negligently exposed to asbestos who have been diagnosed with pleural plaques to continue to be able to raise and pursue actions for damages.'.","date":"2007-12-10","status":"c"},{"topic":"Diseases","id":"34640","proposer":"10351","edm":"507","session":"2007-08","title":"Hiv, Hepatitis B And Hepatitis C In Prisons","text":"That this House notes that a survey by the Department of Health of blood borne virus in prisoners in 1997 showed much higher rates of HIV, hepatitis B and hepatitis C amongst prisoners than is present in the general population; believes that prisons present a good opportunity to reach many of those with blood borne viruses with testing, diagnosis, treatment and education; is deeply concerned that no repeat survey has been conducted in the last 10 years; and joins the National AIDS Trust, British Liver Trust, the Hepatitis B Foundation and the Hepatitis C Trust in calling for the Government to conduct a new anonymous sero-survey of HIV, hepatitis B and hepatitis C prevalence in prisons to obtain the necessary evidence to respond effectively to this growing health problem.","date":"2007-12-06","status":"c"},{"topic":"Diseases","id":"34625","proposer":"10442","edm":"492","session":"2007-08","title":"Cervical Cancer Vaccine","text":"That this House welcomes the recommendation by the Joint Committee on Vaccination and Immunisation (JCVI) that a vaccine to prevent infection by the high risk types of human papilloma virus (HPV) which are the principal cause of cervical cancer should be offered to all girls between 12 and 18 years of age; further welcomes the Government's acceptance of these recommendations and the announcement that a national programme will begin in 2008, and that a comprehensive education and awareness campaign will accompany the vaccination programme; congratulates Jo's Trust for its work on this issue and its continued support for women and their families affected by cervical cancer and pre-cancer and notes that all women should still attend for regular cervical screening when invited to do so; and further notes that women aged 18 to 26 years of age would also benefit from HPV vaccination and urges the JCVI and the Department of Health to consider how to make the protection offered by immunisation available to these women.","date":"2007-12-05","status":"c"},{"topic":"Diseases","id":"34584","proposer":"11427","edm":"451","session":"2007-08","title":"Services For Patients With Muscular Dystrophy","text":"That this House welcomes the publication of a new report by leading neuromuscular clinicians, Building on the Foundations; is concerned that it reveals significant geographical inequalities across England in access to health services for patients with neuromuscular conditions; regrets that specialist neuromuscular centres exist in only four regions and that survival for patients with neuromuscular conditions is severely affected; notes that care from a multidisciplinary team improves patient outcomes; is disappointed that many patients in England do not receive such multidisciplinary specialist care; calls on the Department of Health to recognise neuromuscular services as a specialist service; and urges the Department of Health to work with commissioners and health professionals to improve current service provision across England to ensure improved standards of care for all patients with neuromuscular conditions.","date":"2007-12-03","status":"c"},{"topic":"Diseases","id":"34587","proposer":"10226","edm":"454","session":"2007-08","title":"Cancer Reform Strategy","text":"That this House welcomes the publication of the Cancer Reform Strategy outlining the Government's plans for cancer services in England over the next five years; notes that the All Party Parliamentary Group on Cancer has campaigned extensively to secure a second cancer plan; urges the NHS to implement rapidly the plans outlined in the Strategy to improve the lives of people affected by cancer; and hopes that the Cancer Reform Strategy will deliver cancer services that are amongst the best in Europe by 2012.","date":"2007-12-03","status":"c"},{"topic":"Diseases","id":"34558","proposer":"11489","edm":"437","session":"2007-08","title":"Lymphoedema","text":"That this House notes that at least 100,000 people in the UK suffer from lymphoedema, a chronic swelling which can affect any part of the body; is aware that the condition can be a distressing side effect of cancer and its treatments, but also occurs far more commonly in people who have not suffered from cancer; further notes that, with access to a lymphoedema clinic and the support of a lymphoedema practitioner, patients can do much to manage and control their condition; notes with great concern that there is a postcode lottery in the treatment of lymphoedema; is disappointed that in Ceredigion and in many other areas, patients do not have access to an NHS-funded lymphoedema clinic; is concerned that often treatment is only available for patients who have lymphoedema following treatment for cancer; recognises the excellent work of the Lymphoedema Support Network, a charitable organisation that battles to raise the profile of this condition with insufficient access to public funds; and calls on the Government, in co-operation with the Scottish Executive and the Welsh Assembly Government, to do more to recognise this condition, and on local health boards and primary care trusts to give full recognition to lymphoedema in all its forms, and make sure treatment is available for all patients at a local level.","date":"2007-11-28","status":"c"},{"topic":"Diseases","id":"34519","proposer":"11455","edm":"397","session":"2007-08","title":"Care For Cystic Fibrosis Patients","text":"That this House welcomes the fact that average life expectancy for cystic fibrosis patients has increased to over 30 years and that a child born today with cystic fibrosis can expect to live into their late forties; expresses concern that, despite medical advances, evidence suggests that unacceptable variations in the standard of care, support and treatment still exist; believes that all patients should be entitled to the best care, support and treatment; welcomes the recommendations of the Back the Kid panel of expert clinicians on the future of cystic fibrosis care; and calls on the Government to conduct an audit of cystic fibrosis services in order to plan for high-quality services for all cystic fibrosis patients in the future.","date":"2007-11-27","status":"c"},{"topic":"Diseases","id":"34527","proposer":"11420","edm":"405","session":"2007-08","title":"MUNCHAUSEN'S SYNDROME BY PROXY IN NORTH EAST ENGLAND","text":"That this House notes that Fran Lyon and Marianne Key are emigrating to achieve security for a family life following false allegations of Munchausen's Syndrome by Proxy by medical professionals in the North East; further notes many other cases of false allegations and misconduct by the same professionals; regrets reports of incidents of explicit triumphalism by social workers who have prevented parents seeing their children at Christmas; and calls for the law to be changed so that providing evidence of misbehaviour by professionals to regulatory bodies is never contempt of court.","date":"2007-11-27","status":"c"},{"topic":"Diseases","id":"34531","proposer":"11115","edm":"409","session":"2007-08","title":"World Aids Day 2007 Campaign","text":"That this House notes that on World AIDS Day, 1st December 2007, some 33 million people remain directly affected by HIV\/AIDS; calls for the UK Government and the international community to continue efforts to achieve the goal of universal access to prevention, treatment, care and support by 2010; believes these efforts should be guided as far as possible by detailed annual targets at country level so as to hold governments in both rich and poor countries to account for delivering on their promises; reaffirms the central importance of prevention to halting the spread of the virus and calls for prevention to be central to international efforts to tackle HIV\/AIDS; believes that efforts to tackle HIV\/AIDS should as far as possible act to strengthen basic healthcare systems so as to aid the fight against other killer diseases such as malaria, and common co-infections such as tuberculosis; celebrates the role of many private businesses operating in poor countries in helping to prevent and treat HIV\/AIDS; and calls for governments, businesses and voluntary organisations to work together in tackling the epidemic.","date":"2007-11-27","status":"c"},{"topic":"Diseases","id":"34535","proposer":"10550","edm":"413","session":"2007-08","title":"Lifeblood Thrombosis Charity","text":"That this House congratulates Lifeblood, the thrombosis charity, on the tireless campaigning it has undertaken over the past five years in raising the profile of thrombosis amongst politicians and decision-makers whilst providing vital information and support to patients and their families on all areas of thrombosis and its related conditions; recognises that over 25,000 people die each year from venous thromboembolism (VTE) or blood clots, contracted in hospital, which is many times the number of deaths per year from hospital-acquired infections; notes that many of the deaths from VTE are preventable with safe and cost-effective methods of prevention available; is concerned that hospitals are not following the Chief Medical Officer's best practice recommendations published in April; and calls on the Government to ensure that all patients, both medical and surgical, who are admitted to hospital undergo a mandatory documented risk assessment for venous thrombosis and that this is audited to ensure implementation of this life-saving measure.","date":"2007-11-27","status":"c"},{"topic":"Diseases","id":"34481","proposer":"10571","edm":"361","session":"2007-08","title":"Chlamydia Screening For Men","text":"That this House congratulates the Men's Health Forum for its campaign to raise levels of chlamydia screening amongst men; welcomes the National Chlamydia Screening Programme's publication of the Men Too strategy to support equitable access to chlamydia screening for men within the programme; notes that in 2006-07 only 21 per cent. of those screened under the programme were men; believes that it is vital to screen more men if chlamydia is to be brought under control and both men and women's reproductive health improved; further believes such screening will communicate that sexual health is a responsibility shared by men and women; and calls on the National Chlamydia Screening Programme to continue to work with the Men's Health Forum and other stakeholders to implement its strategy and ensure that men's sexual health is treated with the seriousness it deserves.","date":"2007-11-22","status":"c"},{"topic":"Diseases","id":"34482","proposer":"10571","edm":"362","session":"2007-08","title":"World Chronic Obstructive Pulmonary Disease (Copd) Day 2007","text":"That this House supports World Chronic Obstructive Pulmonary Disease Day on 14th November 2007, which aims to raise awareness of chronic obstructive pulmonary disease; regrets that COPD is the UK's fifth biggest killer, causing the deaths of more people than breast and prostate cancer combined in England and Wales; further regrets that an estimated 2.8 million people in this country have COPD, but don't know it; welcomes the British Lung Foundation report Invisible Lives which identifies the areas of the country where healthcare services face the biggest challenge from COPD, highlighting Glasgow, Lanarkshire, Liverpool, Hull and Sunderland as the top five COPD hotspots; welcomes the development of the National Service Framework for COPD; and supports calls from the British Lung Foundation for the NHS to carry out targeted health campaigns in these hotspot areas and to implement best practice guidelines for COPD services as soon as possible in order that people living with COPD can access the best quality treatment and care at the earliest opportuinty.","date":"2007-11-22","status":"c"},{"topic":"Diseases","id":"34460","proposer":"10240","edm":"340","session":"2007-08","title":"Multiple Sclerosis National Therapy Centres","text":"That this House praises Multiple Sclerosis National Therapy Centres (MSNTCs) which offer invaluable assistance to thousands of MS sufferers and their families in England and Wales by providing a wide range of drug-free symptom management therapies, advice and support; notes that MSNTCs are non-profit-making charities which raise about \u00c2\u00a36 million annually, which is used entirely to meet their cost; is concerned at the Healthcare Commission's decision to impose charges for inspection of MSNTCs; further notes that these fees will have a very serious impact, making MSNTCs the only non-profit-making bodies charged these fees; further notes that Welsh MSNTCs are exempt from charges; and calls on the Government to review the Healthcare Commission's decision on inspection charges.","date":"2007-11-21","status":"c"},{"topic":"Diseases","id":"34461","proposer":"10240","edm":"341","session":"2007-08","title":"Multiple Sclerosis Nurses","text":"That this House believes that multiple sclerosis (MS) nurses provide a vital range of specialist services that are not available elsewhere; notes that the MS Society fears that a quarter of specialist posts may be at risk, despite the Government's long-standing commitment to fund their posts and recognises the financial savings they provide to the NHS; and calls upon the Government to do more to renew its original commitment to the role MS nurses play for the 85,000 people living with multiple sclerosis.","date":"2007-11-21","status":"c"},{"topic":"Diseases","id":"34462","proposer":"10240","edm":"342","session":"2007-08","title":"Childhood Multiple Sclerosis","text":"That this House believes that the current understanding of childhood multiple sclerosis (MS) among health professionals is too low and that some are unaware that the condition can occur in children at all; notes that disease modifying therapies are not automatically available to children with MS through the NHS and that there are few specialist services; further notes that childhood MS can have a huge impact on the educational, social and economic outcomes for children living with the condition; and commends the MS Society for its work to improve the care and support available to children with MS and their families.","date":"2007-11-21","status":"c"},{"topic":"Diseases","id":"34433","proposer":"10571","edm":"315","session":"2007-08","title":"Clinical Nurse Specialists For Men With Prostate Cancer","text":"That this House is concerned that a new report by the Prostate Cancer Charter for Action has revealed significant geographical inequalities in the provision of clinical nurse specialists; notes that the average caseload for prostate cancer clinical nurse specialists is more than double that for breast nurses; further notes that men with prostate cancer report a significantly worse experience of their treatment and care than patients with other cancers; believes that increasing the provision of clinical nurse specialists will make a major contribution to improving the quality of experience reported by men with prostate cancer; and urges the Government to implement the Charter's 18 point action plan on clinical nurse specialists as a priority.","date":"2007-11-20","status":"c"},{"topic":"Diseases","id":"34395","proposer":"10608","edm":"284","session":"2007-08","title":"Pneumococcal Disease In The Developing World","text":"That this House notes with grave concern that according to the World Health Organisation pneumococcal pneumonia and meningitis are responsible for up to 1.6 million deaths each year of which up to one million are children; further notes that 90 per cent. of pneumococcal pneumonia deaths occur in the developing world and that children with HIV\/AIDS are up to 40 times more likely to contract pneumococcal disease; further notes that many of these deaths could be prevented with the use of a vaccine; welcomes the commitment by HM Treasury and the Department for International Development to support the pilot Advanced Market Commitment (AMC) for pneumococcal vaccines, which could save the lives of up to 5.4 million children by 2030; further notes the contribution which this programme will make towards the UK's commitment to meeting the United Nations' Millennium Development Goal 4 to reduce by two thirds the mortality rate among children under five by 2015; further welcomes the work of the All-Party Parliamentary Group on Pneumococcal Disease Prevention in the Developing World in response to the urgent need to improve child survival and as a forum for raising awareness among policymakers nationally, across Europe and around the world about the disease, its prevention through vaccination and international efforts to ensure sustainable financing; and hopes that the pneumococcal vaccine pilot AMC will pave the way for new vaccines against other childhood diseases.","date":"2007-11-15","status":"c"},{"topic":"Diseases","id":"34401","proposer":"11093","edm":"290","session":"2007-08","title":"Ankylosing Spondylitis","text":"That this House welcomes the decision of the National Institute for Health and Clinical Excellence (NICE) to approve two anti-TNF treatments for patients with Ankylosing Spondylitis (AS); believes that such treatments will add quality to the lives of thousands of AS patients and will allow many to take control of their treatment at home; and calls upon the Government to ensure that NICE guidance is implemented as quickly as possible so that these new treatments can be added to NHS services and treatments to improve the welfare of AS patients.","date":"2007-11-15","status":"c"},{"topic":"Diseases","id":"34381","proposer":"11592","edm":"274","session":"2007-08","title":"Insurance For Cancer Sufferers","text":"That this House notes that the number of people diagnosed with breast cancer has increased but that fewer people are dying of the disease; further notes the estimate from Breast Cancer Care that 172,000 women have been diagnosed with breast cancer in the last decade and have survived; believes that the travel insurance industry should become more sensitive in dealing with those who have been diagnosed with breast cancer, including those in remission, and who sometimes face unreasonably high charges for travel insurance, sometimes making it too expensive to enjoy a holiday; supports the efforts of cancer victim Fiona Macrae, who has teamed up with an insurance company and, after consultation with breast cancer charities, launched Insure Pink to halve premiums for sufferers who want to travel; commends such initiatives if they allow and encourage insurance brokers, through better informed questioning, to reflect the true risks of holiday travel, not the perceived risk of travelling with a severe condition; and encourages wider application of these principles in relation to other cancers.","date":"2007-11-14","status":"c"},{"topic":"Diseases","id":"34323","proposer":"10105","edm":"221","session":"2007-08","title":"Mesothelioma And Nice Appraisal Procedure","text":"That this House recognises that since November 2004 Alimta has been the only licensed treatment for mesothelioma and since the Scottish Medicines Consortium's advice in July 2005 victims of asbestos in Scotland have had access to Alimta; welcomes the July 2007 National Institute of Health and Clinical Excellence (NICE) Final Appraisal Determination (FAD) recommending Alimta; applauds some of the primary care trusts (PCTs) and boards that have made Alimta available in parts of England and Wales since 2005-06, notably in the North West and North East of England; is concerned that Alimta is not yet routinely available in other hot spots like Northern Ireland, Plymouth, Southampton, Eastleigh and London; welcomes the MSO1 clinical trial results comparing unlicensed therapies and notes that these other agents did not result in a significant survival benefit, reinforcing the case for Alimta; regrets that an appeal against the current NICE FAD announced on 24th August will not happen until 23rd November and that the report will not be available until 2008; notes that hundreds of patients in England, Wales and Northern Ireland are denied access to Alimta whilst some PCTs and boards wait for the NICE decision and guidance; urges NICE to review its processes to make it faster and more transparent given that this appraisal has already lasted nearly three years; and calls on the Secretary of State for Health to review how best to remove the post code lottery and to accept, given the industrial nature of mesothelioma, that the Government has a duty for the wellbeing of workers and their families exposed to asbestos through no fault of their own.","date":"2007-11-13","status":"c"},{"topic":"Diseases","id":"34333","proposer":"10557","edm":"231","session":"2007-08","title":"Diabetes In Schools And The Living With Diabetes In Schools Campaign","text":"That this House welcomes World Diabetes Day and the Living with Diabetes in Schools campaign run by Diabetes UK, Juvenile Diabetes Research Foundation, INPUT and UK Children with the Diabetes Advocacy Group, which aims to improve care and support for children with diabetes at school; also welcomes the Medical Conditions at School Policy Resource Pack from Diabetes UK, produced in conjunction with the Anaphylaxis Campaign, Asthma UK, Epilepsy Action, and Long Term Conditions Alliance and designed to help schools develop an effective overall policy for children and young people with medical conditions; recognises that many schools are not properly supporting children in managing their diabetes and are consequently preventing them from taking part in various physical activities and extra-curricular programmes; further recognises that 70 per cent. of children with Type 1 diabetes who are unable to administer their own insulin rely on a parent visiting the school to do so due to a lack of coherent policies for managing diabetes in school; and calls upon the Government to support children living with diabetes and issue guidance to local education authorities to encourage and support schools to develop and implement policies that result in best practice in the management of diabetes and enable full participation of children with diabetes in school life.","date":"2007-11-13","status":"c"},{"topic":"Diseases","id":"34285","proposer":"10224","edm":"183","session":"2007-08","title":"Universal Access To HIV Services","text":"That this House welcomes the global commitment to achieve universal access to HIV prevention, treatment, care and support services by 2010; further welcomes the Prime Minister's speech to the UN General Assembly calling on all nations to keep their promises on tackling poverty and disease; notes the current formulation of a new three-year Government strategy to tackle HIV and AIDS in the developing world; believes that the UK Government should use this strategy to outline how it will keep its part of the promise to achieve universal access by 2010; including effectively providing its fair share of funding needed to keep the universal access commitment, proportionate to the UK's wealth, while also outlining concrete plans to promote affordable generic medicines and strengthen developing country health systems.","date":"2007-11-12","status":"c"},{"topic":"Diseases","id":"34303","proposer":"10295","edm":"201","session":"2007-08","title":"CHORLEY GUARDIAN AND MARY'S PRAYER","text":"That this House congratulates the Chorley Guardian for initiating the Mary's Prayer campaign; notes that the campaign is centred upon Mary Wilson, a local councillor and former Mayor of Chorley, who is suffering from cancer, with the aim of raising much needed funds for cancer research and treatment; recognises that so far Mary's Prayer has raised over \u00c2\u00a342,000; pays tribute to the efforts of the editor of the Chorley Guardian, Mr Christopher Maguire, whose vision and drive has ensured that the campaign has been a success; and wishes the Chorley Guardian and all those involved with the campaign the very best for the future in their fundraising activities.","date":"2007-11-12","status":"c"},{"topic":"Diseases","id":"34309","proposer":"10105","edm":"207","session":"2007-08","title":"Lords Ruling On Pleural Plaques","text":"That this House is disappointed by the Lords of Appeal Judgment in the pleural plaques cases given on 17th October; believes that pleural plaques caused by exposure to asbestos result in physiological damage which constitutes a loss of faculty meriting compensation; calls on the Secretary of State for Justice to discuss with the Department for Work and Pensions the introduction of a register for those diagnosed with the disease to include details of employment and the employers' insurers and to instigate discussions on an appropriate compensation scheme financed by the insurance industry because it is now clear that workers suffering the condition will not get compensation through the courts.","date":"2007-11-12","status":"c"},{"topic":"Diseases","id":"34252","proposer":"10715","edm":"156","session":"2007-08","title":"Parliamentary Inquiry Into Nuclear Test Veterans","text":"That this House notes the 50th anniversary of the beginning of British nuclear weapons tests at Christmas Island on 8th November 1957; further notes that servicemen involved in nuclear tests have subsequently attributed cases of ill health to their exposure to radiation during and after the tests; welcomes the conclusions of a recent cross-party inquiry into nuclear test veterans chaired by the hon. Member for Billericay and the hon. Member for Norwich North; believes that the current system for hearing claims for compensation is inconsistent, unfair and in need of complete reform, and that far greater recognition of this problem and co-operation with veterans is required from the Ministry of Defence; and therefore calls on the Government to respond positively to the recommendations of the inquiry, undertake new scientific studies into the effects of nuclear tests on human health, work with veterans to create a new framework for hearing claims for compensation, and ultimately honour its duty of care towards this loyal and dignified group of servicemen and their families.","date":"2007-11-08","status":"c"},{"topic":"Diseases","id":"34225","proposer":"11420","edm":"135","session":"2007-08","title":"Hospital-Acquired Infection","text":"That this House recognises the trauma caused to patients and families by hospital-acquired infections such as MRSA and C difficile; believes that there are examples the United Kingdom can learn from in other countries such as the Netherlands; recognises that this involves having sufficient beds to keep some empty and isolate infected patients from others; recognises that having medical staff travel in their work clothes also gives a risk of infection; requests that the tendency to blame patients for the spread of infection be resisted; and calls for an urgent review of whether reductions in bed numbers and planning for over 70 per cent. bed occupancy and other cost-saving measures are resulting in increased risk of hospital-acquired infection.","date":"2007-11-07","status":"c"},{"topic":"Diseases","id":"34230","proposer":"11427","edm":"140","session":"2007-08","title":"Campaign To Fund Research Into Muscular Dystrophy","text":"That this House recognises the devastating impact of muscular dystrophy; acknowledges that this is a disease that recognises no boundaries and results in loss of muscle strength, progressive muscle wasting and nerve deterioration; accepts that, while the Department of Health has worked closely with campaigners to develop research, much more needs to be done; welcomes the initiative of Mrs Kate Clarkson and a group of women from Northumberland in producing a fund-raising CD with the title Christmas Crackers; wishes them success in their venture and hopes that it raises much needed funds to support further research into the disease; and urges hon. Members and the general public to purchase the CD in order to maximise the amount of money raised.","date":"2007-11-07","status":"c"},{"topic":"Diseases","id":"34232","proposer":"11651","edm":"142","session":"2007-08","title":"National Campaign For Cardiac Rehabilitation","text":"That this House welcomes the National Campaign for Cardiac Rehabilitation launched by the British Heart Foundation, the British Association for Cardiac Rehabilitation and patient groups to push for quality rehabilitation to be made available to all heart patients who need it; notes that cardiac rehabilitation is an inexpensive treatment that saves lives and yet three out of five of heart patients who need it do not have access to it; and supports the five aims of the national campaign which are access to cardiac rehabilitation for all suitable heart patients, a choice of alternative methods, the tackling of the cardiac rehabilitation needs of under-represented groups and that each programme should meet minimum standards and be monitored through national audit.","date":"2007-11-07","status":"c"},{"topic":"Diseases","id":"34092","proposer":"10521","edm":"2","session":"2007-08","title":"Cystic Fibrosis And Prescription Charges","text":"That this House believes people with cystic fibrosis should not have to pay prescription charges.","date":"2007-11-06","status":"c"},{"topic":"Diseases","id":"34129","proposer":"10527","edm":"39","session":"2007-08","title":"Access To Insulin Pump Therapy For People With Type 1 Diabetes","text":"That this House welcomes Diabetes UK's campaign to end the postcode lottery for insulin pump therapy; believes that making a small change through providing the technology can make a big difference to the lives of people with diabetes; notes the National Institute for Health and Clinical Excellence (NICE) recommendation that insulin pump therapy should be available as a treatment option for people with type 1 diabetes in cases where multiple dose insulin therapy has failed, and the person is willing and able to use insulin pump therapy effectively; notes with concern that this guidance is not being adhered to locally in a uniform manner; is aware that currently only two per cent. of people with type 1 diabetes use pumps in the UK, compared to 10 to 20 per cent. in other European member states and around 15 to 20 per cent. in the United States; believes that the use of pumps can have cost benefits to the local NHS through a reduction in primary care contracts, reduction in hospital admissions and hospital outpatient contracts; and calls on the Government to oversee the implementation of NICE guidance by primary care organisations to end the postcode lottery.","date":"2007-11-06","status":"c"},{"topic":"Diseases","id":"34130","proposer":"10527","edm":"40","session":"2007-08","title":"Diabetes And The Fire Service","text":"That this House welcomes the launch of the Diabetes and the Fire Service: Survey Report, which investigates recruitment and retention practices with regard to people with diabetes in the Fire Service; notes that since the extension to the Disability Discrimination Act in October 2004 people with diabetes are protected from discrimation in the emergency services; notes that well-controlled diabetes is not a bar to working in hazardous occupations such as the Fire Service; further notes that individual medical assessment is the best method of ascertaining fitness to work; welcomes the main findings of the report that there is widespread recognition of the need to treat all cases individually; notes with regret that there are still variations in recruitment practice across fire and rescue services; and calls on the Government to promote good practice in order to apply it consistently across the UK.","date":"2007-11-06","status":"c"},{"topic":"Diseases","id":"34131","proposer":"10527","edm":"41","session":"2007-08","title":"United Nations Resolution For Diabetes","text":"That this House supports the International Diabetes Federation's Unite for Diabetes campaign, which aims to highlight the alarming rise of diabetes worldwide; notes with concern new data showing that more than 230 million people have been diagnosed with diabetes and that the number of people living with diabetes is expected to grow to 350 million in less than 20 years if action is not taken; further notes that diabetes is one of the major causes of premature death worldwide, as every 10 seconds a person dies from diabetes-related causes and death rates are predicted to rise by 25 per cent. over the next decade; further notes that World Health Organisation research predicts that the condition could reduce life expectancy globally for the first time in 200 years and that almost six per cent. of the world's adult population now live with diabetes; and encourages Government support for a United Nations Resolution on diabetes, to secure the Resolution on World Diabetes Day on 14th November 2007.","date":"2007-11-06","status":"c"},{"topic":"Diseases","id":"34132","proposer":"10527","edm":"42","session":"2007-08","title":"Access To Inhaled Insulin Products For Diabetics","text":"That this House disagrees with the National Institute for Health and Clinical Excellence's technology appraisal document which proposes the restriction of access to inhaled insulin products on the NHS to patients with `a proven injection phobia diagnosed by a psychiatrist or psychologist'; is concerned that diabetes sufferers often delay treatment for as long as four years due to a fear of injections, risking the complications of heart disease, blindness and kidney failure, a situation that will only be compounded by attaching the unfortunate stigma of mental illness to those with a phobia of needles; expresses concern at the additional workload that will be placed on already overstretched NHS psychiatric services; and believes that the judgment of expert clinicians should be trusted in managing each individual patient's condition.","date":"2007-11-06","status":"c"},{"topic":"Diseases","id":"34133","proposer":"10527","edm":"43","session":"2007-08","title":"Information Prescriptions For People With Diabetes","text":"That this House notes with concern that 65 per cent. of the two million people in the UK with diabetes are not taking their medications as prescribed because one in three do not understand that those medications are for, or how to take them; welcomes the work of a coalition of Diabetes UK, the Association of the British Pharmaceutical Society and Ask About Medicines to facilitate understanding of medicines used to treat diabetes; believes that every one with the condition has a right to expect a personalised information prescription expressed in an appropriate format as part of their care planning process; further believes that such a personalised prescription should help to ensure that access to clear and consistent information that is accurate, up-to-date and trustworthy will enable people with diabetes to understand their condition and treatment options regardless of their age, ethnicity, disability or postcode; further believes that people should be encouraged to seek information on medicines and other treatments by discussing their condition with and asking questions of a range of healthcare professionals and by accessing other forms of support and information tailored for each person in their particular situation; and therefore calls on the Government to ensure that the NHS at a local level provides diabetes care and support in line with these standards.","date":"2007-11-06","status":"c"},{"topic":"Diseases","id":"34134","proposer":"10527","edm":"44","session":"2007-08","title":"Diabetes UK Measure Up Campaign","text":"That this House welcomes the Diabetes UK campaign Measure Up, which aims to raise awareness of diabetes; recognises that there are currently an estimated 750,000 people in the UK who have diabetes who are not aware of their condition; notes that the campaign aims to identify at least 25 per cent. of these people; further notes the seriousness of diabetes, which if left untreated can lead to blindness, kidney disease, heart attacks and other life-threatening complications; supports the key messages of the campaign that if you are a white or black male and your waist is 37 inches or more, a women and your waist is 31.5 inches or more, or a South Asian man and your waist is 35 inches or more, you could need a test for diabetes; observes that keeping people with the condition healthier will also reduce the long-term impact on limited NHS resources; expresses its concern over Department of Health figures which show that only 72 per cent. of the diabetic population has been diagnosed across the UK; further notes that some primary care trusts have only diagnosed around half of their diabetic population; and calls on the Government to encourage primary care trusts to spell out their plans for early identification of people with diabetes in their local area.","date":"2007-11-06","status":"c"},{"topic":"Diseases","id":"34136","proposer":"10527","edm":"46","session":"2007-08","title":"BRITISH HEART FOUNDATION'S DOUBT KILLS CAMPAIGN","text":"That this House welcomes the Doubt Kills campaign launched by the British Heart Foundation, which highlights the importance of recognising the early symptoms of a heart attack and promotes the importance of calling 999 immediately; notes that the campaign includes radio and television advertisements as well as a poster campaign with the heading Chest Pain is Your Body Saying Call 999; further notes that the average heart attack victim waits 90 minutes after the first mild symptoms arise to call for an ambulance and that the mortality rate is twice as high for patients treated four to six hours after the onset of symptoms as it is with patients treated within one to two hours; and calls on the Government to back the campaign.","date":"2007-11-06","status":"c"},{"topic":"Diseases","id":"34143","proposer":"10527","edm":"53","session":"2007-08","title":"Diabetes UK Your Vision Campaign And Access To Retinal Screening","text":"That this House welcomes Diabetes UK's campaign Your Vision; recognises that diabetes is the leading cause of blindness in the UK working age population; considers that all people with diabetes should have access to free annual retinal screening with a digital camera and that each primary care trust should have a systematic call and recall system to ensure that people with diabetes receive an annual letter inviting them for screening; notes with concern that Government targets of all people with diabetes being offered free digital retinal screening by the end of 2007 are not being met and as a result one in four (up to 470,000) people with diabetes in England are needlessly being put at risk of losing their sight; further notes that retinal screening is one of the most cost-effective interventions known in medicine, with 90 per cent. of cases of retinopathy being treatable with early intervention; and calls on the Government to ensure that primary care trusts put in place the appropriate facilities and allocate the necessary budget to their screening programme to prevent people with diabetes from needlessly losing their sight.","date":"2007-11-06","status":"c"},{"topic":"Diseases","id":"34151","proposer":"11924","edm":"61","session":"2007-08","title":"Epilepsy And Screen-Based Electronic Games","text":"That this House recognises that photosensitive epileptic seizures can be triggered by screen-based electronic games; notes with concern that there is no legal duty on computer game publishers to test their products before publication to make sure they do not trigger a seizure; further notes with concern that there is no legal requirement for computer game publishers to offer warnings that their products could trigger a seizure; and calls upon the Government to consider making it a legal requirement for computer game publishers to test their products before publication and to remove scenes that could potentially trigger a photosensitive epileptic seizure.","date":"2007-11-06","status":"c"},{"topic":"Diseases","id":"34177","proposer":"10571","edm":"87","session":"2007-08","title":"Screening For Abdominal Aortic Aneurysm","text":"That this House welcomes the Circulation Foundation's campaign on ultrasound screening for Abdominal Aortic Aneurysm (AAA); recognises that AAA, a widening and weakening of the main artery from the heart to the abdomen which causes massive internal bleeding when it bursts and is usually fatal, is the third most common cause of death for over-65s and that each year nearly 7,000 people, almost all of them men, die suddenly and without symptoms; notes the Vascular Society of Great Britain and Ireland's work on making information about screening available in a variety of formats so that 65 year old men can make an informed choice; and urges the Government to follow the lead of the USA and implement the independent National Screening Committee's recommendation for AAA screening for all men at 65 years, a procedure which has been found to be very accurate in identifying those at risk and referring them for preventative surgery.","date":"2007-11-06","status":"c"}]